    11186	RASSF1	0.42	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.962	2001	2018	  26	   0	BEFREE;CTD_human;LHGDN
    11186	RASSF1	0.42	0.808	C0001430	Adenoma	group	C04	Neoplastic Process	0.03	0.667	2005	2017	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0001618	Tumors of Adrenal Cortex	group	C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0003165	Anthracosis	disease	C08	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2004	2009	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0004997	Benign Ovarian Neoplasm	disease	C04;C13;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	0.941	2003	2019	  17	   1	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0005686	Urinary Bladder Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	0.947	2001	2019	  19	   1	BEFREE;CTD_human;LHGDN
    11186	RASSF1	0.42	0.808	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.10	0.986	2001	2019	  74	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.10	0.967	2001	2019	  90	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0007095	Carcinoid Tumor	phenotype	C04	Neoplastic Process	0.03	1	2001	2012	   3	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.10	1	2001	2015	  19	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.04	1	2016	2019	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.04	1	2006	2017	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007104	Female Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.06	1	2002	2017	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007124	Noninfiltrating Intraductal Carcinoma	disease	C04	Neoplastic Process	0.06	1	2003	2017	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007129	Merkel cell carcinoma	disease	C04;C01	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	0.947	2001	2020	  57	   0	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.10	0.867	2001	2019	  15	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.10	0.966	2002	2018	  29	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.03	1	2006	2020	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0007847	Malignant tumor of cervix	disease	C04;C13	Neoplastic Process	0.06	1	2003	2018	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0008372	Intrahepatic Cholestasis	disease	C06	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0008626	Congenital chromosomal disease	group	C16	Congenital Abnormality	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.02	1	2006	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.958	2002	2019	  24	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.04	1	2004	2008	   4	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0010633	Cystadenoma	disease	C04	Neoplastic Process	0.02	1	2005	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0010692	Cystitis	disease	C13;C12	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0010701	Phyllodes Tumor	disease	C04	Neoplastic Process	0.02	1	2009	2010	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0013080	Down Syndrome	disease	C16;C10	Disease or Syndrome	0.02	1	2014	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0013537	Eclampsia	disease	C13	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.01	1	2006	2006	   1	   0	LHGDN
    11186	RASSF1	0.42	0.808	C0014173	Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0014474	Ependymoma	disease	C04	Neoplastic Process	0.02	1	2005	2006	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0014599	Epithelial hyperplasia	disease	C23	Disease or Syndrome	0.01	1	2002	2002	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.05	1	2005	2016	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.03	1	2010	2015	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0016034	Breast Fibrocystic Disease	disease	C17	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.04	1	2003	2009	   4	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0018965	Hematuria	phenotype	C23;C13;C12	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0019163	Hepatitis B	disease	C06;C01	Disease or Syndrome	0.03	1	2008	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0019562	Von Hippel-Lindau Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.02	0.5	2003	2004	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0020295	Hydronephrosis	disease	C13;C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.32	1	2013	2019	   3	   0	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.03	1	2007	2019	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023269	leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.02	0.5	2005	2014	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.01	0	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023484	Leukemia, Plasma Cell	disease	C04;C20	Neoplastic Process	0.02	1	2003	2004	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023827	liposarcoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.07	1	2003	2020	   7	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.40	1	2000	2018	  27	   0	BEFREE;CTD_human;LHGDN
    11186	RASSF1	0.42	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024314	Lymphoproliferative Disorders	group	C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.10	1	2003	2019	  12	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.37	1	2002	2011	   7	   0	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.10	1	2003	2019	  12	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.02	1	2003	2007	   2	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.33	0.75	2001	2008	   4	   0	BEFREE;CTD_human;LHGDN
    11186	RASSF1	0.42	0.808	C0026277	Mixed Salivary Gland Tumor	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0026470	Monoclonal Gammopathy of Undetermined Significance	disease	C20;C15	Neoplastic Process	0.02	1	2004	2010	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.03	1	2003	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027059	Myocarditis	disease	C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.10	0.96	2004	2019	  25	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.10	0.974	2000	2020	 381	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.03	1	2003	2012	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.10	0.947	2001	2014	  19	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027831	Neurofibromatosis 1	disease	C16;C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027832	Neurofibromatosis 2	disease	C16;C04;C10;C09	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0027859	Acoustic Neuroma	disease	C04;C10;C09	Neoplastic Process	0.01	1	2007	2007	   1	   0	LHGDN
    11186	RASSF1	0.42	0.808	C0027962	Melanocytic nevus	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.03	1	2004	2016	   3	   1	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0030421	Paraganglioma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0030521	Parathyroid Neoplasms	group	C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0030793	Pelvic Neoplasms	group	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0030849	Penile Neoplasms	group	C04;C12	Neoplastic Process	0.01	1	2008	2008	   1	   0	LHGDN
    11186	RASSF1	0.42	0.808	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.03	1	2005	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	0.10	1	2001	2017	  12	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.03	1	2005	2012	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0033036	Atrial Premature Complexes	disease	C23;C14	Disease or Syndrome	0.03	1	2004	2017	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.04	1	2002	2008	   4	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0035078	Kidney Failure	disease	C13;C12	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0035335	Retinoblastoma	disease	C04;C11	Neoplastic Process	0.02	1	2005	2008	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0035436	Rheumatic Fever	disease	C01;C05	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0036323	Schistosomiasis	disease	C01	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.10	1	2017	2019	   2	   1	GWASCAT
    11186	RASSF1	0.42	0.808	C0036631	Seminoma	disease	C04	Neoplastic Process	0.02	1	2003	2018	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.02	1	2005	2007	   2	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0039101	synovial sarcoma	disease	C04	Neoplastic Process	0.02	1	2006	2010	   2	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0039483	Giant Cell Arteritis	disease	C17;C20;C10;C14	Disease or Syndrome	0.02	1	2009	2013	   2	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.09	1	2004	2017	   9	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0040137	Thyroid Nodule	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0040411	Tongue Neoplasms	group	C04;C07	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0042769	Virus Diseases	group	C01	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0079588	Ichthyosis, X-Linked	disease	C16;C18;C17	Disease or Syndrome	0.02	1	2005	2010	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.01	0	2004	2004	   1	   3	BEFREE
    11186	RASSF1	0.42	0.808	C0085136	Central Nervous System Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0085663	Plasmacytosis	disease	C23;C04	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0085695	Chronic gastritis	disease	C06	Disease or Syndrome	0.02	1	2003	2003	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.02	1	2006	2006	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0149826	Gastric adenoma	disease	C06;C04	Neoplastic Process	0.02	1	2003	2003	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.07	0.857	2001	2009	   7	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0151514	Atrophic condition of skin	group	C23;C17	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0151546	Oral Cavity Carcinoma	disease	C06;C04;C07	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.03	1	2003	2015	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.10	1	2002	2019	  11	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.05	1	2005	2016	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.01	1	2018	2018	   1	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0153594	Malignant neoplasm of testis	disease	C04;C12;C19	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0153601	Malignant neoplasm of penis	disease	C04;C12	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0155626	Acute myocardial infarction	disease	C23;C14	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0155826	Chronic nasopharyngitis	disease	C01;C08;C07;C09	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0175754	Agenesis of corpus callosum	disease	C23;C16;C10	Congenital Abnormality	0.03	1	2005	2014	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.05	1	2005	2012	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0205700	Asymmetric Septal Hypertrophy	disease	C23;C16;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0205770	Choroid Plexus Papilloma	disease	C04;C10	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0206623	Adenosquamous carcinoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.03	1	2007	2013	   3	   1	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0206627	Mixed Tumor, Mullerian	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206650	Fibroadenoma	disease	C04	Neoplastic Process	0.03	1	2004	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206659	Embryonal Carcinoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206663	Neuroectodermal Tumor, Primitive	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206677	Adenomatous Polyps	disease	C04	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206681	Adenocarcinoma, Clear Cell	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.04	1	2002	2017	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206685	Acinar Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206687	Carcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.02	1	2008	2008	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.04	1	2002	2005	   4	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0206701	Cystadenocarcinoma, Serous	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206704	Carcinoma, Large Cell	disease	C04	Neoplastic Process	0.02	1	2004	2009	   2	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C0206706	Verrucous carcinoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206708	Cervical Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.02	1	2012	2018	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206713	Papilloma, Intraductal	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0206743	Rhabdoid Tumor	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	LHGDN
    11186	RASSF1	0.42	0.808	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.05	1	2005	2018	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220597	Adult Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220613	Adult Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	2007	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220620	Gastrointestinal Carcinoid Tumor	disease	C06;C04;C19	Neoplastic Process	0.02	1	2004	2004	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.06	1	2007	2018	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220641	Lip and Oral Cavity Carcinoma	disease	C04;C07	Neoplastic Process	0.02	1	2005	2018	   2	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0220644	Childhood Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220645	Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	2007	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220650	Metastatic malignant neoplasm to brain	disease	C23;C04;C10	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220668	Congenital contractural arachnodactyly	disease	C16;C05	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0220756	Niemann-Pick Disease, Type C	disease	C16;C18;C10;C15	Disease or Syndrome	0.03	1	2003	2011	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0221228	Comedone	disease	C17	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0235653	Malignant neoplasm of female breast	disease	C04;C17	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0235782	Gallbladder Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2007	2007	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.02	1	2003	2016	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0238348	Squamous cell carcinoma of penis	disease	C04;C12	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0238461	Anaplastic thyroid carcinoma	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.07	0.857	2002	2014	   7	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.938	2001	2019	  64	   1	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0242596	Neoplasm, Residual	phenotype	C23;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0260037	Multiple tumors	phenotype	C04	Neoplastic Process	0.02	1	2006	2016	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.02	1	2010	2017	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0264490	Acute respiratory failure	disease	C23;C18;C08	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0265264	Holt-Oram syndrome	disease	C16;C05;C14	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0276289	Zika Virus Infection	disease	C01	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278488	Carcinoma breast stage IV	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278504	Non-small cell lung cancer stage I	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.36	1	2002	2011	   6	   0	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0278607	Adult Leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278660	Adult Synovial Sarcoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278704	Malignant Childhood Neoplasm	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278764	Adult Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278802	Recurrent Endometrial Cancer	disease	C04;C13	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278874	Adult Ependymoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.36	1	2002	2011	   6	   0	BEFREE;CTD_human
    11186	RASSF1	0.42	0.808	C0278877	Adult Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278879	Childhood Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279068	Childhood Solid Neoplasm	phenotype		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.10	1	2003	2017	  11	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0279671	Cervical Squamous Cell Carcinoma	disease	C04;C13	Neoplastic Process	0.04	1	2006	2013	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279672	Cervical Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.02	1	2006	2007	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.10	0.786	2001	2019	  14	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279982	Childhood Synovial Sarcoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0279986	Childhood Leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0280099	Adult Solid Neoplasm	group		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.07	0.857	2002	2014	   7	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0280255	stage, endometrial carcinoma	phenotype	C04;C13	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.03	1	2005	2014	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0302592	Cervix carcinoma	disease	C04;C13	Neoplastic Process	0.07	1	2003	2018	   7	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0333693	Triploidy syndrome	disease	C23	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0333875	High-Grade Squamous Intraepithelial Lesions	phenotype	C23;C04;C13	Neoplastic Process	0.02	1	2007	2010	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0334037	Intestinal metaplasia	phenotype		Disease or Syndrome	0.02	1	2009	2015	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0334287	Fibrolamellar Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0334294	Multiple adenomatous polyps	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0334463	Malignant Fibrous Histiocytoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0334489	Pancreatoblastoma	disease	C06;C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.08	0.875	2003	2018	   8	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.02	1	2005	2005	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.03	0.667	2010	2014	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0346156	Benign neoplasm of breast	disease	C04;C17	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.02	1	2003	2016	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0349578	Complex Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.10	1	2001	2019	  24	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0376544	Hematopoietic Neoplasms	group	C04;C15	Neoplastic Process	0.01	0	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.09	1	2006	2017	   9	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.04	1	2005	2013	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0521158	Recurrent tumor	phenotype		Neoplastic Process	0.03	1	2008	2011	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.05	1	2005	2016	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.10	1	2002	2017	  10	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.02	1	2009	2013	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.03	1	2004	2016	   3	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.10	0.97	2001	2019	  67	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0598608	Hyperhomocysteinemia	disease	C16;C18	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0598790	lung sarcoma	disease	C04;C08	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0600041	Infective cystitis	disease	C23;C13;C01;C12	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.10	1	2001	2019	  25	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.04	1	2011	2018	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0677898	invasive cancer	phenotype	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0677944	Sentinel node (disorder)	disease		Disease or Syndrome	0.02	1	2016	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0677950	Stage IV Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.10	1	2001	2019	  65	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.10	0.923	2001	2019	  52	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0685053	Carcinoma in situ of lung	disease	C04;C08	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.10	0.9	2005	2019	  10	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.04	1	2016	2019	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2003	2019	  13	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.10	0.944	2001	2019	  18	   1	BEFREE
    11186	RASSF1	0.42	0.808	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.10	1	2001	2014	  18	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.04	1	2002	2016	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0796611	Newly Diagnosed Childhood Ependymoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.03	1	2005	2012	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0850639	premalignant lesion	phenotype		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0852036	Pregnancy associated hypertension	phenotype	C13;C14	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0853105	Penis carcinoma	disease	C04;C12	Neoplastic Process	0.02	1	2008	2008	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0853879	Invasive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0854985	Adenocarcinoma of lung, stage I	disease		Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0855197	Malignant Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0878500	Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.10	1	2001	2018	  12	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0949541	Hurthle Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C0949804	Polyomavirus Infections	group	C01	Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1135868	Gestational Trophoblastic Neoplasms	group	C04;C13	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.10	1	2001	2019	  12	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1168327	High-Grade Prostatic Intraepithelial Neoplasia	disease	C04;C12	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.05	1	2002	2016	   5	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C1261473	Sarcoma	group	C04	Neoplastic Process	0.03	1	2005	2012	   3	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C1266184	Atypical Teratoid Rhabdoid Tumor	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	0.933	2002	2019	  15	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C1302401	Adenoma of large intestine	disease	C06;C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1302773	Low Grade Squamous Intraepithelial Neoplasia	disease	C23;C04;C13	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.971	2001	2019	  68	   1	BEFREE
    11186	RASSF1	0.42	0.808	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.923	2001	2019	  52	   1	BEFREE
    11186	RASSF1	0.42	0.808	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2001	2011	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1332347	Atypical Ductal Breast Hyperplasia	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.03	1	2004	2016	   3	   1	BEFREE
    11186	RASSF1	0.42	0.808	C1333001	Childhood Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1333015	Childhood Kidney Wilms Tumor	disease	C16;C04;C13;C12	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1333125	combined type small cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1333620	Flat Ductal Epithelial Atypia of the Breast	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1333762	Gastric Cardia Adenocarcinoma	disease		Neoplastic Process	0.02	1	2009	2013	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1334177	Infiltrating Cervical Carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1334274	Invasive Carcinoma	phenotype	C04	Neoplastic Process	0.02	1	2012	2014	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1334358	Lacrimal Gland Carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1334455	Pulmonary Sclerosing Hemangioma	disease	C04;C08	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1334953	Neuroblastic tumors	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1335059	testicular nonseminoma	disease		Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1336538	Supratentorial Embryonal Tumor, Not Otherwise Specified	disease	C04;C10	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.02	1	2018	2020	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.03	1	2003	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1378050	Oncocytic Neoplasm	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.03	1	2004	2016	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1395512	Placental dysfunction	disease		Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1397307	Cardiac fibrosis	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1449861	Micronuclei, Chromosome-Defective	phenotype	C23	Cell Component	0.30	1	2016	2016	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C1449862	Micronuclei, Genotoxicant-Induced	phenotype	C23	Cell Component	0.30	1	2016	2016	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.10	1	2001	2014	  20	   0	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C1510502	Oxyphilic Adenoma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1512409	Hepatocarcinogenesis	disease	C23;C04	Neoplastic Process	0.06	1	2008	2019	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1531608	Smoldering myeloma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.02	1	2015	2016	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1569637	Adenocarcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.04	1	2008	2012	   4	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1611743	Familial (FPAH)	disease		Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.06	1	2003	2020	   6	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.02	1	2004	2015	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1704423	Milroy Disease	disease	C15	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1737250	Progression of non-small cell lung cancer	disease		Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1762616	Meningioma, benign, no ICD-O subtype	disease	C04;C10	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1850900	Familial primary gastric lymphoma	disease	C06;C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1851584	Childhood Ependymoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1851841	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	disease	C16;C17;C05;C07	Disease or Syndrome	0.02	1	2008	2013	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2145472	Urothelial Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2006	2020	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2216702	malignant neoplasm of breast staging	disease	C04;C17	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.979	2002	2020	  48	   1	BEFREE;LHGDN
    11186	RASSF1	0.42	0.808	C2350019	Solitary Pulmonary Nodule	disease	C08	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2698045	Merkel Cell Polyomavirus Infection	disease	C01	Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.02	1	2005	2010	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2826323	Refractory Cytopenia of Childhood	disease		Neoplastic Process	0.01	0	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2931189	Neural crest tumor	disease	C04;C19	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2931618	Gestational trophoblastic disease	disease	C04;C13	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.10	0.909	2001	2018	  22	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2931852	Clear-cell metastatic renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	0.5	2001	2004	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.03	0.667	2004	2016	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C2986665	Early-Stage Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2009	2013	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3146251	Stage IV Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3495917	Advanced breast cancer	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.02	1	2007	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3665593	Melanocytic nevus of skin	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3714514	Infection	group	C01	Pathologic Function	0.01	1	2003	2003	   1	   0	LHGDN
    11186	RASSF1	0.42	0.808	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.02	1	2005	2005	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3898127	Non-Metastatic Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	2007	2012	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C3900097	Adult Penile Carcinoma	disease	C04;C12	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4048306	Multiple endocrine neoplasia Type 2	disease	C16;C04;C19	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.09	1	2001	2018	   9	   1	BEFREE
    11186	RASSF1	0.42	0.808	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.10	1	2001	2014	  18	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4525297	Stage 0 Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4525300	Stage IIA Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4525301	Stage IIB Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4525302	Stage III Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4525305	Stage IV Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4529962	Fatty Liver Disease	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    11186	RASSF1	0.42	0.808	C4551683	Adrenal Gland Pheochromocytoma	disease	C04;C19	Neoplastic Process	0.03	1	2005	2010	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4551687	Sarcoma of soft tissue	group	C04	Neoplastic Process	0.03	1	2005	2012	   3	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.10	1	2001	2019	  15	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.10	1	2002	2019	  10	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4722419	Extrapulmonary Small Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    11186	RASSF1	0.42	0.808	C4733095	HER2-negative breast cancer	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2001	   1	   0	BEFREE;PSYGENET
     5335	PLCG1	0.564	0.692	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.10	1	2019	2019	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0005890	Body Height	phenotype		Organism Attribute	0.10	1	2019	2019	   1	   0	GWASCAT
     5335	PLCG1	0.564	0.692	C0006012	Borderline Personality Disorder	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.05	1	2008	2019	   5	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0006287	Bronchopulmonary Dysplasia	disease	C16;C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.16	1	2012	2019	   7	   1	BEFREE;GWASCAT
     5335	PLCG1	0.564	0.692	C0006849	Oral candidiasis	disease	C01;C07	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0007097	Carcinoma	group	C04	Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.02	1	2009	2017	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0009319	Colitis	disease	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.05	1	1994	2018	   5	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	LHGDN
     5335	PLCG1	0.564	0.692	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0011847	Diabetes	disease	C19	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.20	1	2007	2007	   1	   0	RGD
     5335	PLCG1	0.564	0.692	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.02	1	1992	1997	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.03	1	2015	2019	   3	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0016667	Fragile X Syndrome	disease	C16;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0017638	Glioma	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.55	1	2014	2017	   5	   0	BEFREE;CGI;CTD_human
     5335	PLCG1	0.564	0.692	C0018935	Hematocrit procedure	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0020725	Type II Mucolipidosis	disease	C16;C18;C05;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0020981	Angioimmunoblastic Lymphadenopathy	disease	C20;C15	Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0021053	Immune System Diseases	group	C20	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0021122	Disruptive, Impulse Control, and Conduct Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0022680	Polycystic Kidney Diseases	group	C16;C13;C12	Disease or Syndrome	0.20	1	2002	2002	   1	   0	RGD
     5335	PLCG1	0.564	0.692	C0023418	leukemia	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	LHGDN
     5335	PLCG1	0.564	0.692	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.02	1	2009	2017	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.31	1	2015	2018	   2	   0	BEFREE;CTD_human
     5335	PLCG1	0.564	0.692	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.09	1	2007	2020	   9	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0027651	Neoplasms	group	C04	Neoplastic Process	0.10	0.909	2008	2019	  11	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.02	0.5	2015	2018	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0036220	Kaposi Sarcoma	disease	C04;C01	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.32	0.667	2015	2020	   3	   0	BEFREE;CTD_human
     5335	PLCG1	0.564	0.692	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0042109	Urticaria	disease	C17;C20	Disease or Syndrome	0.01	1	2015	2015	   1	   1	BEFREE
     5335	PLCG1	0.564	0.692	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.35	1	2014	2020	   6	   0	BEFREE;CTD_human
     5335	PLCG1	0.564	0.692	C0085281	Addictive Behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0153676	Secondary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.03	1	2008	2019	   3	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0162823	Dermatitis, Irritant	disease	C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.02	1	2008	2017	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0202117	Low density lipoprotein cholesterol measurement	phenotype		Laboratory Procedure	0.10	1	2018	2018	   1	   0	GWASCAT
     5335	PLCG1	0.564	0.692	C0202236	Triglycerides measurement	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0278592	Adult Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0279988	Childhood Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0337438	Glucose measurement	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.02	1	1992	1993	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0342418	Hypothalamic hamartomas	disease	C04;C10	Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0345907	Angiosarcoma of liver	disease	C06;C04;C14	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0349631	Richter's syndrome	disease	C04;C20;C15	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5335	PLCG1	0.564	0.692	C0392885	High density lipoprotein measurement	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0406484	Sebaceous hyperplasia	disease	C23;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0428883	Diastolic blood pressure	phenotype		Clinical Attribute	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0495706	elevated blood glucose level	phenotype		Finding	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0518015	Hemoglobin measurement	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.02	1	2011	2016	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0549463	X-Linked Lymphoproliferative Disorder	disease	C20;C15	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.04	1	2007	2019	   4	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.02	1	2008	2009	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   1	BEFREE
     5335	PLCG1	0.564	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.05	1	2008	2019	   5	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2009	2017	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0862196	Mycosis fungoides/Sezary syndrome NOS	disease	C04;C20;C15	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C0871470	Systolic Pressure	phenotype		Clinical Attribute	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.06	1	2008	2019	   6	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1305855	Body mass index	phenotype		Clinical Attribute	0.10	1	2016	2016	   1	   1	GWASCAT
     5335	PLCG1	0.564	0.692	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.04	1	2012	2018	   4	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1445957	Serum total cholesterol measurement	phenotype		Laboratory Procedure	0.10	1	2010	2019	   5	   2	GWASCAT;GWASDB
     5335	PLCG1	0.564	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.10	1	2018	2018	   1	   0	GWASCAT
     5335	PLCG1	0.564	0.692	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5335	PLCG1	0.564	0.692	C2674173	Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans	disease	C16;C05	Congenital Abnormality	0.01	0	2018	2018	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.03	1	2013	2019	   3	   0	BEFREE
     5335	PLCG1	0.564	0.692	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.04	1	2009	2020	   4	   0	BEFREE
     5335	PLCG1	0.564	0.692	C3642345	Luminal A Breast Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C4287864	MAGT1 Deficiency	disease	C20	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5335	PLCG1	0.564	0.692	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.02	1	2014	2019	   2	   1	BEFREE
     5335	PLCG1	0.564	0.692	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
	  369	ARAF	0.619	0.654	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE;LHGDN
      369	ARAF	0.619	0.654	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.07	1	2005	2018	   7	   1	BEFREE
      369	ARAF	0.619	0.654	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.02	1	2009	2015	   2	   0	BEFREE
      369	ARAF	0.619	0.654	C0017638	Glioma	disease	C04	Neoplastic Process	0.02	1	2009	2011	   2	   0	BEFREE
      369	ARAF	0.619	0.654	C0019618	Histiocytosis	disease	C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0019621	Histiocytosis, Langerhans-Cell	disease	C08;C15	Neoplastic Process	0.03	1	2014	2015	   3	   0	BEFREE
      369	ARAF	0.619	0.654	C0019624	Histiocytosis, Non-Langerhans-Cell	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0023643	Lichen disease	disease	C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0025202	melanoma	disease	C04	Neoplastic Process	0.03	1	2010	2014	   3	   0	BEFREE
      369	ARAF	0.619	0.654	C0026946	Mycoses	group	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0027651	Neoplasms	group	C04	Neoplastic Process	0.04	1	2011	2019	   4	   0	BEFREE
      369	ARAF	0.619	0.654	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0041296	Tuberculosis	disease	C01	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0085568	Buruli Ulcer	disease	C01;C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0085669	Acute leukemia	disease	C23;C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
      369	ARAF	0.619	0.654	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.41	1	2014	2016	   2	   2	BEFREE;CGI;CLINVAR
      369	ARAF	0.619	0.654	C0162835	Hypopigmentation disorder	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
      369	ARAF	0.619	0.654	C0242621	Isochromosomes	phenotype	C23	Acquired Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0265449	Pallister-Killian syndrome	disease	C16	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0268468	Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency	disease	C23;C16;C18;C10;F01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0334287	Fibrolamellar Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.03	1	2009	2018	   3	   0	BEFREE
      369	ARAF	0.619	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
      369	ARAF	0.619	0.654	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0796663	Childhood Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C0848332	Spots on skin	phenotype	C17	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
      369	ARAF	0.619	0.654	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.07	1	2005	2018	   7	   1	BEFREE
      369	ARAF	0.619	0.654	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
      369	ARAF	0.619	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      369	ARAF	0.619	0.654	C1336078	Papillary renal cell carcinoma, sporadic	disease	C04;C13;C12	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
      369	ARAF	0.619	0.654	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C1844777	CONE DYSTROPHY, X-LINKED, 1	disease	C16;C11	Disease or Syndrome	0.01	1	1994	1994	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.04	1	2014	2019	   4	   0	BEFREE
      369	ARAF	0.619	0.654	C3899655	Childhood Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C3900100	Adult Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      369	ARAF	0.619	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C4727838	Advanced Melanoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.02	1	2014	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.10	1	1968	2013	   8	   2	CLINVAR
      673	BRAF	0.319	0.846	C0001206	Acromegaly	disease	C05;C10;C19	Disease or Syndrome	0.03	1	2014	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.10	0.947	2002	2019	  75	   3	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0001430	Adenoma	group	C04	Neoplastic Process	0.10	0.981	2002	2019	  52	   2	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0001546	Adjustment Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0002448	Ameloblastoma	disease	C04	Neoplastic Process	0.40	0.955	2014	2019	  22	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0002792	anaphylaxis	phenotype	C20	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0002793	Anaplasia	disease	C23;C04	Neoplastic Process	0.10	1	2005	2019	  13	   2	BEFREE
      673	BRAF	0.319	0.846	C0003175	Anthrax disease	disease	C01	Disease or Syndrome	0.03	1	2005	2008	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0003463	Anus Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0003492	Aortic coarctation	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0003857	Congenital arteriovenous malformation	disease	C16;C14	Congenital Abnormality	0.03	1	2018	2020	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0003862	Arthralgia	phenotype	C23;C05	Sign or Symptom	0.03	1	2012	2015	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0003864	Arthritis	disease	C05	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0003872	Arthritis, Psoriatic	disease	C17;C05	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.06	1	2010	2019	   6	   0	BEFREE
      673	BRAF	0.319	0.846	C0004045	Asphyxia Neonatorum	disease	C16	Disease or Syndrome	0.10	1	2006	2009	   3	   1	CLINVAR
      673	BRAF	0.319	0.846	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.40	1	2008	2019	  26	   2	BEFREE;CTD_human;LHGDN
      673	BRAF	0.319	0.846	C0004135	Ataxia Telangiectasia	disease	C16;C18;C20;C10;C14	Disease or Syndrome	0.04	1	2017	2019	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0004565	Melanoma, B16	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.02	1	2011	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.03	1	2009	2015	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0005745	Blepharoptosis	disease	C11	Disease or Syndrome	0.10				   0	   2	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.50	1	2010	2019	  29	   4	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2007	2020	  11	   3	BEFREE;CGI
      673	BRAF	0.319	0.846	C0006281	Congenital bronchogenic cyst	disease	C16;C04;C08	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0006384	Bundle-Branch Block	disease	C23;C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.982	2002	2020	 384	   7	BEFREE;CGI
      673	BRAF	0.319	0.846	C0007095	Carcinoid Tumor	phenotype	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0007097	Carcinoma	group	C04	Neoplastic Process	0.10	0.968	2003	2019	  93	   2	BEFREE
      673	BRAF	0.319	0.846	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.971	2003	2019	 104	   6	BEFREE;UNIPROT
      673	BRAF	0.319	0.846	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.08	1	2005	2016	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.43	0.75	2006	2016	   4	   8	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0007113	Rectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.947	2009	2019	  19	   2	BEFREE
      673	BRAF	0.319	0.846	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.02	0.5	2015	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.40	0.994	2003	2019	 159	   2	BEFREE;CGI
      673	BRAF	0.319	0.846	C0007120	Bronchioloalveolar Adenocarcinoma	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0007129	Merkel cell carcinoma	disease	C04;C01	Neoplastic Process	0.01	0	2006	2006	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0007130	Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.07	0.857	2004	2017	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.50	1	2002	2020	 127	  17	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0007133	Carcinoma, Papillary	disease	C04	Neoplastic Process	0.10	0.925	2003	2018	  40	   3	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.04	1	2003	2016	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.10	0.955	2003	2019	  22	   2	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0007140	Carcinosarcoma	disease	C04	Neoplastic Process	0.03	1	2016	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.12	1	2006	2016	   4	   2	BEFREE;CLINVAR;HPO
      673	BRAF	0.319	0.846	C0007682	CNS disorder	group	C10	Disease or Syndrome	0.02	1	2019	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0007762	Cerebellar Neoplasms	group	C04;C10	Neoplastic Process	0.02	1	2010	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0008309	Bile duct adenoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0008487	Chordoma	disease	C04	Neoplastic Process	0.02	0	2009	2011	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0008497	Choriocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0008626	Congenital chromosomal disease	group	C16	Congenital Abnormality	0.04	0.75	2006	2013	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0009075	Melanoma, Cloudman S91	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2009	2009	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0009319	Colitis	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.20	0.952	2003	2019	  21	   2	BEFREE;CLINVAR;LHGDN
      673	BRAF	0.319	0.846	C0009376	Colonic Polyps	phenotype	C23	Anatomical Abnormality	0.03	1	2016	2017	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.976	2002	2020	 622	  10	BEFREE;CLINVAR;CTD_human;UNIPROT
      673	BRAF	0.319	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.50	0.978	2002	2019	  93	  11	BEFREE;CLINVAR;CTD_human;LHGDN
      673	BRAF	0.319	0.846	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.01	1	2005	2005	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0009681	Anomalous pulmonary artery	disease	C16;C08	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0009761	Conjunctival Neoplasms	group	C04;C11	Neoplastic Process	0.01	1	2004	2004	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0009806	Constipation	phenotype	C23	Sign or Symptom	0.11	1	2004	2004	   1	   1	BEFREE;HPO
      673	BRAF	0.319	0.846	C0010276	Craniopharyngioma	disease	C04	Neoplastic Process	0.60	1	2014	2019	  14	   2	BEFREE;CTD_human;ORPHANET
      673	BRAF	0.319	0.846	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0010633	Cystadenoma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0010635	Cystadenoma, Mucinous	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0010823	Cytomegalovirus Infections	group	C01	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0011168	Deglutition Disorders	group	C06;C09	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0011603	Dermatitis	disease	C17	Disease or Syndrome	0.02	1	2015	2017	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0011649	Dermoid Cyst	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	1	2017	2017	   1	   1	CTD_human;GWASCAT;HPO
      673	BRAF	0.319	0.846	C0011991	Diarrhea	phenotype	C23	Sign or Symptom	0.02	1	2012	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0012739	Disseminated Intravascular Coagulation	disease	C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0013274	Patent ductus arteriosus	disease	C16;C14	Congenital Abnormality	0.12	1	2012	2015	   2	   3	BEFREE;HPO
      673	BRAF	0.319	0.846	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0013362	Dysarthria	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0013403	Dysplastic Nevus Syndrome	disease	C16;C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0014116	Endocardial Cushion Defects	group	C16;C14	Congenital Abnormality	0.10	1	2012	2019	  35	   3	BEFREE
      673	BRAF	0.319	0.846	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.01	1	2007	2007	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.04	1	2005	2018	   4	   0	BEFREE
      673	BRAF	0.319	0.846	C0014457	Eosinophilia	disease	C15	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0014474	Ependymoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0014511	Epithelial cyst	phenotype	C04	Anatomical Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.05	0.8	2011	2017	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0014547	Epilepsies, Partial	disease	C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0014743	Erythema Nodosum	disease	C17;C20;C25	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0014850	Esophageal Atresia	disease	C16;C06	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0015230	Exanthema	phenotype	C17	Sign or Symptom	0.03	1	2011	2015	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0015300	Exophthalmos	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0015414	Eye Neoplasms	group	C04;C11	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0015519	Factor X Deficiency	disease	C16;C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0015526	Factor XII Deficiency	disease	C16;C15	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0015672	Fatigue	phenotype	C23	Sign or Symptom	0.02	1	2018	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0015967	Fever	phenotype	C23	Sign or Symptom	0.03	1	2019	2020	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0016045	fibroma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0016057	Fibrosarcoma	disease	C04	Neoplastic Process	0.03	1	2003	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0016689	Freckles	phenotype	C17	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0016842	Congenital pectus excavatum	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0017168	Gastroesophageal reflux disease	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0017416	Genital Neoplasms, Female	group	C04;C13	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0017525	Giant Cell Tumors	group	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.20	1	2004	2019	  28	   4	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.60	1	2005	2020	  33	   2	BEFREE;CGI;CTD_human
      673	BRAF	0.319	0.846	C0017653	Glomus Tumor	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0017925	Glycogen Storage Disease Type VI	disease	C16;C18	Disease or Syndrome	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0018021	Goiter	phenotype	C19	Disease or Syndrome	0.02	1	2004	2012	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0018023	Nodular Goiter	disease	C19	Disease or Syndrome	0.02	1	2003	2004	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0018202	Granulomatous Angiitis	disease	C20;C10;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0018552	Hamartoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0018598	Melanoma, Harding-Passey	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0018681	Headache	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0018817	Atrial Septal Defects	group	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0018818	Ventricular Septal Defects	group	C16;C14	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0018920	Hemangioma, Cavernous	disease	C04;C15;C14	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0018932	Hematochezia	phenotype	C23;C06	Disease or Syndrome	0.01	1	2004	2004	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0019618	Histiocytosis	disease	C15	Neoplastic Process	0.10	1	2012	2019	  12	   2	BEFREE
      673	BRAF	0.319	0.846	C0019621	Histiocytosis, Langerhans-Cell	disease	C08;C15	Neoplastic Process	0.80	1	2010	2019	  60	   2	BEFREE;CGI;MGD;ORPHANET
      673	BRAF	0.319	0.846	C0019623	Malignant histiocytosis	disease	C04;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0019624	Histiocytosis, Non-Langerhans-Cell	disease	C15	Disease or Syndrome	0.03	1	2015	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0019625	Sinus histiocytosis	disease	C15	Disease or Syndrome	0.02	0.5	2018	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0020224	Polyhydramnios	phenotype	C13	Pathologic Function	0.10	1	2008	2008	   1	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0020255	Hydrocephalus	disease	C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0020295	Hydronephrosis	disease	C13;C12	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0020437	Hypercalcemia	disease	C18	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0020505	Hyperphagia	phenotype	C23	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0020534	Orbital separation excessive	phenotype	C16;C05	Finding	0.10	1	2006	2006	   2	   4	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0020625	Hyponatremia	phenotype	C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0020676	Hypothyroidism	disease	C19	Disease or Syndrome	0.02	1	2008	2011	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0020757	Ichthyoses	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0020981	Angioimmunoblastic Lymphadenopathy	disease	C20;C15	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0021432	Infratentorial Neoplasms	group	C04;C10	Neoplastic Process	0.02	1	2012	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0021670	insulinoma	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0022572	keratoacanthoma	disease	C17	Neoplastic Process	0.07	1	2012	2017	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0022593	Keratosis	disease	C17	Disease or Syndrome	0.04	1	2007	2015	   4	   1	BEFREE
      673	BRAF	0.319	0.846	C0022602	Actinic keratosis	disease	C04;C17	Neoplastic Process	0.02	0.5	2009	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.34	1	2011	2017	   4	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0022672	Acute Kidney Tubular Necrosis	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0023381	Letterer-Siwe Disease	disease	C08;C15	Disease or Syndrome	0.20				   0	   0	MGD
      673	BRAF	0.319	0.846	C0023418	leukemia	disease	C04	Neoplastic Process	0.49	1	1995	2018	  12	   4	BEFREE;CLINVAR;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.47	0.9	2007	2019	  10	   8	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0023443	Hairy Cell Leukemia	disease	C04;C20;C15	Neoplastic Process	0.60	0.938	2011	2020	  65	   2	BEFREE;CGI;ORPHANET
      673	BRAF	0.319	0.846	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2011	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.03	1	2013	2016	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.05	1	2005	2018	   5	   0	BEFREE
      673	BRAF	0.319	0.846	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.43	1	2011	2015	   5	   1	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0023480	Leukemia, Myelomonocytic, Chronic	disease	C04;C15	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0023484	Leukemia, Plasma Cell	disease	C04;C20	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0023486	Prolymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0023501	Leukemoid Reaction	disease	C15	Disease or Syndrome	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0023518	Leukocytosis	phenotype	C23;C15	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0023530	Leukopenia	disease	C15	Disease or Syndrome	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.33	1	2003	2015	   4	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.55	1	2004	2017	   5	   3	BEFREE;CGI;CTD_human;LHGDN
      673	BRAF	0.319	0.846	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2018	2018	   2	   0	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0024236	Lymphedema	disease	C15	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0024291	Lymphohistiocytosis, Hemophagocytic	disease	C15	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.37	0.857	2012	2018	   7	   2	BEFREE;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.02	1	2015	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2015	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.32	1	2003	2017	   2	   3	BEFREE;CGI
      673	BRAF	0.319	0.846	C0024312	Lymphopenia	disease	C20;C15	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0024314	Lymphoproliferative Disorders	group	C20;C15	Neoplastic Process	0.03	1	2012	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0024419	Waldenstrom Macroglobulinemia	disease	C04;C20;C15;C14	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0024433	Macrostomia	disease	C16;C07	Congenital Abnormality	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.38	1	2003	2018	   8	   0	BEFREE;CGI
      673	BRAF	0.319	0.846	C0024636	Malocclusion	disease	C07	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0024694	Mandibular Neoplasms	group	C04;C05;C07	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0024796	Marfan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0024814	Marinesco-Sjogren syndrome	disease	C16;C10	Disease or Syndrome	0.10	1	2006	2019	  11	   2	BEFREE
      673	BRAF	0.319	0.846	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	1.00	0.983	1986	2020	1637	  35	BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN;MGD;UNIPROT
      673	BRAF	0.319	0.846	C0025205	Melanoma, Experimental	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0025209	Melanosis	disease	C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0025362	Mental Retardation	disease	C23;C16;C10;F03;F01	Mental or Behavioral Dysfunction	0.01	0	2009	2009	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0025990	Micrognathism	disease	C16;C05;C07	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0026010	Microphthalmos	disease	C16;C11	Congenital Abnormality	0.02	0.5	2008	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0026106	Mild Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0026267	Mitral Valve Prolapse Syndrome	disease	C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0026277	Mixed Salivary Gland Tumor	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0026499	Monosomy	group	C23	Congenital Abnormality	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.10	1	1968	2013	   8	   1	CLINVAR
      673	BRAF	0.319	0.846	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.50	0.944	2003	2019	  18	  13	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0026826	Muscle Hypertonia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0026827	Muscle hypotonia	phenotype	C23;C10	Finding	0.10	1	1968	2013	   8	   7	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0026985	Myelodysplasia	disease		Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0027092	Myopia	disease	C11	Disease or Syndrome	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0027430	Nasal Polyps	disease	C23;C08;C09	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0027498	Nausea and vomiting	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.02	1	2013	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.10	0.932	2003	2020	 280	   6	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0027651	Neoplasms	group	C04	Neoplastic Process	0.20	0.946	2002	2020	1388	  20	BEFREE;CLINVAR;HPO
      673	BRAF	0.319	0.846	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0027666	Neoplasms, Radiation-Induced	phenotype	C04;C26	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0027672	Neoplastic Syndromes, Hereditary	group	C16;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.02	1	2017	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.02	1	2008	2017	   2	   0	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0027766	Nervous System Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.03	0.667	2013	2015	   3	   3	BEFREE
      673	BRAF	0.319	0.846	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.20	1	2006	2017	  11	   2	BEFREE;HPO
      673	BRAF	0.319	0.846	C0027830	neurofibroma	disease	C04;C10	Neoplastic Process	0.02	1	2015	2017	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0027831	Neurofibromatosis 1	disease	C16;C04;C10	Neoplastic Process	0.10	0.938	2009	2019	  16	   2	BEFREE
      673	BRAF	0.319	0.846	C0027859	Acoustic Neuroma	disease	C04;C10;C09	Neoplastic Process	0.01	0	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0027947	Neutropenia	disease	C15	Disease or Syndrome	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0027960	Nevus	disease	C04	Neoplastic Process	0.10	0.826	2003	2018	  23	   3	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0027962	Melanocytic nevus	disease	C04	Neoplastic Process	0.50	0.892	2003	2019	  65	   6	BEFREE;CLINVAR;GENOMICS_ENGLAND;HPO;LHGDN
      673	BRAF	0.319	0.846	C0028259	Nodule	phenotype		Acquired Abnormality	0.06	1	2010	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.77	1	2003	2019	  34	  18	BEFREE;CLINGEN;CLINVAR;CTD_human;GENOMICS_ENGLAND;ORPHANET
      673	BRAF	0.319	0.846	C0028738	Nystagmus	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0028880	Odontogenic Tumors	group	C04	Neoplastic Process	0.02	1	2014	2017	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0028945	oligodendroglioma	disease	C04	Neoplastic Process	0.06	1	2012	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0029124	Optic Atrophy	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0029166	Oral Manifestations	phenotype	C23;C07	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0029182	orbit (eye disorders)	group	C11	Disease or Syndrome	0.02	1	2016	2020	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0029295	Oropharyngeal Neoplasms	group	C04;C07;C09	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.34	1	2003	2014	   4	   2	BEFREE;CGI
      673	BRAF	0.319	0.846	C0030283	Pancreatic Cyst	disease	C06;C04	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.02	1	2003	2014	   2	   0	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.01	1	2008	2008	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0030326	Panniculitis	disease	C17	Disease or Syndrome	0.05	1	2012	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0030353	Papilledema	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0030354	Papilloma	disease	C04	Neoplastic Process	0.05	1	2014	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0030421	Paraganglioma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0031117	Peripheral Neuropathy	group	C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0031941	Pineal Gland Neoplasm	disease	C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0032019	Pituitary Neoplasms	group	C04;C10;C19	Neoplastic Process	0.01	1	2007	2007	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0032131	Plasmacytoma	disease	C04;C20	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	0.10	1	2002	2019	  11	   3	BEFREE
      673	BRAF	0.319	0.846	C0032584	polyps	phenotype	C23	Anatomical Abnormality	0.10	0.977	2003	2019	  43	   2	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0032897	Prader-Willi Syndrome	disease	C16;C18;C10	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.01	1	2003	2003	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0033036	Atrial Premature Complexes	disease	C23;C14	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0033377	Ptosis	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2006	2018	   4	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0033626	Protein Deficiency	disease	C18	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0034012	Delayed Puberty	phenotype	C19	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0034089	Pulmonary Valve Stenosis	disease	C14	Disease or Syndrome; Anatomical Abnormality	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0034885	Rectal Neoplasms	group	C06;C04	Neoplastic Process	0.06	1	2004	2017	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0035290	Reticulohistiocytic granuloma	disease	C15	Neoplastic Process	0.02	1	2019	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0035309	Retinal Diseases	group	C11	Disease or Syndrome	0.11	1	2017	2017	   1	   0	BEFREE;HPO
      673	BRAF	0.319	0.846	C0035335	Retinoblastoma	disease	C04;C11	Neoplastic Process	0.05	1	2008	2018	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0036202	Sarcoidosis	disease	C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0036439	Scoliosis, unspecified	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.14	0.857	2006	2019	   7	   2	BEFREE;CLINVAR;HPO
      673	BRAF	0.319	0.846	C0036631	Seminoma	disease	C04	Neoplastic Process	0.03	1	2005	2016	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0037277	Skin Diseases, Genetic	group	C16;C17	Disease or Syndrome	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0037284	Skin lesion	group	C17	Disease or Syndrome	0.10	0.909	2009	2017	  11	   2	BEFREE
      673	BRAF	0.319	0.846	C0037285	Skin Manifestations	phenotype	C23	Sign or Symptom	0.01	1	2020	2020	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.06	0.833	2006	2018	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C0037287	Skin nodule	disease	C04;C17	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0037315	Sleep Apnea Syndromes	disease	C08;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0037579	Soft Tissue Neoplasms	group	C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0038002	Splenomegaly	phenotype	C23	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2003	2007	   2	   0	CGI;LHGDN
      673	BRAF	0.319	0.846	C0038379	Strabismus	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0038478	Struma Ovarii	disease	C04	Neoplastic Process	0.02	1	2007	2015	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0038874	Supratentorial Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0039103	Synovitis	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0039538	Teratoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0040100	Thymoma	disease	C04;C15	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0040128	Thyroid Diseases	group	C19	Disease or Syndrome	0.05	1	2005	2018	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.70	0.99	2003	2020	 208	   5	BEFREE;CGI;CLINVAR;CTD_human;LHGDN
      673	BRAF	0.319	0.846	C0040137	Thyroid Nodule	disease	C04;C19	Neoplastic Process	0.10	0.935	2004	2020	  77	   3	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0040147	Thyroiditis	disease	C19	Disease or Syndrome	0.04	0.75	2006	2014	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0041341	Tuberous Sclerosis	disease	C16;C04;C10	Neoplastic Process	0.03	0.333	2015	2017	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0041409	Turner Syndrome, Male	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0042164	Uveitis	disease	C11	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0042571	Vertigo	phenotype	C23;C10;C09	Sign or Symptom	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0042834	Vital capacity	phenotype		Clinical Attribute	0.10	1	2019	2019	   1	   1	GWASCAT
      673	BRAF	0.319	0.846	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.03	1	2015	2019	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0042963	Vomiting	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0043324	Juvenile Xanthogranuloma	disease	C17;C15	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0043346	Xeroderma Pigmentosum	disease	C16;C04;C18;C17	Congenital Abnormality	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0078918	Albinism, Oculocutaneous	disease	C16;C18;C11;C17	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0079218	Fibromatosis, Aggressive	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0079588	Ichthyosis, X-Linked	disease	C16;C18;C17	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.05	1	2011	2015	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   3	BEFREE
      673	BRAF	0.319	0.846	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0080032	Pleural Effusion, Malignant	disease	C04;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0080174	Spina Bifida Occulta	disease	C16;C10	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0085074	Granuloma Annulare	disease	C23;C17	Disease or Syndrome	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0085136	Central Nervous System Neoplasms	group	C04;C10	Neoplastic Process	0.10	1	2012	2019	  10	   2	BEFREE
      673	BRAF	0.319	0.846	C0085281	Addictive Behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.04	1	2003	2019	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0085653	Pyogenic granuloma	disease	C23	Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0085669	Acute leukemia	disease	C23;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0086437	Joint laxity	phenotype	C05	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.06	1	2005	2017	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0149722	Hutchinson's Melanotic Freckle	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.16	1	2007	2019	   7	   4	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0149978	Adenocarcinoma of rectum	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.36	1	2003	2019	  12	   3	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0151526	Premature Birth	phenotype	C13	Pathologic Function	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0151546	Oral Cavity Carcinoma	disease	C06;C04;C07	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0151611	Electroencephalogram abnormal	phenotype	C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0151718	Hypocholesterolemia	disease	C18	Disease or Syndrome	0.01	1	2009	2009	   1	   3	BEFREE
      673	BRAF	0.319	0.846	C0151740	Intracranial Hypertension	disease	C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.50	0.979	2003	2020	  94	  15	BEFREE;CGI;CLINVAR
      673	BRAF	0.319	0.846	C0151786	Muscle Weakness	phenotype	C23;C05;C10	Sign or Symptom	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0151811	Subcutaneous nodule	phenotype	C04;C17;C05	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0151908	Dry skin	phenotype	C17	Sign or Symptom	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.70	1	2002	2019	  50	  16	BEFREE;CGI;CLINVAR;CTD_human
      673	BRAF	0.319	0.846	C0152021	Congenital heart disease	group	C16;C14	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0152421	Macrotia	disease		Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0152438	Sprengel deformity	disease	C16	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0153446	Malignant neoplasm of anus	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0153574	Malignant Uterine Corpus Neoplasm	disease	C04;C13	Neoplastic Process	0.10	1	2016	2016	   1	   3	CLINVAR
      673	BRAF	0.319	0.846	C0153594	Malignant neoplasm of testis	disease	C04;C12;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.34	1	2011	2019	   4	   2	BEFREE;CGI
      673	BRAF	0.319	0.846	C0153676	Secondary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.941	2006	2019	  17	   3	BEFREE
      673	BRAF	0.319	0.846	C0153687	Secondary malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.05	1	2012	2018	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0153690	Secondary malignant neoplasm of bone	disease	C23;C04;C05	Neoplastic Process	0.02	1	2018	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0156147	Crohn's disease of large bowel	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0158465	Acquired cubitus valgus	disease		Acquired Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0158570	Vascular anomaly	phenotype	C16;C14	Anatomical Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0158731	Congenital pectus carinatum	disease	C16;C17;C05	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0158761	Radioulnar Synostosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0162316	Iron deficiency anemia	disease	C18;C15	Disease or Syndrome	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0162323	Polyarthritis	disease	C05	Disease or Syndrome	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0162504	Neutrophilic Eccrine Hidradenitis	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0162678	Neurofibromatoses	group	C16;C04;C10	Neoplastic Process	0.04	0.75	2013	2017	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0162830	Dermatitis, Phototoxic	disease	C17	Disease or Syndrome	0.03	1	2016	2020	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0162834	Hyperpigmentation	phenotype	C17	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0162848	Lichenoid Eruptions	group	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0175704	LEOPARD Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.65	1	2009	2017	  10	   2	BEFREE;CLINGEN;CLINVAR;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.10	0.955	2003	2019	  44	   2	BEFREE
      673	BRAF	0.319	0.846	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.10	1	2003	2019	  15	   3	BEFREE
      673	BRAF	0.319	0.846	C0205695	Carcinoid, Goblet Cell	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.05	1	2003	2015	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.08	0.875	2004	2016	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C0205748	Dysplastic Nevus	disease	C16;C04	Neoplastic Process	0.07	0.714	2003	2015	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.31	0.5	2013	2015	   2	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0205824	Liposarcoma, Dedifferentiated	disease	C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.06	1	2005	2016	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0205945	Sarcoma, Spindle Cell	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206180	Ki-1+ Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0206620	Lymphangioma, Cystic	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0206633	Angiomyolipoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	LHGDN
      673	BRAF	0.319	0.846	C0206638	Giant Cell Tumor of Bone	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206651	Clear Cell Sarcoma of Soft Tissue	disease	C04	Neoplastic Process	0.06	1	2005	2015	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0206659	Embryonal Carcinoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206674	Adenoma, Villous	disease	C04	Neoplastic Process	0.03	1	2008	2014	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.10	1	2004	2019	  19	   3	BEFREE
      673	BRAF	0.319	0.846	C0206683	Papillary and follicular adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
      673	BRAF	0.319	0.846	C0206685	Acinar Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.42	1	2009	2016	   4	   2	BEFREE;CLINVAR;CTD_human
      673	BRAF	0.319	0.846	C0206687	Carcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.04	0.75	2007	2020	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0206693	Medullary carcinoma	disease	C04	Neoplastic Process	0.04	1	2003	2016	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0206694	Mucoepidermoid Carcinoma	disease	C04	Neoplastic Process	0.01	0	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206695	Carcinoma, Neuroendocrine	disease	C04	Neoplastic Process	0.07	1	2015	2020	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0206696	Carcinoma, Signet Ring Cell	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.39	1	2003	2019	   9	   2	BEFREE;CGI
      673	BRAF	0.319	0.846	C0206701	Cystadenocarcinoma, Serous	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206709	Cystadenoma, Serous	disease	C04	Neoplastic Process	0.03	1	2004	2017	   3	   2	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0206715	Neoplasms, Neuroepithelial	group	C04	Neoplastic Process	0.02	1	2015	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0206716	Ganglioglioma	disease	C04	Neoplastic Process	0.20	0.974	2011	2020	  38	   3	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C0206726	gliosarcoma	disease	C04	Neoplastic Process	0.03	1	2005	2020	   3	   2	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0206729	Neurofibrosarcoma	disease	C04;C10	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0206735	Melanoma, Amelanotic	disease	C04	Neoplastic Process	0.02	1	2013	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0206736	Nevus, Blue	disease	C04	Neoplastic Process	0.02	1	2011	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0206739	Epithelioid and spindle cell nevus	disease	C04	Neoplastic Process	0.02	1	2004	2018	   2	   0	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C0206740	Calcifying Odontogenic Cyst	disease	C04;C05;C07	Anatomical Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.37	0.875	2005	2019	   8	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0206769	Nevi and Melanomas	group	C04	Neoplastic Process	0.05	1	2005	2016	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0220597	Adult Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220603	Childhood Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220605	Adult Non-Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220611	Childhood Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0220612	Childhood Non-Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220620	Gastrointestinal Carcinoid Tumor	disease	C06;C04;C19	Neoplastic Process	0.02	1	2009	2014	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2018	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.10	0.92	2003	2020	  25	   3	BEFREE
      673	BRAF	0.319	0.846	C0220641	Lip and Oral Cavity Carcinoma	disease	C04;C07	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220644	Childhood Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0220650	Metastatic malignant neoplasm to brain	disease	C23;C04;C10	Neoplastic Process	0.10	0.977	2011	2020	  43	   3	BEFREE
      673	BRAF	0.319	0.846	C0220668	Congenital contractural arachnodactyly	disease	C16;C05	Congenital Abnormality	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0221013	Mastocytosis, Systemic	disease	C04;C20	Neoplastic Process	0.01	0	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0221055	Paramyotonia Congenita (disorder)	disease	C05;C10	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0221184	Bitemporal Hemianopia	phenotype	C23;C11;C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221217	Neck webbing	disease	C16;C17	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0221263	Cafe-au-Lait Spots	phenotype	C23;C17	Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0221354	Frontal bossing	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221356	Brachycephaly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221357	Brachydactyly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221358	Long narrow head	disease		Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0221391	Melanosis coli	disease	C23;C06;C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0221406	Pituitary-dependent Cushing's disease	disease	C10;C19	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0221505	Lesion of brain	group		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0234166	Hyperexplexia	phenotype	C10	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0234894	Dermatitis acneiform	disease	C17	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0234979	Dysdiadochokinesis	phenotype	C23;C10	Sign or Symptom	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0235752	Port-Wine Stain	disease	C16;C17	Congenital Abnormality	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0235782	Gallbladder Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2011	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.37	1	2003	2020	   7	   0	BEFREE;CGI
      673	BRAF	0.319	0.846	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.50	1	2002	2019	  34	   3	BEFREE;CGI;CLINVAR;LHGDN
      673	BRAF	0.319	0.846	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0238348	Squamous cell carcinoma of penis	disease	C04;C12	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0238397	Pulmonary artery stenosis	disease	C14	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0238461	Anaplastic thyroid carcinoma	disease	C04	Neoplastic Process	0.10	1	2003	2019	  69	   3	BEFREE
      673	BRAF	0.319	0.846	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.10	1	2005	2017	  10	   2	BEFREE
      673	BRAF	0.319	0.846	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.90	0.968	2003	2020	 686	  10	BEFREE;CLINVAR;CTD_human;MGD;ORPHANET
      673	BRAF	0.319	0.846	C0239234	Low set ears	disease		Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0239676	High forehead	phenotype		Finding	0.10				   0	   2	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0239998	Recurrent infections	phenotype	C23;C01;C05	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0240379	Open mouth (finding)	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0240543	Bulbous nose	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0240635	Byzanthine arch palate	disease	C16;C05;C10;C07	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0240953	Winged scapula	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0241074	Hyperextensible skin	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0241654	Abnormal heart valve morphology	phenotype	C16;C14	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.60	1	2002	2020	  48	   6	BEFREE;CGI;CTD_human
      673	BRAF	0.319	0.846	C0242510	Drug usage	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0242596	Neoplasm, Residual	phenotype	C23;C04	Neoplastic Process	0.02	1	2013	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0242994	Hantavirus Infections	group	C01	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0243038	Carcinoma, Lewis Lung	disease	C04	Neoplastic Process; Experimental Model of Disease	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0259781	Compound nevus of skin	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0259786	Rhabdoid meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0260037	Multiple tumors	phenotype	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0262444	Abnormality of the dentition	phenotype	C16;C07	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0263218	Pyogenic granuloma of skin	disease	C23;C04;C01;C17	Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0263383	Keratosis pilaris	disease	C16;C17	Acquired Abnormality	0.11	1	2019	2019	   1	   0	BEFREE;HPO
      673	BRAF	0.319	0.846	C0263490	Brittle hair	disease		Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.10	0.913	2003	2019	  23	   2	BEFREE
      673	BRAF	0.319	0.846	C0265610	Clinodactyly of fingers	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0266061	Open Bite	phenotype	C07	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0267026	Actinic cheilitis	disease	C07	Disease or Syndrome	0.01	0	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0267561	Perianal fistula	disease	C23;C06;C17	Anatomical Abnormality	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0268398	Familial lichen amyloidosis	disease	C16;C18;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0269106	Endosalpingiosis	disease	C23;C13	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0270685	Cerebral calcification	phenotype	C18;C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0271270	Oculovestibuloauditory syndrome	disease	C11;C10;C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0277959	Coarse hair	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0278480	Stage III Colon Cancer	disease	C06;C04	Neoplastic Process	0.07	1	2010	2019	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0278484	Malignant neoplasm of colon stage IV	disease	C06;C04	Neoplastic Process	0.04	1	2013	2019	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0278488	Carcinoma breast stage IV	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0278592	Adult Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278595	Adult Fibrosarcoma	disease	C04	Neoplastic Process	0.03	1	2003	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0278600	Childhood Brain Stem Glioma	disease		Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0278622	Adult Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0278652	Childhood Craniopharyngioma	disease	C04	Neoplastic Process	0.05	1	2016	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2016	2016	   1	   3	CLINVAR
      673	BRAF	0.319	0.846	C0278764	Adult Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278803	Adenocarcinoma of small intestine	disease	C06;C04	Neoplastic Process	0.02	1	2016	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0278851	Stage IV Thyroid Gland Papillary Carcinoma AJCC v7	disease	C04;C19	Neoplastic Process	0.05	1	2010	2016	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0278875	Adult Craniopharyngioma	disease	C04	Neoplastic Process	0.35	1	2014	2019	   6	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.10	1	2011	2019	  13	   2	BEFREE
      673	BRAF	0.319	0.846	C0278879	Childhood Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278880	Stage I Cutaneous Melanoma AJCC v6	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278881	stage II melanoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0278882	Stage III Cutaneous Melanoma AJCC v6	disease		Neoplastic Process	0.09	1	2014	2019	   9	   2	BEFREE
      673	BRAF	0.319	0.846	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.10	0.992	2003	2020	 400	   8	BEFREE
      673	BRAF	0.319	0.846	C0278884	Melanoma recurrent	phenotype	C04;C17	Neoplastic Process	0.03	1	2015	2020	   3	   1	BEFREE
      673	BRAF	0.319	0.846	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.06	1	2016	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2018	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0279014	Childhood Germ Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279068	Childhood Solid Neoplasm	phenotype		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279070	Adult Oligodendroglioma	disease	C04	Neoplastic Process	0.05	1	2012	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0279550	Adult Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0279557	Adenosquamous cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.04	1	2012	2015	   4	   0	BEFREE
      673	BRAF	0.319	0.846	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279637	Anal carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279651	Gallbladder adenocarcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279663	Serous cystadenocarcinoma ovary	disease	C04	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
      673	BRAF	0.319	0.846	C0279672	Cervical Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.14	0.8	2009	2019	   5	   8	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.03	1	2015	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0279987	Childhood Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0279988	Childhood Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0280099	Adult Solid Neoplasm	group		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.10	1	2004	2019	  19	   2	BEFREE
      673	BRAF	0.319	0.846	C0280302	Squamous cell carcinoma of lip	disease	C04;C17;C07	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.10	1	2011	2019	  14	   2	BEFREE
      673	BRAF	0.319	0.846	C0280475	Childhood Oligodendroglioma	disease	C04	Neoplastic Process	0.05	1	2012	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0280483	Adult Anaplastic Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0280781	Adult Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.10	0.932	2008	2019	  44	   2	BEFREE
      673	BRAF	0.319	0.846	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.31	1	2010	2013	   2	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.33	1	2009	2016	   4	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0281361	Adenocarcinoma of pancreas	disease	C06;C04;C19	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0302142	Deformity	group	C23;C16	Anatomical Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0302323	Reticulohistiocytosis	disease		Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0311361	Adenomatous goiter	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0332563	Papule	phenotype	C23	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0333516	Tumor necrosis	phenotype	C23	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0333983	Hyperplastic Polyp	disease	C23	Neoplastic Process	0.10	1	2002	2018	  32	   2	BEFREE
      673	BRAF	0.319	0.846	C0334108	Multiple polyps	disease	C23	Neoplastic Process	0.02	1	2005	2006	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334230	Malignant tumor, fusiform cell type	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334277	Adenocarcinoma, metastatic	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334307	Tubulovillous adenoma	disease	C04	Neoplastic Process	0.02	1	2012	2014	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0334345	Apocrine adenoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334348	Hidradenoma Papilliferum	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0334350	Eccrine papillary adenoma	disease	C04;C17	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334355	Serous cystadenoma, borderline malignancy	disease	C04	Neoplastic Process	0.07	1	2007	2019	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0334359	Papillary serous cystadenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2007	2008	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0334424	Nodular melanoma	disease	C04;C17	Neoplastic Process	0.06	0.667	2005	2020	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0334431	Melanocytoma	disease		Neoplastic Process	0.02	1	2013	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0334438	Superficial spreading malignant melanoma of skin	disease	C04;C17	Neoplastic Process	0.09	1	2006	2020	   9	   2	BEFREE
      673	BRAF	0.319	0.846	C0334439	Malignant desmoplastic melanoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334443	Epithelioid Cell Melanoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0334444	Spindle Cell Melanoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334459	Infantile fibrosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334509	Clear cell sarcoma, of tendons and aponeuroses	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334525	Struma ovarii, malignant	disease	C04;C13;C19	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334533	Arteriovenous hemangioma	disease	C16;C04;C14	Neoplastic Process	0.02	1	2019	2020	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0334576	Gliomatosis cerebri	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.51	1	2013	2015	   2	   0	BEFREE;CGI;CTD_human
      673	BRAF	0.319	0.846	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.31	1	2013	2014	   2	   0	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.60	0.957	2008	2020	  92	   2	BEFREE;CGI;CTD_human
      673	BRAF	0.319	0.846	C0334586	Pleomorphic Xanthoastrocytoma	disease	C04	Neoplastic Process	0.10	1	2011	2020	  28	   2	BEFREE
      673	BRAF	0.319	0.846	C0334587	Astroblastoma	disease	C04	Neoplastic Process	0.02	1	2017	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.04	1	2013	2016	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0334633	Malignant lymphoma - lymphoplasmacytic	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0334663	Histiocytic sarcoma	disease	C04;C15	Neoplastic Process	0.05	1	2014	2019	   5	   5	BEFREE
      673	BRAF	0.319	0.846	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0338106	Adenocarcinoma of colon	disease	C06;C04	Neoplastic Process	0.06	1	2009	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.12	1	2009	2018	   2	   0	BEFREE;HPO
      673	BRAF	0.319	0.846	C0340279	Ventricular hypertrophy	disease	C23;C14	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0341038	Jaw Keratocyst	disease	C04;C05;C07	Disease or Syndrome	0.02	1	2017	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0342190	C-cell hyperplasia of thyroid	disease	C23;C19	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0342199	Iodine deficiency syndrome	disease	C19	Disease or Syndrome	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0342409	Hypophysitis	disease	C10;C19	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0342422	Pituitary gland enlarged	disease	C10;C19	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.05	1	2009	2019	   5	   0	BEFREE
      673	BRAF	0.319	0.846	C0344460	Carcinoma ex pleomorphic adenoma	disease	C04;C07	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0344482	Hypoplasia of corpus callosum	disease	C23;C16;C10	Congenital Abnormality	0.10	1	2006	2006	   2	   1	CLINVAR
      673	BRAF	0.319	0.846	C0345392	Congenital kyphoscoliosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.32	1	2007	2018	   3	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.07	1	2013	2019	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C0345946	Squamous cell carcinoma of trachea	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0345964	Adenoma of lung	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0346023	Syringocystadenoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0346037	Acral Lentiginous Malignant Melanoma	disease	C04;C17	Neoplastic Process	0.08	1	2006	2019	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C0346040	Stage 0 Skin Melanoma	disease	C04;C17	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0346360	Malignant melanoma of conjunctiva	disease		Neoplastic Process	0.10	0.929	2004	2020	  14	   2	BEFREE
      673	BRAF	0.319	0.846	C0346373	Malignant melanoma of iris	disease	C04;C11	Neoplastic Process	0.01	1	2007	2007	   1	   1	BEFREE
      673	BRAF	0.319	0.846	C0346388	Malignant melanoma of choroid	disease	C04;C11	Neoplastic Process	0.02	1	2003	2006	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0346398	Mixed follicular and papillary thyroid carcinoma	disease		Neoplastic Process	0.10	1	2008	2018	  11	   3	BEFREE
      673	BRAF	0.319	0.846	C0346429	Multiple malignancy	phenotype	C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.09	0.889	2003	2020	   9	   2	BEFREE
      673	BRAF	0.319	0.846	C0346787	Malignant melanoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0346989	Secondary malignant neoplasm of peritoneum	disease		Neoplastic Process	0.05	1	2014	2020	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0349515	Amelanotic Skin Melanoma	disease	C04;C17	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0349533	Lymphoma of intestine	disease	C06;C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0349534	Carcinoma of anal margin	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0349588	Short stature	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0349620	Pilocytic astrocytoma of cerebellum	disease	C04;C10	Neoplastic Process	0.02	1	2013	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0349632	Splenic Marginal Zone B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.06	0.833	2012	2017	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C0349633	Hairy cell leukemia variant	disease	C04;C20;C15	Neoplastic Process	0.03	1	2012	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.02	1	2007	2014	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0349658	Trichoepithelioma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0376338	Diagnosis, Psychiatric	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2006	2006	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.36	1	2006	2018	   8	   0	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.04	0.75	2012	2015	   4	   0	BEFREE
      673	BRAF	0.319	0.846	C0393525	Progressive cerebellar ataxia	disease	C23;C16;C10	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0398597	Histiocytic syndrome	disease	C20;C15	Disease or Syndrome	0.05	1	2012	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0398639	Amegakaryocytic thrombocytopenia	disease	C15	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0406484	Sebaceous hyperplasia	disease	C23;C17	Disease or Syndrome	0.01	0	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0406803	Syringocystadenoma Papilliferum	disease	C04	Neoplastic Process	0.33	1	2009	2019	   4	   0	BEFREE;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0423110	Downward slant of palpebral fissure	phenotype		Finding	0.10	1	2006	2006	   2	   2	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0423224	Sunken eyes	phenotype	C23;C11;C10	Finding	0.10				   0	   2	CLINVAR
      673	BRAF	0.319	0.846	C0423798	Increased tendency to bruise	phenotype	C26	Finding	0.10	1	2008	2008	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C0423867	Fine hair	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.05	1	2010	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.10	1	2006	2008	   5	   3	CLINVAR
      673	BRAF	0.319	0.846	C0431108	Anaplastic Oligoastrocytoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0431112	Anaplastic ganglioglioma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0431128	Papillary craniopharyngioma	disease	C04	Neoplastic Process	0.40	1	2014	2019	  15	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0431129	Adamantinous Craniopharyngioma	disease	C04	Neoplastic Process	0.36	1	2014	2019	   7	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0431448	Absent eyebrow	disease	C16;C17	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0431478	Posteriorly rotated ear	disease		Congenital Abnormality	0.10	1	2006	2006	   2	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0432072	Dysmorphic features	disease		Congenital Abnormality	0.10	1	1968	2013	  10	   8	CLINVAR
      673	BRAF	0.319	0.846	C0432103	Submucous cleft of hard palate	disease	C16;C08;C07;C09	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0432333	Abnormal dermatoglyphic pattern	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0452138	Sensorineural hearing loss, bilateral	disease	C23;C10;C09	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0457179	Desmoplastic infantile astrocytoma	disease	C04	Neoplastic Process	0.04	1	2013	2018	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0457521	Unicystic ameloblastoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0474808	Follicular neoplasm	disease	C04	Neoplastic Process	0.09	1	2005	2018	   9	   3	BEFREE
      673	BRAF	0.319	0.846	C0475801	Leukemia, Prolymphocytic, B-Cell	disease	C04;C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.10	1	2004	2016	  13	   2	BEFREE
      673	BRAF	0.319	0.846	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	0.933	2012	2020	  15	   2	BEFREE
      673	BRAF	0.319	0.846	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0520739	Hereditary pyropoikilocytosis	disease	C16;C15	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0520927	Decreased fertility	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0521158	Recurrent tumor	phenotype		Neoplastic Process	0.10	0.812	2005	2019	  16	   2	BEFREE
      673	BRAF	0.319	0.846	C0521525	Short neck	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0521579	Congenital strabismus	disease	C16;C11;C10	Congenital Abnormality	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0521585	Gastrointestinal mucositis	disease	C06;C07	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0521698	Vogt-Koyanagi-Harada like syndrome	disease	C11	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.02	1	2017	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0541764	Delayed bone age	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0544886	Somatic mutation	phenotype		Cell or Molecular Dysfunction	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0549410	Palmar-plantar erythrodysesthesia syndrome	disease	C17;C25	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.60	0.99	2003	2019	 199	   2	BEFREE;CGI;CTD_human
      673	BRAF	0.319	0.846	C0553694	Oropharyngeal disorders	group	C06;C08;C07;C09	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0553721	Diminished sweating	phenotype	C17;C10	Finding	0.10	1	2008	2008	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C0553723	Squamous cell carcinoma of skin	disease	C04;C17	Neoplastic Process	0.20	1	2009	2018	  14	   4	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.34	1	2013	2019	   5	   2	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.10	1	2006	2009	   4	   6	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0558165	Curly hair (finding)	phenotype		Finding	0.10	1	2008	2008	   1	   4	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0558356	Malignant melanoma of eye	disease	C04;C11	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0574974	Finger joint hypermobility	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0575158	Kyphoscoliosis deformity of spine	disease	C05	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0576093	Knee joint valgus deformity	disease	C05	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0578038	Thin lips	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C0578682	Madarosis of eyebrow	disease	C23;C11;C17	Disease or Syndrome	0.10	1	2008	2008	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C0581342	Redundant skin	phenotype	C16;C17	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.54	1	2006	2016	   6	   0	BEFREE;CLINGEN;CTD_human
      673	BRAF	0.319	0.846	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.924	2003	2020	 157	   4	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0598935	Tumor Initiation	phenotype	C23;C04	Neoplastic Process	0.05	1	2009	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0600033	Acquired Kyphoscoliosis	disease	C05	Acquired Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.06	1	2006	2018	   6	   0	BEFREE
      673	BRAF	0.319	0.846	C0677607	Hashimoto Disease	disease	C19	Disease or Syndrome	0.10	1	2005	2019	  24	   2	BEFREE
      673	BRAF	0.319	0.846	C0677865	Brain Stem Glioma	disease	C04;C10	Neoplastic Process	0.10	1	2016	2016	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.04	1	2008	2015	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C0677898	invasive cancer	phenotype	C04	Neoplastic Process	0.01	0	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0677932	Progressive Neoplastic Disease	phenotype		Neoplastic Process	0.10	1	2006	2019	  12	   3	BEFREE
      673	BRAF	0.319	0.846	C0677936	Refractory cancer	phenotype	C04	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0677944	Sentinel node (disorder)	disease		Disease or Syndrome	0.08	1	2009	2019	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C0677948	Stage II Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0677949	Stage III Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0677950	Stage IV Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2007	2020	  10	   3	BEFREE;CGI
      673	BRAF	0.319	0.846	C0678230	Congenital Epicanthus	disease		Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.70	1	2002	2019	  45	  16	BEFREE;CGI;CLINVAR;UNIPROT
      673	BRAF	0.319	0.846	C0684686	Secondary malignant neoplasm of soft tissues	group	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0685938	Malignant neoplasm of gastrointestinal tract	disease	C06;C04	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0686377	CNS metastases	phenotype	C04;C10	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.10	0.852	2004	2020	 115	   5	BEFREE
      673	BRAF	0.319	0.846	C0687720	Central Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0694563	Excessive daytime somnolence	phenotype		Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.978	2003	2019	  90	   4	BEFREE;CGI
      673	BRAF	0.319	0.846	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2003	2018	   6	   0	BEFREE;CGI
      673	BRAF	0.319	0.846	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.03	0.667	2009	2015	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0699893	Skin carcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2010	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.10	1	2006	2017	  11	   2	BEFREE
      673	BRAF	0.319	0.846	C0700199	Multiple nevi	disease	C04;C17	Neoplastic Process	0.02	1	2014	2015	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0740277	Bile duct carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2003	2011	   2	   0	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C0741899	Poorly differentiated carcinoma	phenotype		Neoplastic Process	0.03	1	2006	2017	   3	   1	BEFREE
      673	BRAF	0.319	0.846	C0742468	Central nervous system lesion	disease		Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0742965	Eosinophilic cystitis	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0743086	Granulomatous dermatitis	disease	C17	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0744333	Gastrointestinal polyps	phenotype	C23;C06	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0746408	mass lesion	phenotype		Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2004	2014	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.03	1	2018	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0751061	Craniopharyngioma, Child	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0751297	Leptomeningeal Neoplasms	disease	C04;C10	Neoplastic Process	0.03	1	2015	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0751396	Well Differentiated Oligodendroglioma	disease	C04	Neoplastic Process	0.06	1	2012	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.06	0.833	2008	2017	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C0751691	Perineurioma	disease	C04;C10	Neoplastic Process	0.03	1	2010	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C0752244	Rathke Cleft Cysts	disease	C16;C04;C10	Congenital Abnormality	0.02	1	2015	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0796004	Kabuki make-up syndrome	disease	C16;C09;C15	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0796074	MOHR-TRANEBJAERG SYNDROME	disease	C23;C16;C11;C10;F03;C09;F01	Disease or Syndrome	0.01	0	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0796418	Visual Pathway Glioma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0848558	Hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0848860	endocrine carcinoma	disease		Neoplastic Process	0.01	1	2004	2004	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0849748	caruncle	disease	C13;C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0850639	premalignant lesion	phenotype		Neoplastic Process	0.01	1	2006	2006	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0852711	Sickle Cell Dactylitis	disease	C16;C17;C25;C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0854021	Abnormal visual field test	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0854750	Colorectal cancer recurrent	disease	C06;C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0854917	Rhabdoid Tumor of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.03	1	2017	2018	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0854923	Mucinous endometrial carcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C0854985	Adenocarcinoma of lung, stage I	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0855139	Monocytoid B-cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0855740	Abnormal platelet function	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.31	0	2019	2019	   1	   0	BEFREE;CGI
      673	BRAF	0.319	0.846	C0860594	Malignant melanoma, metastatic	disease	C04	Neoplastic Process	0.10	1	2008	2020	  12	   4	BEFREE
      673	BRAF	0.319	0.846	C0862506	Borderline ovarian tumour	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0869083	Other specified congenital malformation syndromes, not elsewhere classified in ICD10CM	disease		Disease or Syndrome	0.20				   0	   0	MGD
      673	BRAF	0.319	0.846	C0870082	Hyperkeratosis	disease	C23;C17	Disease or Syndrome	0.13	1	2012	2019	   3	   0	BEFREE;HPO
      673	BRAF	0.319	0.846	C0878500	Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.02	1	2004	2012	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0878660	Proportionate short stature	phenotype	C16;C05;C19	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0878675	Erdheim-Chester Disease	disease	C15	Disease or Syndrome	0.40	1	2012	2020	  24	   2	BEFREE;CGI
      673	BRAF	0.319	0.846	C0879615	Stromal Neoplasm	disease	C04	Neoplastic Process	0.01	0	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0917804	Arteriovenous Malformations, Cerebral	group	C16;C10;C14	Congenital Abnormality	0.10	1	2019	2019	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.50	0.958	2002	2019	  24	   4	BEFREE;CGI;CLINVAR;LHGDN
      673	BRAF	0.319	0.846	C0919645	Tumour ulceration	disease		Neoplastic Process	0.02	1	2014	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C0920184	Fundic gland polyp	disease	C23	Neoplastic Process	0.01	0	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0920269	Microsatellite Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0920350	Autoimmune thyroiditis	disease	C20;C19	Disease or Syndrome	0.05	1	2008	2017	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C0936282	Blastoma	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0940937	precancerous lesions	phenotype		Neoplastic Process	0.02	1	2015	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C0948387	Secondary Adrenal Insufficiency	disease	C19	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C0948775	High weight	phenotype	C23;C18	Sign or Symptom	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C0949059	Polyp of large intestine	disease	C23;C06;C04	Neoplastic Process	0.03	1	2006	2016	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C0949541	Hurthle Cell Tumor	disease	C04	Neoplastic Process	0.02	1	2013	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1096063	Drug Resistant Epilepsy	disease	C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1096168	Chromosome 17 trisomy	disease	C23	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2019	2019	   1	   1	BEFREE
      673	BRAF	0.319	0.846	C1136033	Cutaneous Mastocytosis	disease	C04;C17	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.60	0.941	2003	2019	  17	   3	BEFREE;CGI;UNIPROT
      673	BRAF	0.319	0.846	C1142025	Stage IV Esophageal Squamous Cell Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1167791	Skin toxicity	disease		Disease or Syndrome	0.06	1	2009	2019	   6	   0	BEFREE
      673	BRAF	0.319	0.846	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.13	0.75	2003	2016	   4	   4	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.02	1	2016	2017	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1260325	Dendritic Cell Sarcoma, Follicular	disease	C04;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1260326	Dendritic Cell Sarcoma, Interdigitating	disease	C04;C15	Neoplastic Process	0.02	1	2015	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1261473	Sarcoma	group	C04	Neoplastic Process	0.10	1	2003	2019	  12	   2	BEFREE
      673	BRAF	0.319	0.846	C1262091	Lymphocytic infiltration	disease		Disease or Syndrome	0.03	1	2004	2014	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1263887	Neoplasm of temporal lobe	disease	C04;C10	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1265996	Large cell neuroendocrine carcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1266005	Basaloid squamous cell carcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1266025	Traditional Serrated Adenoma	disease	C04	Neoplastic Process	0.10	0.95	2007	2019	  20	   2	BEFREE
      673	BRAF	0.319	0.846	C1266032	Atypical carcinoid tumor	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1266045	Metanephric adenoma	disease	C04	Neoplastic Process	0.06	0.833	2012	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C1266050	Poorly Differentiated Thyroid Carcinoma	disease	C04;C19	Neoplastic Process	0.03	1	2009	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1266051	Papillary microcarcinoma	disease		Neoplastic Process	0.08	0.875	2008	2017	   8	   3	BEFREE
      673	BRAF	0.319	0.846	C1266111	Glomus tumor, malignant	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1266112	Diffuse melanocytosis	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1266141	Nephrogenic adenofibroma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1266158	Nongerminomatous Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.40				   0	   1	CGI;CLINVAR
      673	BRAF	0.319	0.846	C1266177	Dysembryoplastic neuroepithelial tumor	disease	C04	Neoplastic Process	0.06	0.833	2013	2017	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C1266184	Atypical Teratoid Rhabdoid Tumor	disease	C04	Neoplastic Process	0.02	1	2015	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	0.97	2004	2020	 101	   2	BEFREE
      673	BRAF	0.319	0.846	C1274943	Drug-induced panniculitis	disease	C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	1.00	0.972	2003	2019	  71	  48	BEFREE;CLINGEN;CLINVAR;CTD_human;GENOMICS_ENGLAND;MGD;ORPHANET;UNIPROT
      673	BRAF	0.319	0.846	C1275419	Desmoplastic spindle and epithelioid cell melanocytic nevus of skin	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1292753	Primary Effusion Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1298180	Single tumor	phenotype		Neoplastic Process	0.02	1	2012	2013	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1301034	Pancreatic intraepithelial neoplasia	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1301194	Salivary duct carcinoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1302401	Adenoma of large intestine	disease	C06;C04	Neoplastic Process	0.03	1	2006	2011	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1302808	Myopericytoma	disease	C04;C17	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1304321	Eruptive melanocytic nevi	disease		Neoplastic Process	0.01	1	2010	2010	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1306214	ACTH-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.979	2002	2020	 283	   6	BEFREE
      673	BRAF	0.319	0.846	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	1	2002	2019	  35	   4	BEFREE
      673	BRAF	0.319	0.846	C1306587	Acute encephalopathy	disease	C10	Disease or Syndrome	0.03	1	2018	2019	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1306759	Eosinophilic disorder	group	C15	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1314678	Ameloblastic Carcinoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1314694	Astrocytoma, low grade	disease	C04	Neoplastic Process	0.03	1	2011	2017	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1318558	Congenital melanocytic nevus	disease	C16;C04;C17	Neoplastic Process	0.06	1	2007	2018	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.60	1	2011	2019	  10	   5	BEFREE;CGI;UNIPROT
      673	BRAF	0.319	0.846	C1321427	Epithelioid Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1321872	Stage IV Skin Melanoma	disease	C04;C17	Neoplastic Process	0.10	1	2007	2019	  22	   3	BEFREE
      673	BRAF	0.319	0.846	C1321878	Desmoplastic infantile ganglioglioma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1328931	Multiple lentigines	disease		Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1332166	Adenocarcinoma of the gastroesophageal junction	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1332182	Adult Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1332200	Adult Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	0.667	2015	2018	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1332460	Barrett's Adenocarcinoma	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1332942	Childhood Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1332965	Congenital Mesoblastic Nephroma	disease	C04;C13;C12	Neoplastic Process	0.05	1	2011	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C1332969	Childhood Ganglioglioma	disease	C04	Neoplastic Process	0.20	1	2011	2020	  21	   3	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.06	1	1995	2018	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	0.667	2015	2018	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1332995	Childhood Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.10	0.93	2008	2019	  43	   2	BEFREE
      673	BRAF	0.319	0.846	C1333015	Childhood Kidney Wilms Tumor	disease	C16;C04;C13;C12	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1333043	Chronic Myelomonocytic Leukemia-1	disease	C04;C15	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1333116	Colorectal Traditional Serrated Adenoma	disease		Neoplastic Process	0.02	1	2013	2014	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1333119	Colorectal Villous Adenoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1333280	Desmoplastic melanoma	disease	C04;C17	Neoplastic Process	0.03	1	2005	2015	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1333600	Hereditary Malignant Neoplasm	disease	C04	Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1333749	Gallbladder Melanoma	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1333826	Glomus Tumor of Uncertain Malignant Potential	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.10	0.952	2004	2020	  62	   2	BEFREE
      673	BRAF	0.319	0.846	C1334015	High Grade Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1334030	Histiocytic and Dendritic Cell Neoplasm	disease	C04;C15	Neoplastic Process	0.02	1	2014	2015	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1334243	Intracranial Melanoma	disease		Neoplastic Process	0.03	1	2015	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1334274	Invasive Carcinoma	phenotype	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1334386	Meningeal melanoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1334455	Pulmonary Sclerosing Hemangioma	disease	C04;C08	Neoplastic Process	0.02	1	2018	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1334633	Mature B-Cell Neoplasm	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1334720	Metastatic Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1334811	Mucinous neoplasm	disease		Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1334953	Neuroblastic tumors	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1335114	Optic Nerve Astrocytoma	disease	C04;C11;C10	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1335177	Ovarian Serous Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2003	2004	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1335475	Primary Carcinoma	phenotype	C04	Neoplastic Process	0.02	1	2014	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1336078	Papillary renal cell carcinoma, sporadic	disease	C04;C13;C12	Neoplastic Process	0.10	1	2016	2016	   1	   3	CLINVAR
      673	BRAF	0.319	0.846	C1336753	Thyroid Lymphoma	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1337013	Differentiated Thyroid Gland Carcinoma	disease		Neoplastic Process	0.10	1	2008	2019	  20	   2	BEFREE
      673	BRAF	0.319	0.846	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.02	1	2004	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1368910	Mature Teratoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1378050	Oncocytic Neoplasm	disease		Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1384494	Metastatic Carcinoma	group	C23;C04	Neoplastic Process	0.02	1	2016	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1389016	ATRIOVENTRICULAR CANAL DEFECT	disease	C16;C14	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1390474	Increased susceptibility to fractures	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1402291	Pigmented lesions	disease		Disease or Syndrome	0.02	1	2007	2008	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1402294	Primary Lesion	phenotype		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1402315	Vascular lesions	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1412004	Tumor of the Pineal Region	disease	C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1412036	Anal squamous cell carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1455705	Pulmonary Histiocytosis X	disease	C08;C15	Disease or Syndrome	0.08	1	2014	2018	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C1456781	Benign melanocytic nevus	disease	C04	Neoplastic Process	0.10	0.808	2003	2019	  26	   5	BEFREE
      673	BRAF	0.319	0.846	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.11	1	2002	2014	   4	   1	BEFREE;CLINVAR
      673	BRAF	0.319	0.846	C1504404	Hippocampal sclerosis	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1510502	Oxyphilic Adenoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1510885	Angiogenic Switch	disease		Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1511104	Benign Struma Ovarii	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1511789	Desmoplastic	disease		Disease or Syndrome	0.04	1	2005	2018	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C1512127	HER2 gene amplification	disease		Disease or Syndrome	0.10	1	2011	2018	  10	   2	BEFREE
      673	BRAF	0.319	0.846	C1512419	Hereditary Melanoma	disease	C16;C04;C17	Neoplastic Process	0.03	0.667	2003	2005	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1513734	Solid/Multicystic Ameloblastoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1519086	Pilomyxoid astrocytoma	disease	C04	Neoplastic Process	0.33	0.833	2008	2016	   6	   2	BEFREE;ORPHANET
      673	BRAF	0.319	0.846	C1519353	Skin Papule	phenotype	C17	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.01	1	2012	2012	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1519680	Tumor Immunity	phenotype	C23	Disease or Syndrome	0.02	1	2016	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1527349	Ductal Breast Carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1527358	Phototoxicity	disease	C17	Disease or Syndrome	0.02	1	2016	2020	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1527366	Salaam Seizures	disease	C10	Disease or Syndrome	0.01	1	2011	2011	   1	   1	BEFREE
      673	BRAF	0.319	0.846	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.02	1	2016	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1527404	Female Pseudo-Turner Syndrome	disease	C16;C17;C05;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1531553	Dendritic cell neoplasm	disease	C04;C15	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1535510	ADENOMAS AND ADENOCARCINOMAS	group	C04	Neoplastic Process	0.02	1	2011	2013	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1541316	Adult Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.04	1	2013	2016	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C1541317	Adult Gliosarcoma	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1562113	Fleck corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1569637	Adenocarcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.03	0.667	2012	2020	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.10	0.947	2002	2018	  19	   2	BEFREE
      673	BRAF	0.319	0.846	C1611743	Familial (FPAH)	disease		Disease or Syndrome	0.05	1	2003	2013	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.10	1	2008	2019	  18	   2	BEFREE
      673	BRAF	0.319	0.846	C1704214	Lipogranuloma	disease	C23;C18;C15	Disease or Syndrome	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1704216	Basaloid carcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1704231	Metastatic Malignant Neoplasm to the Leptomeninges	disease	C10	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1704423	Milroy Disease	disease	C15	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1707439	Colorectal Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1707440	Colorectal Signet Ring Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1708565	Invasive Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.05	1	2005	2017	   5	   3	BEFREE
      673	BRAF	0.319	0.846	C1708604	Keratocystic Odontogenic Tumor	disease	C04	Neoplastic Process	0.02	1	2017	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C1708773	Lung Melanoma	disease	C04;C08	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1709103	Myxoinflammatory fibroblastic sarcoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1709457	Papillary Thyroid Microcarcinoma	disease	C04;C19	Neoplastic Process	0.10	0.958	2005	2020	  24	   2	BEFREE
      673	BRAF	0.319	0.846	C1720430	Papillary carcinoma, clear cell	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
      673	BRAF	0.319	0.846	C1721098	Replication Error Phenotype	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1827524	Wide spaced nipples	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1827668	Tongue thrusting when swallowing, abnormal persistence beyond early childhood	phenotype	C07	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1829460	Tongue thrusting	phenotype	F03	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1832160	Abnormality of temperature regulation	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1832348	Slow-growing hair	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1832446	Sparse eyebrow	phenotype		Finding	0.10	1	2008	2008	   1	   1	CLINVAR
      673	BRAF	0.319	0.846	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1834124	Shield chest	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1835884	Triangular face	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1836047	Long face	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1836189	Radial deviation of finger	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1836542	Depressed nasal bridge	phenotype		Finding	0.10	1	2006	2006	   2	   3	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1836543	Thick vermilion border	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1836830	Developmental regression	disease	F03	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1836940	Thickened nuchal skin fold	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1837142	Poor suck	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1837260	Prominent forehead	phenotype		Finding	0.10	1	2006	2006	   2	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1837404	High, narrow palate	phenotype		Finding	0.10	1	2006	2006	   2	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1837732	Thickened helices	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1837770	Sparse hair	phenotype		Finding	0.10	1	2006	2006	   2	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1839364	Progressive visual loss	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1839739	Thick lower lip vermilion	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1839758	Narrow forehead	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1839797	Deep philtrum	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1840077	Anteverted nostril	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1840264	IMMUNE SUPPRESSION	phenotype		Disease or Syndrome	0.04	1	2012	2015	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C1842364	Central hypotonia	phenotype		Finding	0.10	1	2006	2006	   2	   1	CLINVAR
      673	BRAF	0.319	0.846	C1843005	Absent eyelashes	phenotype		Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1843181	Noonan syndrome-like disorder with loose anagen hair	disease	C23;C17	Disease or Syndrome	0.30				   0	   0	CLINGEN
      673	BRAF	0.319	0.846	C1843300	Sparse eyelashes	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1843367	Poor school performance	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1844577	Hyperextensibility of the finger joints	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1845847	Coarse facial features	phenotype	C23	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1846821	Abnormality of coagulation	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1847835	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	disease	C17	Disease or Syndrome	0.03	1	2015	2019	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1847874	PHACE association	disease	C16;C11;C17;C10;C14	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1848395	Large for gestational age	phenotype	C23;C13	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1848760	Increased anterioposterior diameter of thorax	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1849075	Relative macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1849172	Frontal lobe hypoplasia	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1849340	Long palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1849367	Nasal bridge wide	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1849452	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)	disease		Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1849667	Wide nasal base	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1849677	Numerous nevi	phenotype	C04	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1850049	Clinodactyly of the 5th finger	disease		Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1851897	Anterior creases of earlobe	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1853124	NEPHROTIC SYNDROME, TYPE 3	disease	C13;C12	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1853141	Slow decrease in visual acuity	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1853242	Midface retrusion	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1854114	Short nose	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1854418	Biparietal narrowing	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1855728	Low posterior hairline	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1857486	Low-set, posteriorly rotated ears	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
      673	BRAF	0.319	0.846	C1857534	Postnatal onset growth deficiency	phenotype		Finding	0.10	1	2006	2006	   2	   1	CLINVAR
      673	BRAF	0.319	0.846	C1857539	Deep palmar crease	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1858091	Long fingers	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1858120	Generalized hypotonia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1859778	Postnatal growth retardation	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1860707	TUBEROUS SCLEROSIS 2 (disorder)	disease	C16;C04;C10	Disease or Syndrome	0.03	1	2011	2016	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C1860991	NOONAN SYNDROME 3	disease	C16;C17;C05;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1861305	TARSAL-CARPAL COALITION SYNDROME	disease	C16;C05	Disease or Syndrome	0.02	1	2011	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1861862	Familial Hypertrophic Cardiomyopathy Type 4	disease	C16;C14	Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C1861866	Aplasia/Hypoplasia of the corpus callosum	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1861869	Underdeveloped supraorbital ridges	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1861872	Multiple palmar creases	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1861873	Multiple plantar creases	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1861975	Cafe au lait spots, multiple	disease	C23;C17	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1864795	Superior pectus carinatum	phenotype	C16;C17;C05	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1864796	Pectus excavatum of inferior sternum	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1865014	Long philtrum	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1866231	Full cheeks	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1867873	Failure to thrive in infancy	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1868810	Neutrophilic panniculitis	disease	C17	Disease or Syndrome	0.02	1	2013	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C1869123	Limb-girdle muscular dystrophy type 2A	disease	C16;C05;C10	Disease or Syndrome	0.04	1	1998	2010	   4	   0	BEFREE
      673	BRAF	0.319	0.846	C1956257	Pulmonary Stenosis	disease	C14	Disease or Syndrome	0.11	1	2006	2011	   3	   3	BEFREE;CLINVAR;HPO
      673	BRAF	0.319	0.846	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1959632	Plasma Cell Neoplasm	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2005	2011	   3	   0	BEFREE;LHGDN
      673	BRAF	0.319	0.846	C1961121	Congenital vascular anomaly	group	C16	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1962966	Retinopathy, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1963094	Dry Skin, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1963099	Myelodysplasia, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1963184	Nystagmus, CTCAE 3.0	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C1969623	NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME	disease	C23;C17	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C1997217	Low grade glioma	disease	C04	Neoplastic Process	0.05	1	2017	2020	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C2004493	Leukemia, B-Cell	disease	C04;C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C2076600	Influenza due to Influenza A virus subtype H1N1	disease	C01;C08	Disease or Syndrome	0.10	1	2015	2015	   1	   1	GWASCAT
      673	BRAF	0.319	0.846	C2237142	Moderate global developmental delay	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2003	2019	   9	   1	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C2242657	Metastatic ocular melanoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2243051	Large head (disorder)	phenotype		Finding	0.10	1	2006	2008	   3	   4	CLINVAR
      673	BRAF	0.319	0.846	C2267233	Neonatal Hypotonia	disease	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C2347613	Childhood Atypical Teratoid/Rhabdoid Tumor	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2347979	Rosette-forming glioneuronal tumor of the fourth ventricle	disease	C04;C10	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2363902	Glioneuronal tumor	disease		Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C2609093	Pancreatic neuroendocrine tumour metastatic	disease	C06;C04;C19	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C2674608	Feeding difficulties in infancy	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C2674727	ASTROCYTOMA, LOW-GRADE, SOMATIC	disease		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C2676026	Optic nerve dysplasia	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2732618	Sessile Serrated Adenoma/Polyp	disease		Neoplastic Process	0.10	1	2006	2019	  15	   2	BEFREE
      673	BRAF	0.319	0.846	C2739810	Lentigo maligna melanoma	disease	C04;C17	Neoplastic Process	0.12	1	2008	2015	   2	   3	BEFREE;HPO
      673	BRAF	0.319	0.846	C2919142	Short Stature, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.10	1	2012	2019	  35	   3	BEFREE
      673	BRAF	0.319	0.846	C2931201	Urachal adenocarcinoma	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2931202	Urachal cancer	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2931367	Thyroid cancer, follicular	disease	C04	Neoplastic Process	0.02	1	2007	2010	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.02	1	2009	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.10	0.944	2003	2020	 125	   5	BEFREE
      673	BRAF	0.319	0.846	C2945759	aggressive cancer	phenotype		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2985219	Papillary tumor of the pineal region	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C2986561	Spindle Cell Oncocytoma of the Adenohypophysis	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C2986682	Locally Recurrent Malignant Neoplasm	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C2987120	Intramucosal Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3146250	Stage III Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3146251	Stage IV Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C3146252	Stage II Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3146254	Stage III Colon Cancer AJCC v7	disease		Neoplastic Process	0.07	1	2010	2019	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C3150613	Long toe	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C3150970	NOONAN SYNDROME 7	disease		Disease or Syndrome	0.70	1	2006	2017	   5	   8	CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
      673	BRAF	0.319	0.846	C3150971	LEOPARD SYNDROME 3	disease		Disease or Syndrome	0.70	1	2006	2013	   4	   5	CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
      673	BRAF	0.319	0.846	C3160718	PARKINSON DISEASE, LATE-ONSET	disease		Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3160815	Intraductal papillary mucinous neoplasm	disease		Neoplastic Process	0.03	1	2007	2008	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3164374	Abnormality of pulmonary valve	disease		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3164445	Abnormality of aortic valve	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3263719	Primary acquired melanosis	disease	C04;C11	Disease or Syndrome	0.02	1	2015	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C3266123	Serrated polyp	disease	C23	Anatomical Abnormality	0.02	1	2006	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.03	1	2007	2018	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C3267126	Trichodysplasia spinulosa	disease		Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3272607	Colorectal Neuroendocrine Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3272793	Filiform Serrated Adenoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3272809	Colorectal Serrated Adenocarcinoma	disease		Neoplastic Process	0.02	1	2011	2014	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C3272841	MUTYH-Associate Polyposis	disease	C16;C04	Neoplastic Process	0.02	1	2007	2014	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C3280492	TUMOR PREDISPOSITION SYNDROME	disease		Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3282896	Glandular papilloma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3472608	Micropapillary carcinoma	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3472623	Serrated adenocarcinoma	disease		Neoplastic Process	0.03	1	2011	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C3489630	Somatotrophinoma, Familial	disease	C04;C10;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3489733	Oculomotor apraxia	disease	C23;C11;C10;F01;C14	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3495721	Spitzoid melanoma	disease		Neoplastic Process	0.02	0.5	2006	2009	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3501843	Nonmedullary Thyroid Carcinoma	disease	C04;C19	Neoplastic Process	0.30	1	2016	2017	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C3501844	Familial Nonmedullary Thyroid Cancer	disease	C04;C19	Neoplastic Process	0.31	1	2005	2017	   3	   1	BEFREE;CTD_human
      673	BRAF	0.319	0.846	C3501846	Noonan-Like Syndrome With Loose Anagen Hair	disease	C23;C16;C17;C05;C14	Disease or Syndrome	0.30				   0	   0	CLINGEN
      673	BRAF	0.319	0.846	C3536714	Renal dysplasia	disease	C16;C13;C12	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3539781	Progressive cGVHD	disease		Disease or Syndrome	0.10	1	2006	2019	  12	   3	BEFREE
      673	BRAF	0.319	0.846	C3541994	Drug Hypersensitivity Syndrome	disease	C17;C20;C25	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3544205	Ovarian clear cell carcinoma	disease		Neoplastic Process	0.03	1	2014	2018	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C3551426	Dystrophic fingernails	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3551431	Sparse or absent eyelashes	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3553764	Joint hyperflexibility	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3647143	Secondary malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.02	1	2018	2018	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C3665349	Secondary hypothyroidism	disease	C19	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C3665489	Borderline epithelial tumor of ovary	disease		Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3665593	Melanocytic nevus of skin	disease	C04	Neoplastic Process	0.10	0.968	2003	2019	  31	   2	BEFREE
      673	BRAF	0.319	0.846	C3697936	Sialadenoma papilliferum	disease		Neoplastic Process	0.01	1	2020	2020	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3714644	Thymus Neoplasms	group	C04;C15	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3714651	Follicular Variant Thyroid Gland Papillary Carcinoma	disease	C04;C19	Neoplastic Process	0.10	0.857	2006	2018	  14	   3	BEFREE
      673	BRAF	0.319	0.846	C3714753	RETINOSCHISIS 1, X-LINKED, JUVENILE	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.11	0.667	2006	2009	   3	   1	BEFREE;CLINVAR;HPO
      673	BRAF	0.319	0.846	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.02	1	2015	2019	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	C04	Neoplastic Process	0.07	0.857	2006	2018	   7	   0	BEFREE
      673	BRAF	0.319	0.846	C3827253	Classical Glioblastoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3839184	Low grade serous carcinoma	disease		Neoplastic Process	0.06	1	2013	2019	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C3839280	High grade serous carcinoma	disease		Neoplastic Process	0.03	1	2013	2019	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C3854181	Nevus sebaceous	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3854222	Human immunodeficiency virus (HIV) II infection category B1	disease		Disease or Syndrome	0.01	1	2006	2006	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3875007	Nodular thyroid disease	disease	C19	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3896578	Familial Colorectal Cancer Type X	disease	C16;C06;C04;C18	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3896673	Familial Nonmedullary Thyroid Gland Carcinoma	disease		Neoplastic Process	0.03	0.667	2005	2012	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C3897070	Childhood Gliomatosis Cerebri	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3897744	recurrent childhood pleomorphic xanthoastrocytoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3897746	recurrent childhood pilocytic astrocytoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3898222	mucosal melanoma	disease		Neoplastic Process	0.07	1	2011	2019	   7	   0	BEFREE
      673	BRAF	0.319	0.846	C3898709	Intestinal-Type Sinonasal Adenocarcinoma	disease		Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C3899645	Childhood Pleomorphic Xanthoastrocytoma	disease		Neoplastic Process	0.10	1	2011	2020	  27	   2	BEFREE
      673	BRAF	0.319	0.846	C3899646	Childhood Pilomyxoid Astrocytoma	disease		Neoplastic Process	0.03	0.667	2012	2016	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C3899655	Childhood Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.10	1	2010	2019	  27	   2	BEFREE
      673	BRAF	0.319	0.846	C3899658	Childhood Gliosarcoma	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3899659	Childhood Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.04	1	2013	2016	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C3899662	Childhood Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C3899668	Childhood Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3899676	Childhood Anaplastic Oligoastrocytoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C3900100	Adult Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.10	1	2010	2019	  27	   2	BEFREE
      673	BRAF	0.319	0.846	C3900101	Adult Germ Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4020962	Enlarged thorax	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4020968	Abnormal localization of kidney	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021095	Abnormal hypothalamus morphology	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021242	Hypoplasia of the zygomatic bone	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021250	Intracranial cystic lesion	phenotype	C16;C04;C10	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021533	Severe sensorineural hearing impairment	disease	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021662	Abnormal endocardium morphology	phenotype	C16;C14	Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021776	Abnormality of the voice	disease		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021789	Abnormality of the vertebral column	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021873	Abnormality of the frontal bone	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4021956	Aplasia/Hypoplasia of the eyebrow	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4022755	Functional abnormality of the gastrointestinal tract	phenotype		Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4022855	Abnormal involuntary eye movements	disease		Anatomical Abnormality	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4023205	Neoplasm of the anterior pituitary	disease	C04;C10;C19	Neoplastic Process	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4023385	Aplasia of the semicircular canal	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4023397	Abnormal hair quantity	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4023637	Abnormality of the nasal bone	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4023909	Aplasia/Hypoplasia of the abdominal wall musculature	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024220	Hypomelanotic macule	phenotype	C17	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024692	Reduced factor XIII activity	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024760	Progressive visual field defects	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024878	Generalized hyperpigmentation	phenotype	C17	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024890	Excessive wrinkled skin	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4024989	Hereditary nonpolyposis colorectal carcinoma	disease	C16;C06;C04;C18	Neoplastic Process	0.01	1	2005	2005	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4025662	Abnormality of the ulna	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4025749	Abnormality of the spleen	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4025759	Abnormal mitral valve morphology	disease		Anatomical Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4025846	Abnormality of vision	disease		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4041089	Poorly differentiated sarcoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4048329	Immunosuppression	disease		Disease or Syndrome	0.02	1	2010	2012	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C4049272	Tumour budding	disease		Neoplastic Process	0.03	1	2012	2019	   3	   0	BEFREE
      673	BRAF	0.319	0.846	C4049491	Verrucous keratosis	disease		Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4053521	Hemosiderotic Fibrolipomatous Tumor	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4072828	Sudden loss of visual acuity	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4073145	Hyperkeratosis pilaris	disease		Disease or Syndrome	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4073184	Thick hair	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4085873	LUSCAN-LUMISH SYNDROME	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.08	1	2012	2019	   8	   2	BEFREE
      673	BRAF	0.319	0.846	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.10	1	2006	2017	  11	   2	BEFREE
      673	BRAF	0.319	0.846	C4086178	Childhood Thyroid Gland Papillary Carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4087124	Immunoglobulin G4-Related Disease	disease	C20	Disease or Syndrome	0.01	1	2017	2017	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4087141	Skin squamous cell carcinoma metastatic	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4225426	THYROID CANCER, NONMEDULLARY, 2	disease		Neoplastic Process	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4281993	Neonatal respiratory distress	phenotype	C08	Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4282128	PATENT DUCTUS ARTERIOSUS 1	disease	C16;C14	Congenital Abnormality	0.02	1	2012	2015	   2	   3	BEFREE
      673	BRAF	0.319	0.846	C4282407	Sparse and thin eyebrow	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4283858	Anaplastic Pleomorphic Xanthoastrocytoma	disease	C04	Neoplastic Process	0.04	1	2018	2019	   4	   2	BEFREE
      673	BRAF	0.319	0.846	C4283978	Primary adenocarcinoma of lower third of esophagus due to Barrett esophagus	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.05	1	2013	2019	   5	   2	BEFREE
      673	BRAF	0.319	0.846	C4287590	Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features	disease	C04;C19	Neoplastic Process	0.06	0.833	2018	2019	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C4289580	Epithelioid glioblastoma	disease		Neoplastic Process	0.10	0.933	2014	2019	  15	   2	BEFREE
      673	BRAF	0.319	0.846	C4289690	Diffuse Glioma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4296896	Hyperplastic polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4477013	Impaired oropharyngeal swallow response	phenotype	C06;C09	Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4509816	Squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4511687	Pancreatic Intraductal Papillary Mucinous Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.03	1	2008	2020	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C4520731	Stage II Cutaneous Melanoma AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4520732	Stage IV Cutaneous Melanoma AJCC v6 and v7	disease		Neoplastic Process	0.10	1	2013	2019	  17	   3	BEFREE
      673	BRAF	0.319	0.846	C4520764	Stage 0 Cutaneous Melanoma AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4522181	Brachial Amyotrophic Diplegia	disease	C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4523846	MSI-high	disease		Neoplastic Process	0.10	1	2007	2019	  28	   2	BEFREE
      673	BRAF	0.319	0.846	C4524211	Sellar lesion	disease		Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4524257	MSI-low	disease		Neoplastic Process	0.09	0.889	2006	2018	   9	   2	BEFREE
      673	BRAF	0.319	0.846	C4524268	Advanced lung cancer	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4525124	Stage III Colon Cancer AJCC v8	disease		Neoplastic Process	0.07	1	2010	2019	   7	   2	BEFREE
      673	BRAF	0.319	0.846	C4525297	Stage 0 Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4525300	Stage IIA Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4525301	Stage IIB Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4525302	Stage III Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4525305	Stage IV Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4526729	Refractory Erdheim-Chester Disease	disease	C15	Neoplastic Process	0.01	1	2013	2013	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4544822	Microsatellite instability-high colorectal cancer	disease	C06;C04	Neoplastic Process	0.02	1	2008	2013	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.02	1	2016	2016	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C4551484	Leopard Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C4551485	Clinodactyly	disease		Congenital Abnormality	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4551517	Flared nostrils abnormality	phenotype		Finding	0.10				   0	   1	CLINVAR
      673	BRAF	0.319	0.846	C4551546	Refractory Hairy Cell Leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2014	2015	   2	   0	BEFREE
      673	BRAF	0.319	0.846	C4551548	Grade III Childhood Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4551583	Cerebral cortical atrophy	disease		Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4551602	Noonan Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.40	1	2007	2007	   1	   8	CLINVAR;CTD_human
      673	BRAF	0.319	0.846	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4551683	Adrenal Gland Pheochromocytoma	disease	C04;C19	Neoplastic Process	0.02	1	2016	2019	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.10	1	2003	2019	  12	   2	BEFREE
      673	BRAF	0.319	0.846	C4552097	Nevus Sebaceus of Jadassohn	disease	C16;C04;C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.10	0.957	2007	2020	  46	   2	BEFREE
      673	BRAF	0.319	0.846	C4553962	Hyperkeratosis, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4554036	Nystagmus, CTCAE 5.0	phenotype		Finding	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4684942	Refractory Thyroid Gland Carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4688319	Refractory Melanoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4721411	Osteolysis	phenotype	C05	Pathologic Function	0.10				   0	   0	HPO
      673	BRAF	0.319	0.846	C4721414	Mantle cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2015	2016	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.42	1	2003	2017	   2	   3	BEFREE;CLINVAR;UNIPROT
      673	BRAF	0.319	0.846	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.10	0.993	2008	2020	 145	   2	BEFREE
      673	BRAF	0.319	0.846	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.10	0.933	2003	2019	  15	   2	BEFREE
      673	BRAF	0.319	0.846	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.07	0.857	2006	2018	   7	   0	BEFREE
      673	BRAF	0.319	0.846	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.10	0.988	2004	2020	 252	   4	BEFREE
      673	BRAF	0.319	0.846	C4722099	High grade glioma	disease	C04	Neoplastic Process	0.03	1	2015	2019	   3	   2	BEFREE
      673	BRAF	0.319	0.846	C4722172	Primary differentiated carcinoma of thyroid gland	disease		Neoplastic Process	0.10	1	2009	2019	  11	   2	BEFREE
      673	BRAF	0.319	0.846	C4725091	metastatic intraocular melanoma	disease	C04;C11	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4725093	Unresectable Melanoma	disease	C04	Neoplastic Process	0.06	1	2013	2019	   6	   3	BEFREE
      673	BRAF	0.319	0.846	C4725861	Metastatic Malignant Neoplasm in the Viscera	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4727838	Advanced Melanoma	disease		Neoplastic Process	0.10	0.979	2011	2020	  94	   3	BEFREE
      673	BRAF	0.319	0.846	C4733213	stage IIIB melanoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   2	BEFREE
      673	BRAF	0.319	0.846	C4733333	familial non-medullary thyroid cancer	disease	C16;C04	Neoplastic Process	0.31	1	2012	2015	   2	   0	BEFREE;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C4733534	stage IVC anaplastic thyroid cancer	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4733538	recurrent papillary thyroid cancer	disease	C04;C19	Neoplastic Process	0.02	1	2011	2020	   2	   2	BEFREE
      673	BRAF	0.319	0.846	C4744444	Metastatic Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2013	2017	   2	   1	BEFREE
      673	BRAF	0.319	0.846	C4744527	Temporal Lobe Pleomorphic Xanthoastrocytoma	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      673	BRAF	0.319	0.846	C4744564	Metastatic Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.06	1	2011	2019	   6	   2	BEFREE
      673	BRAF	0.319	0.846	C4749367	Mesial temporal lobe epilepsy with hippocampal sclerosis	disease	C10	Disease or Syndrome	0.01	1	2018	2018	   1	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0221238	Mesangial proliferative glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0221271	Elastosis perforans serpiginosa	disease	C17	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0221352	Syndactyly of fingers	disease	C16;C13;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0221354	Frontal bossing	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.20	1	2012	2019	  17	   1	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0221357	Brachydactyly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0221500	Effects of heat	phenotype		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0221505	Lesion of brain	group		Disease or Syndrome	0.03	1	2015	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0233401	Psychiatric symptom	phenotype		Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0233514	Abnormal behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.13	1	2017	2019	   3	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0234132	Pyramidal sign	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0234144	Dysgraphia	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0234251	Inflammatory pain	phenotype	C23	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0235653	Malignant neoplasm of female breast	disease	C04;C17	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0235752	Port-Wine Stain	disease	C16;C17	Congenital Abnormality	0.12	1	2017	2019	   2	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0235782	Gallbladder Carcinoma	disease	C06;C04	Neoplastic Process	0.20	1	2011	2019	  13	   4	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.10	1	2003	2020	  57	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0235989	Renal interstitial fibrosis	disease	C13;C17;C12	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0236663	Alcohol withdrawal syndrome	disease	C25;F03	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0236734	Caffeine related disorders	group		Mental or Behavioral Dysfunction	0.05	1	2017	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238019	Carcinoma of extrahepatic bile duct	disease	C06;C04	Neoplastic Process	0.02	1	2016	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238033	Carcinoma of Male Breast	disease	C04;C17	Neoplastic Process	0.03	1	2013	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238034	Intraductal papilloma of breast	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.10	1	2006	2019	  20	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238301	Cancer of Nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.02	1	2008	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238348	Squamous cell carcinoma of penis	disease	C04;C12	Neoplastic Process	0.05	1	2018	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238461	Anaplastic thyroid carcinoma	disease	C04	Neoplastic Process	0.10	1	2005	2019	  21	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.03	1	2006	2015	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.10	1	2007	2019	  24	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0239676	High forehead	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.10	1	2013	2019	  14	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0240310	Hypoplasia of the maxilla	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0240635	Byzanthine arch palate	disease	C16;C05;C10;C07	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0240958	sciatic nerve pain	phenotype	C23	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0241665	Abnormal venous morphology	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242362	Disk, Herniated	disease	C23;C05	Acquired Abnormality	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.60	0.967	2002	2019	 123	   2	BEFREE;CGI;CTD_human
     5290	PIK3CA	0.292	0.923	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.02	1	2011	2013	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242596	Neoplasm, Residual	phenotype	C23;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242621	Isochromosomes	phenotype	C23	Acquired Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2019	2019	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C0242787	Malignant neoplasm of male breast	disease	C04;C17;C19	Neoplastic Process	0.03	1	2013	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242852	Proliferative vitreoretinopathy	disease	C11	Disease or Syndrome	0.04	1	2018	2020	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0242966	Systemic Inflammatory Response Syndrome	disease	C23	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.09	1	2011	2019	   9	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0243050	Cardiovascular Abnormalities	group	C16;C14	Congenital Abnormality	0.11	1	2019	2019	   1	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0262401	Carcinoma of ampulla of Vater	disease	C06;C04;C19	Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0263401	Cutis marmorata	disease	C16;C04;C17;C14;C26	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0265101	Carotid artery occlusion	phenotype	C10;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265210	Weaver syndrome	disease	C16;C05;C19	Disease or Syndrome	0.20				   0	   0	MGD
     5290	PIK3CA	0.292	0.923	C0265316	Neurocutaneous Syndromes	disease	C16;C17;C10	Disease or Syndrome	0.02	1	2015	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265319	Fibrous skin tumor of tuberous sclerosis	disease	C16;C04;C10	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.03	1	2005	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265326	Bannayan-Riley-Ruvalcaba Syndrome	disease	C16;C04	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265493	Cat eye syndrome	disease	C23;C16;C11	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265529	Plagiocephaly	disease	C16;C05	Congenital Abnormality	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C0265552	Congenital macrodactylia	disease	C16;C05	Congenital Abnormality	0.67	1	2009	2020	   8	   3	BEFREE;CLINVAR;GENOMICS_ENGLAND;HPO;UNIPROT
     5290	PIK3CA	0.292	0.923	C0265660	Syndactyly of the toes	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0265783	Congenital hypoplasia of lung	disease	C16;C08	Congenital Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0265950	Venous malformation	disease	C16	Congenital Abnormality	0.15	1	2015	2019	   5	   1	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0266166	Congenital duplication of intestine	disease		Congenital Abnormality	0.10	1	2019	2019	   1	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C0266464	Polymicrogyria	disease	C16;C10	Congenital Abnormality	0.12	1	2014	2017	   2	   1	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0266525	Irido-corneal dysgenesis	disease	C16;C11	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0266929	Chronic Periodontitis	disease	C07	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0267176	Gastroparesis with diabetes mellitus	disease	C23;C06;C10;C19	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0267812	Micronodular cirrhosis	disease	C23;C06	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0268074	Indian childhood cirrhosis	disease	C23;C06;C08	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0268575	Isovaleryl-CoA dehydrogenase deficiency	disease	C16;C18	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0268583	Methylmalonic acidemia	phenotype	C16;C18	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0271240	Blindness of one eye (disorder)	disease	C23;C11;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0271561	Somatotropin deficiency	disease	C16;C05;C10;C19	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0271713	Ketotic hypoglycemia	phenotype	C18	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0272139	Erythrocytosis due to low atmospheric pressure	disease	C15	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0272401	Virchow's node (disorder)	disease		Sign or Symptom	0.02	1	2014	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0274294	Chronic mountain sickness	disease	C23;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0275524	Coinfection	phenotype	C01	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0276096	Mastitis-metritis-agalactia syndrome	disease	C13;C01;C17	Disease or Syndrome	0.03	1	2005	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0276168	Egg drop syndrome	disease	C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0276289	Zika Virus Infection	disease	C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.02	1	2004	2008	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278479	Stage II Colon Cancer	disease	C06;C04	Neoplastic Process	0.03	0.667	2014	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278480	Stage III Colon Cancer	disease	C06;C04	Neoplastic Process	0.02	0.5	2011	2013	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278484	Malignant neoplasm of colon stage IV	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278488	Carcinoma breast stage IV	disease		Neoplastic Process	0.10	0.972	2010	2020	  36	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0278498	Malignant neoplasm of stomach stage IV	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.10	1	2005	2019	  15	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278579	Cervix carcinoma recurrent	disease	C04;C13	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278592	Adult Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278595	Adult Fibrosarcoma	disease	C04	Neoplastic Process	0.02	1	2002	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278601	Inflammatory Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.07	0.857	2014	2019	   7	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278607	Adult Leiomyosarcoma	disease	C04	Neoplastic Process	0.04	1	2007	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278608	Adult Liposarcoma	disease	C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278660	Adult Synovial Sarcoma	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278678	Metastatic Renal Cell Cancer	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.15	1	2005	2020	   6	  27	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C0278704	Malignant Childhood Neoplasm	disease	C04	Neoplastic Process	0.02	1	2013	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278764	Adult Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.10	1	2004	2020	  11	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278791	Chronic lymphocytic leukaemia refractory	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278802	Recurrent Endometrial Cancer	disease	C04;C13	Neoplastic Process	0.03	1	2017	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278803	Adenocarcinoma of small intestine	disease	C06;C04	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278838	Prostate cancer recurrent	disease	C04;C12	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278874	Adult Ependymoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.10	1	2005	2019	  15	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278877	Adult Meningioma	disease	C04;C10	Neoplastic Process	0.02	1	2016	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.10	0.924	2000	2020	  92	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278879	Childhood Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.10	1	2004	2020	  11	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.08	1	2008	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.40	1	2008	2020	  18	   0	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2008	2020	  16	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279068	Childhood Solid Neoplasm	phenotype		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279070	Adult Oligodendroglioma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279530	Malignant Bone Neoplasm	disease	C04;C05	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279550	Adult Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.10	1	2000	2019	  14	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279557	Adenosquamous cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279563	Lobular carcinoma in situ of breast	disease	C04;C17	Neoplastic Process	0.03	1	2015	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279565	Invasive Lobular Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.05	1	2016	2018	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279583	Childhood T Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2008	2009	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279584	Childhood B Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279592	Adult T Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2008	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279593	Adult B Acute Lymphoblastic Leukemia	disease		Neoplastic Process	0.02	1	2014	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279607	Adult Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	ORPHANET
     5290	PIK3CA	0.292	0.923	C0279612	Childhood Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.10	0.966	2003	2019	  59	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.35	1	2006	2017	   6	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C0279637	Anal carcinoma	disease	C06;C04	Neoplastic Process	0.05	1	2016	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279646	Childhood Acute Monocytic Leukemia	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279663	Serous cystadenocarcinoma ovary	disease	C04	Neoplastic Process	0.12	1	2008	2019	   3	   6	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C0279671	Cervical Squamous Cell Carcinoma	disease	C04;C13	Neoplastic Process	0.08	1	2014	2019	   8	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0279672	Cervical Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.11	1	2012	2016	   2	  20	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0279698	Squamous cell carcinoma of nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.40	1	2006	2019	  49	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C0279748	Undifferentiated carcinoma of nasopharynx	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279751	Adenoid cystic carcinoma of salivary gland	disease	C04;C07	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279982	Childhood Synovial Sarcoma	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279984	Childhood Liposarcoma	disease	C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279986	Childhood Leiomyosarcoma	disease	C04	Neoplastic Process	0.04	1	2007	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0279988	Childhood Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280099	Adult Solid Neoplasm	group		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.40	1	2005	2020	  47	   0	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C0280220	stage, ovarian epithelial cancer	disease		Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280222	stage, pancreatic cancer	phenotype	C06;C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280232	stage, cervical cancer	phenotype	C04;C13	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280321	Squamous cell carcinoma of the hypopharynx	disease		Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280324	Laryngeal Squamous Cell Carcinoma	disease	C04;C08;C09	Neoplastic Process	0.06	1	2016	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.10	0.924	2000	2020	  92	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280475	Childhood Oligodendroglioma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280630	Uterine Carcinosarcoma	disease	C04;C13	Neoplastic Process	0.12	1	2013	2016	   3	  14	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C0280631	Leiomyosarcoma of uterus	disease	C04;C13	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0280634	Adult Acute Monocytic Leukemia	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280781	Adult Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2011	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280803	Primary central nervous system lymphoma	disease	C04;C20;C10;C15	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0280856	Squamous cell carcinoma of vulva	disease	C04;C13	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0281361	Adenocarcinoma of pancreas	disease	C06;C04;C19	Neoplastic Process	0.13	1	2007	2016	   4	  10	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.03	1	2007	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0282193	Iron Overload	disease	C18	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0282488	Interstitial Cystitis	disease	C13;C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0302142	Deformity	group	C23;C16	Anatomical Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0302592	Cervix carcinoma	disease	C04;C13	Neoplastic Process	0.10	0.957	2000	2020	  47	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0302894	Stucco keratosis	disease	C17	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0332563	Papule	phenotype	C23	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0332573	Macule	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0332890	Congenital hemihypertrophy	disease	C23;C16;C13	Congenital Abnormality	0.12	1	2014	2015	   2	   1	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0333068	Flexion contracture	disease	C05	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0333307	Superficial ulcer	disease	C23	Acquired Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0333463	Senile Plaques	disease	C23	Acquired Abnormality	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0333516	Tumor necrosis	phenotype	C23	Neoplastic Process	0.02	1	2015	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0333983	Hyperplastic Polyp	disease	C23	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334082	NEVUS, EPIDERMAL (disorder)	disease	C04	Disease or Syndrome	0.43	1	2007	2009	   3	   2	BEFREE;CLINVAR;CTD_human
     5290	PIK3CA	0.292	0.923	C0334102	Lymphangiomatosis	disease	C04;C15;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334246	Squamous cell carcinoma, metastatic	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334254	Lymphoepithelial carcinoma	disease	C04	Neoplastic Process	0.01	0	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334294	Multiple adenomatous polyps	disease	C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334299	Carcinoid tumor no ICD-O subtype	phenotype	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334317	Cystadenofibroma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334345	Apocrine adenoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334348	Hidradenoma Papilliferum	disease	C04	Neoplastic Process	0.05	1	2016	2019	   5	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0334381	Non-infiltrating lobular carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334463	Malignant Fibrous Histiocytoma	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334471	Round Cell Liposarcoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334494	Proliferating Brenner Tumor	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334576	Gliomatosis cerebri	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.03	1	2011	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334590	Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0334595	Ganglioneuromatosis	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.06	1	2012	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0334663	Histiocytic sarcoma	disease	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0338078	Non-Functioning Pituitary Gland Neoplasm	disease	C04;C10;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0338106	Adenocarcinoma of colon	disease	C06;C04	Neoplastic Process	0.04	1	2011	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.20	1	2012	2019	  23	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0339143	Thyroid associated opthalmopathies	disease	C16;C11;C20;C19	Disease or Syndrome	0.03	1	2014	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0339543	Epiretinal Membrane	disease	C11	Acquired Abnormality	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0340044	Acute exacerbation of chronic obstructive airways disease	phenotype	C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0340279	Ventricular hypertrophy	disease	C23;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0340803	Capillary malformation (disorder)	disease	C16;C14	Congenital Abnormality	0.13	1	2015	2020	   3	   2	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0341823	Epithelial tumor of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5290	PIK3CA	0.292	0.923	C0341858	Endometriosis of uterus	disease	C13	Disease or Syndrome	0.04	1	2015	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0342257	Complications of Diabetes Mellitus	group	C19	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0342782	Depletion of mitochondrial DNA	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.06	1	2010	2018	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.08	1	2016	2020	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345893	Juvenile polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	1	2008	2020	  16	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.06	1	2015	2018	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345907	Angiosarcoma of liver	disease	C06;C04;C14	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345946	Squamous cell carcinoma of trachea	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346053	Atypical fibroxanthoma of skin	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346109	Malignant Mesothelioma of Peritoneum	disease	C04;C08	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CLINGEN
     5290	PIK3CA	0.292	0.923	C0346163	Endometrioid carcinoma ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346170	Serous cystadenoma of ovary	disease	C04;C13;C19	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0346210	Vulval intraepithelial neoplasia	disease	C04;C13	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346255	Oncocytoma, renal	disease	C04;C13;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346326	Optic Nerve Glioma	disease	C04;C11;C10	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346360	Malignant melanoma of conjunctiva	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346388	Malignant melanoma of choroid	disease	C04;C11	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346429	Multiple malignancy	phenotype	C04	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346629	Malignant neoplasm of large intestine	disease	C06;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.10	1	2003	2020	  57	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346975	Secondary malignant neoplasm of rectum	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346989	Secondary malignant neoplasm of peritoneum	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0347180	Penile intraepithelial neoplasia	disease	C23;C04;C13;C17;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0347509	Benign neoplasm of central nervous system	group	C04;C10	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0349458	Cervical intraepithelial neoplasia grade 1	disease	C04;C13	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349459	Cervical intraepithelial neoplasia grade 2	disease	C04;C13	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349534	Carcinoma of anal margin	disease	C06;C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349566	Squamous cell carcinoma of tongue	disease	C04;C07	Neoplastic Process	0.04	1	2003	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349588	Short stature	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0349636	Pre B-cell acute lymphoblastic leukemia	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.04	1	2014	2017	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0349788	Arrhythmogenic Right Ventricular Dysplasia	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0362030	Verrucous epidermal nevus	disease	C16;C04;C10	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0374997	Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0375206	Hemiplegia/hemiparesis	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.50	0.984	2005	2020	 127	   1	BEFREE;CLINVAR;CTD_human
     5290	PIK3CA	0.292	0.923	C0376544	Hematopoietic Neoplasms	group	C04;C15	Neoplastic Process	0.03	1	2008	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.10	1	2006	2020	  15	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0391826	Lhermitte-Duclos disease	disease	C16;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.04	1	2014	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0392525	Nephrolithiasis	disease	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0392885	High density lipoprotein measurement	phenotype		Laboratory Procedure	0.10	1	2012	2012	   1	   1	GWASDB
     5290	PIK3CA	0.292	0.923	C0393576	Chorea Acanthocytosis Syndrome	disease	C16;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0393626	Opsoclonus-Myoclonus Syndrome	disease	C04;C11;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0393706	Early infantile epileptic encephalopathy with suppression bursts	disease	C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0393754	Headache associated with sexual activity	phenotype	C23	Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0398368	Lymphatic Abnormalities	group	C16;C15	Anatomical Abnormality	0.10	1	2015	2019	  12	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0398686	Primary immune deficiency disorder	group	C20	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0398689	Hyper-IgM Immunodeficiency Syndrome, Type 1	disease	C16;C20;C15	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0398738	Leukocyte adhesion deficiency type 1	disease	C16;C20	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0398791	Nijmegen Breakage Syndrome	disease	C18	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0399440	Hereditary gingival fibromatosis	disease	C16;C07	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.10	1	2017	2019	  11	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0409959	Osteoarthritis, Knee	disease	C05	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0410480	Avascular Necrosis of Femur Head	phenotype	C23;C05	Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0423110	Downward slant of palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0423224	Sunken eyes	phenotype	C23;C11;C10	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.10	1	2000	2019	  20	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0424939	Learning difficulties	phenotype		Finding	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C0428472	Serum HDL cholesterol measurement	phenotype		Laboratory Procedure	0.10	1	2012	2012	   1	   1	GWASDB
     5290	PIK3CA	0.292	0.923	C0431380	Cortical Dysplasia	disease	C16;C10	Congenital Abnormality	0.31	1	2012	2017	   2	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C0431391	Hemimegalencephaly	disease	C16;C05;C10	Disease or Syndrome	0.45	1	2012	2018	   5	   1	BEFREE;CLINVAR;ORPHANET
     5290	PIK3CA	0.292	0.923	C0432072	Dysmorphic features	disease		Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0432283	Osteoglophonic dwarfism	disease	C16;C05	Congenital Abnormality	0.05	1	2017	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0432487	Post-transplant lymphoproliferative disorder	disease	C01;C20;C15	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0442874	Neuropathy	group	C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0456103	Sepsis of the newborn	disease	C23;C16;C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0472390	High altitude cerebral edema	disease	C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.20	0.991	2001	2019	 106	   7	BEFREE;CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	1	2006	2019	  16	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0495640	Congenital malformation syndromes involving early overgrowth	disease		Disease or Syndrome	0.20				   0	   0	MGD
     5290	PIK3CA	0.292	0.923	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     5290	PIK3CA	0.292	0.923	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5290	PIK3CA	0.292	0.923	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     5290	PIK3CA	0.292	0.923	C0497156	Lymphadenopathy	phenotype	C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0520679	Sleep Apnea, Obstructive	disease	C08;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0521158	Recurrent tumor	phenotype		Neoplastic Process	0.04	1	2014	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0521857	Increased drug resistance	phenotype		Disease or Syndrome	0.02	1	2002	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0524528	Pervasive Development Disorder	group	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.06	1	2014	2020	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.10	1	2011	2020	  10	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.02	1	1998	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0542476	Forgetful	phenotype	C23;C10;F03;F01	Sign or Symptom	0.11	1	2019	2019	   1	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0542518	Enlarged kidney	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0544886	Somatic mutation	phenotype		Cell or Molecular Dysfunction	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0545074	Myxoid/Round Cell Liposarcoma	disease	C04	Neoplastic Process	0.02	1	2012	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.10	0.95	2006	2020	  20	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.40	0.977	2005	2019	  43	   1	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C0549523	Oropharynx (excludes nasopharynx)	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.08	0.875	2002	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0553694	Oropharyngeal disorders	group	C06;C08;C07;C09	Disease or Syndrome	0.03	1	2013	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0553723	Squamous cell carcinoma of skin	disease	C04;C17	Neoplastic Process	0.10	1	2014	2019	  11	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.06	1	2002	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.12	1	2017	2019	   2	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C0558353	Tongue Carcinoma	disease	C04;C07	Neoplastic Process	0.03	1	2011	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0558355	Tonsillar Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0563312	IgM monoclonal gammopathy of uncertain significance	disease	C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0575081	Gait abnormality	group	C23;C10	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0585362	Squamous cell carcinoma of mouth	disease	C06;C04;C07	Neoplastic Process	0.30				   0	   0	CGI
     5290	PIK3CA	0.292	0.923	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.10	1	2012	2020	  81	   5	BEFREE
     5290	PIK3CA	0.292	0.923	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0595921	Intraocular pressure disorder	disease	C11	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0595989	Carcinoma of larynx	disease	C04;C08;C09	Neoplastic Process	0.07	1	2015	2018	   7	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.10	0.982	2000	2020	 335	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0598608	Hyperhomocysteinemia	disease	C16;C18	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0598766	Leukemogenesis	disease	C23;C04	Neoplastic Process	0.10	1	2005	2020	  13	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0598935	Tumor Initiation	phenotype	C23;C04	Neoplastic Process	0.08	1	2005	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0600041	Infective cystitis	disease	C23;C13;C01;C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.10	0.984	2003	2020	 125	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677607	Hashimoto Disease	disease	C19	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677659	Gastro-esophageal reflux disease with esophagitis	disease	C23;C06	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677728	Indolent Adult Non-Hodgkin Lymphoma	disease		Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677865	Brain Stem Glioma	disease	C04;C10	Neoplastic Process	0.10	1	2016	2016	   1	   9	CLINVAR
     5290	PIK3CA	0.292	0.923	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.20	1	2007	2020	  24	   3	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C0677898	invasive cancer	phenotype	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677932	Progressive Neoplastic Disease	phenotype		Neoplastic Process	0.04	1	2013	2018	   4	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0677936	Refractory cancer	phenotype	C04	Neoplastic Process	0.02	1	2009	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677944	Sentinel node (disorder)	disease		Disease or Syndrome	0.03	0.667	2013	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0677948	Stage II Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.987	2001	2020	 520	   8	BEFREE;CGI;CTD_human;HPO
     5290	PIK3CA	0.292	0.923	C0678230	Congenital Epicanthus	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0679403	Vascular stenosis	disease	C23	Anatomical Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.50	0.972	2002	2019	 106	   4	BEFREE;CGI;CLINVAR
     5290	PIK3CA	0.292	0.923	C0684337	Ewings sarcoma-primitive neuroectodermal tumor (PNET)	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0685938	Malignant neoplasm of gastrointestinal tract	disease	C06;C04	Neoplastic Process	0.02	1	2005	2012	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0686377	CNS metastases	phenotype	C04;C10	Neoplastic Process	0.02	1	2016	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.10	1	2006	2019	  22	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0687150	Parathyroid Gland Adenocarcinoma	disease	C04;C19	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0687720	Central Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0699753	Cancer Relapse	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2000	2019	  69	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.992	2003	2020	 121	   0	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.10	1	2006	2020	  39	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C0699889	Malignant Female Reproductive System Neoplasm	disease	C04;C13	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0699893	Skin carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.10	0.952	2002	2019	  42	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0730328	Central Serous Chorioretinopathy	disease	C11	Disease or Syndrome	0.02	1	2012	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0740277	Bile duct carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.10	1	2017	2019	  10	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0740447	Diabetic peripheral neuropathy	disease	C10;C19	Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.05	1	2007	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0740766	Acute pneumonia	disease	C01;C08	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0741250	aspirin sensitivity	phenotype		Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0744619	Head and neck cancer metastatic	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0744620	Metastatic Head and Neck Squamous Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0745730	Multiple lipomata	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0746731	Acute myocardial ischemia	disease	C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0747548	Pharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.02	1	2006	2008	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0747845	early pregnancy	phenotype		Disease or Syndrome	0.01	0	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0748355	Acute respiratory distress	disease	C23;C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0748607	Recurrent seizure	disease	C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0750929	Arnold-Chiari Malformation, Type I	disease	C16;C10	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.07	1	2015	2019	   7	   3	BEFREE
     5290	PIK3CA	0.292	0.923	C0751396	Well Differentiated Oligodendroglioma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0751560	Malignant neoplasm tonsil	disease	C04;C07;C09	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.10	1	2008	2019	  10	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0751688	Malignant Squamous Cell Neoplasm	disease	C04	Neoplastic Process	0.04	1	2011	2017	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0752130	Spinal Cord Ischemia	disease	C10;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0752304	Hypoxic-Ischemic Encephalopathy	disease	C10;C14	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0795839	Chromosome 10, monosomy 10q	disease	C23	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0796070	MICROPHTHALMIA, SYNDROMIC 7	disease	C16;C11;C17	Disease or Syndrome; Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0796074	MOHR-TRANEBJAERG SYNDROME	disease	C23;C16;C11;C10;F03;C09;F01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0796160	MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE	disease	C16;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0796611	Newly Diagnosed Childhood Ependymoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0796663	Childhood Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.07	1	2008	2017	   7	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0813148	Metastatic Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0848558	Hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0851140	Carcinoma in situ of uterine cervix	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0851887	Adenoviral infections	group		Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0852036	Pregnancy associated hypertension	phenotype	C13;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0853105	Penis carcinoma	disease	C04;C12	Neoplastic Process	0.04	1	2008	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0853879	Invasive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.10	1	2010	2019	  13	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0854178	Metastases to adrenals	disease	C04;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0854917	Rhabdoid Tumor of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.04	1	2009	2017	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0854924	Papillary serous endometrial carcinoma	disease	C04;C13	Neoplastic Process	0.08	1	2009	2016	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0855073	Undifferentiated (Embryonal) Sarcoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C0855090	B-cell lymphoma refractory	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0855095	Small Lymphocytic Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0855112	Diffuse large B-cell lymphoma refractory	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0856169	Endothelial dysfunction	phenotype		Disease or Syndrome	0.08	1	2017	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0858004	Influenza A virus infection	disease	C01;C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.41	1	2018	2018	   1	   3	BEFREE;CGI;CLINVAR
     5290	PIK3CA	0.292	0.923	C0860581	Mucinous breast cancer	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0861772	Stage IV Rectal Carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0862506	Borderline ovarian tumour	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0862878	Dedifferentiated chondrosarcoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0867389	Chronic graft-versus-host disease	disease	C20	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0870082	Hyperkeratosis	disease	C23;C17	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0872084	Sarcopenia	phenotype	C23;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0876973	Infectious Lung Disorder	group	C01;C08	Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0877008	Enzyme inhibition disorder	phenotype		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0878500	Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.05	1	1997	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0878649	Gastric hyperplastic polyp	disease	C06;C04	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0878675	Erdheim-Chester Disease	disease	C15	Disease or Syndrome	0.02	1	2014	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0878684	SHORT syndrome	disease	C23;C18;C13;C12	Disease or Syndrome	0.04	1	2013	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.70	0.984	1999	2019	  62	  13	BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN
     5290	PIK3CA	0.292	0.923	C0920350	Autoimmune thyroiditis	disease	C20;C19	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0920372	Carcinogenesis, Radiation	phenotype	C23;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0920646	Ischemia of kidney	disease	C13;C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0936223	Metastatic Prostate Carcinoma	disease	C04;C12	Neoplastic Process	0.04	1	2005	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0940937	precancerous lesions	phenotype		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0947751	Vascular inflammations	phenotype	C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0948008	Ischemic stroke	disease	C10;C14	Disease or Syndrome	0.10	1	2016	2019	  11	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0948444	Mitochondrial DNA mutation	disease		Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C0949059	Polyp of large intestine	disease	C23;C06;C04	Neoplastic Process	0.12	1	2008	2012	   2	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C1096063	Drug Resistant Epilepsy	disease	C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1096184	West Nile viral infection	disease	C01;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1096903	Sialic Acid Storage Disease, Finnish Type (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
     5290	PIK3CA	0.292	0.923	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1135868	Gestational Trophoblastic Neoplasms	group	C04;C13	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.70	0.986	1999	2019	  72	   4	BEFREE;CGI;CTD_human;UNIPROT
     5290	PIK3CA	0.292	0.923	C1142533	Smooth philtrum	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1145628	Autonomic nervous system disorders	group	C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1167791	Skin toxicity	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1168327	High-Grade Prostatic Intraepithelial Neoplasia	disease	C04;C12	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.50	1	2001	2020	  68	  29	BEFREE;CLINVAR;CTD_human
     5290	PIK3CA	0.292	0.923	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.10	1	2007	2019	  10	   1	BEFREE;LHGDN
     5290	PIK3CA	0.292	0.923	C1257915	Intestinal Polyposis	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2015	   8	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1260954	Morphologically altered structure	disease		Anatomical Abnormality	0.01	1	2006	2006	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1261473	Sarcoma	group	C04	Neoplastic Process	0.40	1	2007	2019	  11	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C1261502	Finding of Mean Corpuscular Hemoglobin	phenotype		Finding	0.10	1	2018	2019	   2	   2	GWASCAT
     5290	PIK3CA	0.292	0.923	C1262048	Glial scar	phenotype		Acquired Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1262477	Weight decreased	phenotype	C23	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.11	1	2009	2009	   1	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C1265968	Hyperparakeratosis	phenotype	C17	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1266005	Basaloid squamous cell carcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266025	Traditional Serrated Adenoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266029	Enterochromaffin-like cell carcinoid	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2013	2018	   2	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1266050	Poorly Differentiated Thyroid Carcinoma	disease	C04;C19	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266146	Adenomyoepithelioma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266177	Dysembryoplastic neuroepithelial tumor	disease	C04	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1266184	Atypical Teratoid Rhabdoid Tumor	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	0.99	2000	2020	 382	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1274594	Lichenoid actinic keratosis	disease	C04;C17	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1275122	Familial multiple trichoepitheliomata	disease	C16;C04;C17	Neoplastic Process	0.04	1	2013	2017	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1275126	TNF receptor-associated periodic fever syndrome (TRAPS)	disease	C23;C16;C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1280433	Lipoatrophy	disease	C18;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1282496	Metastasis from malignant tumor of prostate	disease		Neoplastic Process	0.04	1	2005	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1285162	Degenerative disorder	group	C23	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1290884	Inflammatory disorder	group	C23	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1290886	Chronic inflammatory disorder	group	C23	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1292754	Mediastinal (Thymic) Large B-Cell Lymphoma	disease	C04;C08;C20;C15	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.04	0.75	2013	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.08	1	2012	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1297883	Radial scar	disease	C23	Acquired Abnormality	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1298180	Single tumor	phenotype		Neoplastic Process	0.02	1	2013	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1301034	Pancreatic intraepithelial neoplasia	disease	C04	Neoplastic Process	0.02	1	2012	2014	   2	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C1301194	Salivary duct carcinoma	disease	C04	Neoplastic Process	0.07	0.857	2013	2019	   7	   3	BEFREE
     5290	PIK3CA	0.292	0.923	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.986	2001	2020	 629	   4	BEFREE
     5290	PIK3CA	0.292	0.923	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.971	2002	2019	 105	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C1306557	Chronic venous insufficiency	disease	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1306710	Facial asymmetry	phenotype	C23	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1318544	M5b Acute differentiated monocytic leukemia	disease	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.32	1	2016	2018	   2	   0	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C1328402	Metastatic glioma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1328504	Hormone refractory prostate cancer	disease	C04;C12	Neoplastic Process	0.10	1	2004	2020	  20	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332167	Adenoid cystic breast carcinoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.10	1	2008	2019	  13	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.10	1	2012	2019	  18	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332271	Perianal Squamous Intraepithelial Neoplasia	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332347	Atypical Ductal Breast Hyperplasia	disease	C04	Neoplastic Process	0.03	1	2010	2014	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332638	Breast Small Cell Carcinoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332912	Cervical Clear Cell Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.10	0.963	2008	2019	  27	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.10	1	2012	2019	  18	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.10	1	2012	2020	  79	   5	BEFREE
     5290	PIK3CA	0.292	0.923	C1332995	Childhood Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2011	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333015	Childhood Kidney Wilms Tumor	disease	C16;C04;C13;C12	Neoplastic Process	0.04	1	2008	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333064	Classical Hodgkin's Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333190	Cystic Neoplasm	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333394	Endometrial intraepithelial neoplasia	disease	C04;C13	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333431	EBV-Related Lymphoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333472	Ethmoid Sinus Adenocarcinoma	disease		Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.32	1	2007	2010	   2	   0	BEFREE;ORPHANET
     5290	PIK3CA	0.292	0.923	C1333992	Hereditary Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334170	Indolent Non-Hodgkin Lymphoma	disease		Neoplastic Process	0.06	1	2017	2020	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334177	Infiltrating Cervical Carcinoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334274	Invasive Carcinoma	phenotype	C04	Neoplastic Process	0.04	1	2007	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334664	Mediastinal Lymphangioma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334699	Mesenchymal Cell Neoplasm	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334708	Metaplastic carcinoma of breast	disease		Neoplastic Process	0.03	1	2017	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334807	Mucinous carcinoma of breast	disease	C04;C17	Neoplastic Process	0.02	1	2012	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1334815	Multi-centric Castleman's Disease	disease	C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.10	1	2007	2019	  20	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1335367	Parotid Gland Squamous Cell Carcinoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1335389	Lipomatosis of Nerve	disease	C04;C18;C17;C10	Disease or Syndrome	0.01	0	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1335975	Skull Base Chordoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1336076	Sporadic Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1336078	Papillary renal cell carcinoma, sporadic	disease	C04;C13;C12	Neoplastic Process	0.10	1	2016	2016	   1	   5	CLINVAR
     5290	PIK3CA	0.292	0.923	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1336745	Thymic Lymphoma	disease	C04;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1336905	Endometrial Endometrioid Adenocarcinoma	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1337011	Well Differentiated Pancreatic Endocrine Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1337013	Differentiated Thyroid Gland Carcinoma	disease		Neoplastic Process	0.03	1	2008	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1367654	Marginal Zone B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1368275	Pigmented Basal Cell Carcinoma	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1368404	Hypopharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.03	1	2002	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1368920	Atypical Lobular Breast Hyperplasia	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.05	1	2007	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1384583	Congenital absence of germinal epithelium of testes	disease	C12	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1403035	Subcutaneous lipoma	disease	C04;C17	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1412036	Anal squamous cell carcinoma	disease	C06;C04	Neoplastic Process	0.06	1	2014	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.08	1	2007	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1456633	Cancer, Benign	phenotype		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.978	2004	2020	  89	  34	BEFREE;CLINVAR;CTD_human;LHGDN
     5290	PIK3CA	0.292	0.923	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.06	1	2009	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1510885	Angiogenic Switch	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1512127	HER2 gene amplification	disease		Disease or Syndrome	0.10	0.967	1996	2019	  30	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1512409	Hepatocarcinogenesis	disease	C23;C04	Neoplastic Process	0.06	1	2006	2018	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1512981	Mammary Tumorigenesis	phenotype	C23;C04	Neoplastic Process	0.03	1	2013	2018	   3	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C1514422	Glioblastoma, IDH-Wildtype	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1518693	Clear cell adenocarcinoma of ovary	disease	C04	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1519353	Skin Papule	phenotype	C17	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.10	1	2004	2018	  16	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1519678	Tumor Expansion	phenotype		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1519680	Tumor Immunity	phenotype	C23	Disease or Syndrome	0.04	1	2017	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1519689	Tumor Promotion	phenotype	C23;C04	Neoplastic Process	0.02	1	2010	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1527336	Sjogren's Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1527349	Ductal Breast Carcinoma	disease	C04	Neoplastic Process	0.02	1	2009	2010	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1531647	Cerebral ventriculomegaly	phenotype	C10	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1536999	cancer angiogenesis	phenotype		Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1541317	Adult Gliosarcoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.04	1	2017	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1562113	Fleck corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1569637	Adenocarcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.02	1	2009	2015	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1608389	Autoimmune myocarditis	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.10	1	2005	2018	  13	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1610069	Circulatory depression	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1611743	Familial (FPAH)	disease		Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.50	0.941	2000	2020	 152	   0	BEFREE;CGI;HPO
     5290	PIK3CA	0.292	0.923	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.02	1	2013	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1654637	androgen independent prostate cancer	disease		Neoplastic Process	0.04	1	2014	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1691215	Penile hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1695782	Cerebral hypoperfusion	disease		Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1701919	EBV viremia	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.03	1	2018	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1704356	Enchondroma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1704376	Uterine Corpus Carcinosarcoma	disease		Neoplastic Process	0.02	1	2013	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1707291	NUT midline carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1707444	Columnar Cell Change of the Breast	phenotype		Neoplastic Process	0.01	1	2014	2014	   1	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1708566	Invasive Prostate Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1709527	B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1717947	Incisional pain	phenotype		Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1720771	Testicular Hydrocele	disease	C12	Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1739135	Progression of prostate cancer	disease		Neoplastic Process	0.06	0.833	2005	2018	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1762616	Meningioma, benign, no ICD-O subtype	disease	C04;C10	Neoplastic Process	0.02	1	2016	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.09	1	2013	2019	   9	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1827293	Carcinoma of urinary bladder, invasive	disease	C04;C13;C12	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1832451	Cranial hyperostosis	phenotype	C05	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.10	0.967	2007	2019	  30	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1834711	CEREBELLOPARENCHYMAL DISORDER VI	disease	C16;C04;C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1834712	Cerebellar Granule Cell Hypertrophy and Megalencephaly	disease	C16;C04;C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1836542	Depressed nasal bridge	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1836599	Macrocephaly at birth	phenotype	C16;C05;C10	Finding	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1836735	hypopigmented skin patch	phenotype	C17	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1836830	Developmental regression	disease	F03	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1840069	Sandal gap	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1840264	IMMUNE SUPPRESSION	phenotype		Disease or Syndrome	0.03	1	2011	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1840311	Laryngeal cleft	disease	C16	Congenital Abnormality	0.02	1	2018	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1840380	Persistent cavum septum pellucidum	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1841972	Glucocorticoid Receptor Deficiency	disease	C16;C18	Disease or Syndrome	0.03	1	2015	2016	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1842774	Hypermelanotic macule	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1843013	Alzheimer disease, familial, type 3	disease	C10;F03	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1844573	Large earlobe	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1845668	Perisylvian syndrome	disease	C23;C16;C10;F03;F01	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1846385	FOCAL CORTICAL DYSPLASIA OF TAYLOR	disease	C16;C10	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1847540	Azoospermia, Nonobstructive	disease	C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1847835	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1848395	Large for gestational age	phenotype	C23;C13	Finding	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1849089	Broad forehead	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1849157	Resistance to Insulin-Like Growth Factor I	disease	C23;C16	Disease or Syndrome	0.03	0.667	2017	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1849265	Overgrowth	phenotype		Finding	0.10	1	2006	2018	  14	   3	CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C1849677	Numerous nevi	phenotype	C04	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1851584	Childhood Ependymoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1851710	LATERAL MENINGOCELE SYNDROME	disease	C23;C16;C10	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1851841	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	disease	C16;C17;C05;C07	Disease or Syndrome	0.06	1	2011	2015	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1853237	Isolated cases	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1854465	TUBEROUS SCLEROSIS 1 (disorder)	disease	C16;C04;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1855038	Hepatocellular necrosis	phenotype		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1855204	Cellular immunodeficiency	phenotype	C20	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1856184	HEMIHYPERPLASIA, ISOLATED	disease	C23	Disease or Syndrome	0.02	1	2014	2015	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1857276	Trichohepatoenteric Syndrome	disease	C23;C16;C13;C17	Disease or Syndrome	0.01	1	2018	2018	   1	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C1858120	Generalized hypotonia	phenotype	C23;C10	Finding	0.10				   0	   1	CLINVAR;HPO
     5290	PIK3CA	0.292	0.923	C1858430	Death in infancy	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1859896	Progressive macrocephaly	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1861901	Subacute progressive viral hepatitis	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1861906	Breast Cancer, Familial Male	disease	C04;C17	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1861975	Cafe au lait spots, multiple	disease	C23;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1862382	SVEINSSON CHORIORETINAL ATROPHY	disease	C16;C11	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1863753	LIMB-MAMMARY SYNDROME	disease	C16;C05	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C1865285	Megalencephaly cutis marmorata telangiectatica congenita	disease	C16;C17;C05;C10;C14	Disease or Syndrome	0.77	1	2009	2020	  12	  16	BEFREE;CLINVAR;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5290	PIK3CA	0.292	0.923	C1866129	Abnormality of the cerebellum	group	C10	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1866231	Full cheeks	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1866376	Pten Hamartoma Tumor Syndrome With Granular Cell Tumor	disease	C16;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1866398	Proteus-Like Syndrome (disorder)	disease	C16;C04;C05	Disease or Syndrome	0.10				   0	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C1867441	Pterygium Of Conjunctiva And Cornea	disease	C11	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.02	1	2010	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1868773	Diabetic encephalopathy	disease		Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1881254	Inverted Squamous Cell Papilloma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1883722	Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1955869	Malformations of Cortical Development	disease	C16;C10	Disease or Syndrome	0.32	1	2012	2018	   3	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.04	1	2009	2019	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1959582	PTEN Hamartoma Tumor Syndrome	disease	C16;C04	Neoplastic Process	0.15	1	2014	2020	   5	   1	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.10	1	2005	2020	  32	   3	BEFREE
     5290	PIK3CA	0.292	0.923	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.10	1	2005	2019	  22	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.05	1	2012	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1961121	Congenital vascular anomaly	group	C16	Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1962942	TRICHOMONAS VAGINALIS (finding)	disease		Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1963165	Malabsorption, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1963167	Memory Impairment, CTCAE 3.0	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C1968949	Cakut	disease	C16;C13;C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1969372	Tubulointerstitial fibrosis	phenotype		Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C1969913	Generalized hyperkeratosis	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C2004493	Leukemia, B-Cell	disease	C04;C20;C15	Neoplastic Process	0.02	1	2013	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2062441	Influenza A	disease		Disease or Syndrome	0.06	1	2010	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2118460	Acute colitis	disease	C06	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2145472	Urothelial Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.09	0.778	2009	2018	   9	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.80	0.966	2002	2020	 175	  13	BEFREE;CGI;CLINVAR;CTD_human;HPO;UNIPROT
     5290	PIK3CA	0.292	0.923	C2243051	Large head (disorder)	phenotype		Finding	0.10				   0	   2	CLINVAR
     5290	PIK3CA	0.292	0.923	C2243086	basal cell adenocarcinoma of salivary gland	disease	C04	Neoplastic Process	0.02	1	2016	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2347747	Adult Classical Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2347748	Adult Erythroleukemia	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2347761	Childhood Myelodysplastic Syndrome	disease	C15	Neoplastic Process	0.02	1	2012	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2349952	Oropharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.04	1	2013	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2363741	HIV-1 infection	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2363955	Venous reflux	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2607914	Allergic rhinitis (disorder)	disease	C08;C20;C09	Disease or Syndrome	0.02	1	2011	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2609289	Diabetic arteriosclerosis	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2700617	Irritation - emotion	phenotype	F01	Mental Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C2711110	Hepatitis B and hepatitis C	disease	C06;C01	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.05	1	2017	2020	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2720434	Macroencephaly	disease		Congenital Abnormality	0.10	1	2012	2019	  15	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C2732473	Ductal Carcinoma In Situ with Microinvasion	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2732618	Sessile Serrated Adenoma/Polyp	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2732838	Neoplasm of skeletal system	disease		Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C2732979	Acquired long QT syndrome	disease	C23;C16;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2745900	Promyelocytic leukemia	disease		Neoplastic Process	0.02	1	2014	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2745963	Kashin-Beck Disease	disease	C05	Disease or Syndrome	0.03	1	2015	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2749484	NEUROBLASTOMA, SUSCEPTIBILITY TO	phenotype		Finding	0.10	1	2016	2016	   1	   3	CLINVAR
     5290	PIK3CA	0.292	0.923	C2751313	CLAPO Syndrome	disease	C16;C15;C14	Disease or Syndrome; Congenital Abnormality	0.60	1	2009	2018	   2	   5	CLINVAR;GENOMICS_ENGLAND;UNIPROT
     5290	PIK3CA	0.292	0.923	C2752042	Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	disease	C16;C04;C05;C14	Disease or Syndrome	0.95	1	2009	2017	   8	   5	BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;MGD;ORPHANET;UNIPROT
     5290	PIK3CA	0.292	0.923	C2752147	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	disease	C16;C04;C18;C17	Disease or Syndrome; Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2827407	Infectious Otitis Media	disease	C09	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2828150	HPV positive oropharyngeal squamous cell carcinoma	disease		Neoplastic Process	0.03	1	2013	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2894027	Post traumatic osteoarthritis	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2919142	Short Stature, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C2919828	Chronic ulcerative colitis	disease	C06	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.02	1	2014	2014	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2931202	Urachal cancer	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2931367	Thyroid cancer, follicular	disease	C04	Neoplastic Process	0.04	1	2009	2017	   4	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C2931618	Gestational trophoblastic disease	disease	C04;C13	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.40	1	2002	2020	  49	   0	BEFREE;CTD_human
     5290	PIK3CA	0.292	0.923	C2931826	Potassium aggravated myotonia	disease	C16;C05;C10	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2936349	Plaque, Amyloid	disease	C23	Acquired Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.03	1	2019	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2936904	Opitz GBBB Syndrome, X-Linked	disease	C16;C13;C05;C12;C07	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2937220	Congenital abnormality of vein	group	C16;C14	Congenital Abnormality	0.15	1	2015	2019	   5	   1	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C2937421	Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2938905	Central Nervous System Sensitization	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2938924	Oestrogen receptor positive breast cancer	disease		Neoplastic Process	0.10	1	2009	2019	  28	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2938983	Focal cortical dysplasia	disease	C16;C10	Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.10	0.957	2003	2019	  47	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2945695	Limb ischemia	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2973725	Pulmonary arterial hypertension	disease	C08;C14	Disease or Syndrome	0.03	1	2017	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.31	1	2013	2013	   1	   0	BEFREE;PSYGENET
     5290	PIK3CA	0.292	0.923	C2986561	Spindle Cell Oncocytoma of the Adenohypophysis	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2986658	Diffuse Intrinsic Pontine Glioma	disease		Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2986665	Early-Stage Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.05	1	2006	2018	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C2986703	Overgrowth Syndrome	disease	C23	Disease or Syndrome	0.05	1	2014	2019	   5	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C3146252	Stage II Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3146254	Stage III Colon Cancer AJCC v7	disease		Neoplastic Process	0.02	0.5	2011	2013	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3146257	Stage II Colon Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3160815	Intraductal papillary mucinous neoplasm	disease		Neoplastic Process	0.02	0.5	2006	2008	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3160887	Node-positive breast cancer	disease		Neoplastic Process	0.02	0.5	2015	2016	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3179502	Linear Verrucous Epidermal Nevus	disease	C16;C04;C10	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.08	1	2016	2019	   8	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.05	0.8	2017	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3272399	Gastric Neuroendocrine Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3272802	Hamartomatous polyposis	disease	C23;C04	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3278509	Spinal fusion	disease		Anatomical Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3278923	Dilated ventricles (finding)	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3279222	Aplasia/Hypoplasia of the cerebellum	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.04	1	2007	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3495831	Aluminium overload	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3495917	Advanced breast cancer	disease		Neoplastic Process	0.10	1	2017	2020	  14	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3501843	Nonmedullary Thyroid Carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3536893	Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	disease	C04	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3539781	Progressive cGVHD	disease		Disease or Syndrome	0.04	1	2013	2018	   4	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.10	0.938	2012	2020	  81	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3544205	Ovarian clear cell carcinoma	disease		Neoplastic Process	0.10	1	2009	2019	  19	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3549742	Breast cancer, lobular	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3550024	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     5290	PIK3CA	0.292	0.923	C3553764	Joint hyperflexibility	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3554518	COWDEN SYNDROME 5	disease		Disease or Syndrome	0.70	1	2005	2013	   2	   9	CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
     5290	PIK3CA	0.292	0.923	C3642345	Luminal A Breast Carcinoma	disease		Neoplastic Process	0.04	1	2012	2017	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3642346	Luminal B Breast Carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3642347	Basal-Like Breast Carcinoma	disease		Neoplastic Process	0.09	1	2009	2016	   9	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3647143	Secondary malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3665339	Bacterial sepsis of newborn	disease	C23;C16;C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3665419	intracranial glioma	disease	C04;C10	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3665596	Warts	disease	C01;C17	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3714514	Infection	group	C01	Pathologic Function	0.01	1	2007	2007	   1	   0	LHGDN
     5290	PIK3CA	0.292	0.923	C3714619	Insulin resistance syndrome	disease	C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.05	1	2016	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3714651	Follicular Variant Thyroid Gland Papillary Carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3714745	Malabsorption	phenotype	C06	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.12	1	2017	2019	   2	   0	BEFREE;HPO
     5290	PIK3CA	0.292	0.923	C3714796	Isolated somatotropin deficiency	disease		Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3714948	PACHYONYCHIA CONGENITA 3	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3714976	ACTIVATED PI3K-DELTA SYNDROME	disease	C16;C20	Disease or Syndrome	0.07	1	2016	2019	   7	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3805727	MEGALENCEPHALY, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.10	1	2019	2019	   1	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C3809250	ESTROGEN RESISTANCE	disease		Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3810365	Central visual impairment	disease	C23;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	C04	Neoplastic Process	0.05	1	2009	2019	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3812874	Endometrioid intraepithelial neoplasia	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3838879	Tubulolobular carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3839280	High grade serous carcinoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3850141	Acute-On-Chronic Liver Failure	disease	C06	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3873567	Peripheral neuropathy due to and following chemotherapy	disease	C10	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3875321	Inflammatory dermatosis	disease	C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.40	1	2008	2020	  18	   0	BEFREE;CGI
     5290	PIK3CA	0.292	0.923	C3887499	Renal cyst	phenotype	C23;C04;C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3887524	Skin Erosion	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3887551	Memory dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3887875	Visual field defects	group	C23;C11;C10	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C3887949	Apparent mineralocorticoid excess	disease	C16;C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3888391	Nonnuclear polymorphic congenital cataract	disease		Congenital Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3888788	Minimal hepatic encephalopathy	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3890429	Liquid Tumor	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3896673	Familial Nonmedullary Thyroid Gland Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3897752	Recurrent Childhood Glioblastoma	disease		Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3899155	hereditary neuroblastoma	disease	C16;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3899658	Childhood Gliosarcoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3900097	Adult Penile Carcinoma	disease	C04;C12	Neoplastic Process	0.03	1	2018	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C3900098	Adult Myelodysplastic Syndrome	disease	C15	Neoplastic Process	0.02	1	2012	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4011754	Nevus, Keratinocytic, Nonepidermolytic	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C4013425	Neuroendocrine cervical carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4016282	BREAST CANCER, SOMATIC	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4020965	Cardiac diverticulum	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4021234	2-4 toe syndactyly	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4021768	Abnormality of metabolism/homeostasis	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4021790	Abnormality of the skeletal system	disease		Anatomical Abnormality	0.03	1	2012	2015	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4021849	Conjunctival hamartoma	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4021976	Abnormality of the lymphatic system	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4021977	Visceral angiomatosis	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4022001	Abnormality of the cerebral vasculature	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4022012	Death in early adulthood	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4022018	Telangiectasia of the skin	phenotype	C14	Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4022020	Mucosal telangiectasiae	disease	C14	Anatomical Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4022025	Asymmetric growth	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4024297	Abnormality of the hairline	disease		Anatomical Abnormality	0.10	1	2019	2019	   1	   1	CLINVAR
     5290	PIK3CA	0.292	0.923	C4024641	Enlarged polycystic ovaries	disease	C04;C13;C19	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4024896	Motor neuron atrophy	disease		Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4024979	Ovarian papillary adenocarcinoma	disease	C04;C13;C19	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4024989	Hereditary nonpolyposis colorectal carcinoma	disease	C16;C06;C04;C18	Neoplastic Process	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4025896	Abnormality of the penis	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4041147	Acute exacerbation of chronic obstructive bronchitis	disease	C01;C08	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.10	0.978	2000	2020	  46	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4048329	Immunosuppression	disease		Disease or Syndrome	0.03	1	2008	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4049272	Tumour budding	disease		Neoplastic Process	0.02	1	2017	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4049446	Neointimal hyperplasia	disease		Disease or Syndrome	0.04	1	2008	2020	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4054188	Ph-Like Acute Lymphoblastic Leukemia	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4055466	Soft Tissue Angiosarcoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4082937	Necrotizing enterocolitis in fetus OR newborn	disease	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.03	1	2011	2014	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4086159	Childhood Gastrointestinal Stromal Tumor	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.10	0.952	2002	2019	  42	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4225270	Kosaki overgrowth syndrome	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4274414	Epstein-Barr virus associated gastric carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4277512	Breast Cancer Lymphedema	phenotype	C23;C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4282128	PATENT DUCTUS ARTERIOSUS 1	disease	C16;C14	Congenital Abnormality	0.02	1	2014	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.03	1	2015	2017	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4285730	Activated PI3 kinase delta syndrome	disease		Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4288305	Recurrent Glioblastoma	disease	C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4288891	Infant T Acute Lymphoblastic Leukemia	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4290046	trachomatis	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4317089	Infantile hemangioma	disease	C04;C14	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4324656	Non-squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4331262	Rosette-forming glioneuronal neoplasm	disease		Neoplastic Process	0.11	1	2017	2017	   1	   1	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C4509816	Squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4511687	Pancreatic Intraductal Papillary Mucinous Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.05	1	2008	2016	   5	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4518194	Epithelioid angiomyolipoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4518356	MiT family translocation renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4520840	Erythroleukemia (Erythroid/Myeloid)	disease	C04;C15	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4520843	Pterygium of eye	disease	C11	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4520854	Stage I Colorectal Cancer AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4522181	Brachial Amyotrophic Diplegia	disease	C10	Disease or Syndrome	0.06	1	2008	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4523846	MSI-high	disease		Neoplastic Process	0.02	1	2013	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4524268	Advanced lung cancer	disease		Neoplastic Process	0.01	0	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4525119	Stage II Colon Cancer AJCC v8	disease		Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4525124	Stage III Colon Cancer AJCC v8	disease		Neoplastic Process	0.02	0.5	2011	2013	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4525297	Stage 0 Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2015	2019	   6	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4525300	Stage IIA Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2015	2019	   6	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4525301	Stage IIB Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2015	2019	   6	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4525302	Stage III Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2015	2019	   6	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4525305	Stage IV Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2015	2019	   6	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4528668	Acute myeloid leukaemia refractory	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4529962	Fatty Liver Disease	disease		Disease or Syndrome	0.03	1	2018	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4531084	Mucinous colorectal carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4543929	Primary osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4544791	PIK3CA related overgrowth syndrome	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4551683	Adrenal Gland Pheochromocytoma	disease	C04;C19	Neoplastic Process	0.06	1	2012	2018	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.10	1	2007	2019	  10	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4551861	Telangiectasia, Hereditary Hemorrhagic, Type 1	disease	C16;C15;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4551915	Gait Disturbance, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4552000	Episodic Kinesigenic Dyskinesia 1	disease	C23;C10	Disease or Syndrome	0.04	1	2016	2020	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4552810	Irritability, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4553765	Memory Impairment, CTCAE 5.0	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4684880	Advanced Bile Duct Carcinoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4687446	Refractory Glioblastoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4703473	Atherosclerotic lesion	disease	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4703633	Increased level of L-fucose in urine	phenotype		Finding	0.10				   0	   0	HPO
     5290	PIK3CA	0.292	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2015	   8	   0	CTD_human
     5290	PIK3CA	0.292	0.923	C4721208	Metastatic castration-resistant prostate cancer	disease		Neoplastic Process	0.06	0.833	2016	2019	   6	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721209	Metastatic human epidermal growth factor 2 positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.04	1	2010	2018	   4	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721414	Mantle cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.10	1	2006	2019	  18	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
     5290	PIK3CA	0.292	0.923	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.10	0.971	2009	2019	  35	   1	BEFREE
     5290	PIK3CA	0.292	0.923	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.10	0.988	1999	2020	  85	   3	BEFREE
     5290	PIK3CA	0.292	0.923	C4721661	Stage IV Lung Squamous Cell Carcinoma AJCC v7	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721666	Bladder cancer stage IV	disease	C04;C13;C12	Neoplastic Process	0.03	1	2010	2018	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721698	Metastatic Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721773	Postoperative cognitive dysfunction	phenotype		Mental or Behavioral Dysfunction	0.02	1	2018	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721779	Ovarian cancer stage IV	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.45	1	2009	2019	   6	   0	BEFREE;CTD_human;HPO
     5290	PIK3CA	0.292	0.923	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.10	1	2005	2020	 125	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4722099	High grade glioma	disease	C04	Neoplastic Process	0.02	1	2017	2017	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4722172	Primary differentiated carcinoma of thyroid gland	disease		Neoplastic Process	0.03	1	2008	2019	   3	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4722419	Extrapulmonary Small Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.10	0.971	2012	2020	  70	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4725076	Advanced Urothelial Carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4725091	metastatic intraocular melanoma	disease	C04;C11	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4725671	High-Risk Neuroblastoma	disease	C04	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4727392	Recurrent Salivary Duct Carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4728035	CTLA4 deficiency	disease		Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4728046	Diabetic wound	disease		Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4728213	PIK3CA related overgrowth spectrum	disease		Disease or Syndrome	0.20	1	2015	2020	  25	   8	BEFREE;CLINVAR
     5290	PIK3CA	0.292	0.923	C4733092	estrogen receptor-negative breast cancer	disease		Neoplastic Process	0.09	1	2010	2019	   9	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4733095	HER2-negative breast cancer	disease		Neoplastic Process	0.10	1	2012	2019	  11	   2	BEFREE
     5290	PIK3CA	0.292	0.923	C4744564	Metastatic Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4745063	Biliary Tract Carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5290	PIK3CA	0.292	0.923	C4749056	MACRODACTYLY, SOMATIC	disease		Congenital Abnormality	0.10				   0	   1	CLINVAR
      842	CASP9	0.458	0.808	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0001339	Acute pancreatitis	disease	C06	Disease or Syndrome	0.02	1	2017	2019	   2	   2	BEFREE
      842	CASP9	0.458	0.808	C0001342	Acute periodontitis	disease	C07	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.02	1	2002	2006	   2	   0	LHGDN
      842	CASP9	0.458	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.21	1	2000	2018	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.20	1	2006	2006	   1	   0	RGD
      842	CASP9	0.458	0.808	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.01	1	2006	2006	   1	   0	LHGDN
      842	CASP9	0.458	0.808	C0003850	Arteriosclerosis	disease	C14	Disease or Syndrome	0.02	1	2015	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.01	0	2002	2002	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0004135	Ataxia Telangiectasia	disease	C16;C18;C20;C10;C14	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.02	1	2015	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0004623	Bacterial Infections	group	C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.03	1	2009	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.03	1	2009	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.02	1	2017	2018	   2	   1	BEFREE
      842	CASP9	0.458	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.08	1	2010	2019	   8	   2	BEFREE
      842	CASP9	0.458	0.808	C0006287	Bronchopulmonary Dysplasia	disease	C16;C08	Disease or Syndrome	0.20	1	2016	2016	   1	   0	RGD
      842	CASP9	0.458	0.808	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.10	1	2001	2019	  21	   5	BEFREE
      842	CASP9	0.458	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.02	1	2006	2010	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0007113	Rectal Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.10	1	2006	2019	  10	   1	BEFREE
      842	CASP9	0.458	0.808	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2013	2013	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.02	1	2019	2019	   2	   1	BEFREE
      842	CASP9	0.458	0.808	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.20	1	2015	2015	   1	   0	RGD
      842	CASP9	0.458	0.808	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.50	1	2001	2011	   3	   0	CTD_human;RGD
      842	CASP9	0.458	0.808	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0008149	Chlamydia Infections	group	C13;C01;C12	Disease or Syndrome	0.02	1	2015	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0008487	Chordoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0008497	Choriocarcinoma	disease	C04;C13	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.02	1	2011	2018	   2	   1	BEFREE
      842	CASP9	0.458	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.03	0.667	2011	2013	   3	   2	BEFREE
      842	CASP9	0.458	0.808	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.02	1	2011	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0011847	Diabetes	disease	C19	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.02	1	2016	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.20	1	2005	2005	   1	   0	RGD
      842	CASP9	0.458	0.808	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.21	0.5	2018	2018	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0014065	Congenital cerebral hernia	disease	C23;C16;C10	Congenital Abnormality	0.01	0	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0014072	Experimental Autoimmune Encephalomyelitis	disease	C20;C10	Experimental Model of Disease	0.20	1	2008	2008	   1	   0	RGD
      842	CASP9	0.458	0.808	C0014121	Bacterial Endocarditis	disease	C01;C14	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0014179	Endometritis	disease	C13	Disease or Syndrome	0.20	1	2016	2016	   1	   0	RGD
      842	CASP9	0.458	0.808	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0014772	Red Blood Cell Count measurement	phenotype		Laboratory Procedure	0.10	1	2019	2019	   1	   1	GWASCAT
      842	CASP9	0.458	0.808	C0015923	Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0015967	Fever	phenotype	C23	Sign or Symptom	0.04	1	2005	2019	   4	   0	BEFREE
      842	CASP9	0.458	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.07	1	2002	2018	   7	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.07	1	2004	2018	   7	   1	BEFREE
      842	CASP9	0.458	0.808	C0017654	Glomerular Filtration Rate	phenotype		Diagnostic Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
      842	CASP9	0.458	0.808	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.20	1	2017	2017	   1	   0	RGD
      842	CASP9	0.458	0.808	C0018213	Graves Disease	disease	C11;C20;C19	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.20	1	2005	2017	   2	   0	RGD
      842	CASP9	0.458	0.808	C0019097	Hemorrhagic Fever, Argentinian	disease	C01	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.02	1	2005	2012	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0019348	Herpes Simplex Infections	group	C01;C17	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.20	1	2014	2014	   1	   0	RGD
      842	CASP9	0.458	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.20	1	2016	2016	   1	   0	RGD
      842	CASP9	0.458	0.808	C0021171	Bloch Sulzberger syndrome	disease	C16;C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.02	0.5	2011	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0022568	Keratitis	disease	C11	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0022578	Keratoconus	disease	C11	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.21	1	2017	2018	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0023418	leukemia	disease	C04	Neoplastic Process	0.02	1	2017	2018	   2	   1	BEFREE
      842	CASP9	0.458	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.04	1	2010	2019	   4	   0	BEFREE
      842	CASP9	0.458	0.808	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.05	1	2006	2019	   5	   1	BEFREE
      842	CASP9	0.458	0.808	C0023492	Leukemia, T-Cell	disease	C04;C20;C15	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0023524	Leukoencephalopathy, Progressive Multifocal	disease	C01;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C0024031	Low Back Pain	phenotype	C23	Sign or Symptom	0.02	1	2011	2013	   2	   2	BEFREE
      842	CASP9	0.458	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.05	1	2006	2014	   5	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0024131	Lupus Vulgaris	disease	C01;C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.03	1	2007	2010	   3	   2	BEFREE
      842	CASP9	0.458	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.03	1	2011	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.20	1	2007	2016	   3	   0	RGD
      842	CASP9	0.458	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2020	2020	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0024897	Mastocytoma	disease	C04;C17	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.05	0.8	2000	2013	   5	   0	BEFREE
      842	CASP9	0.458	0.808	C0025281	Meniere Disease	disease	C09	Disease or Syndrome	0.01	1	2019	2019	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.04	1	2007	2014	   4	   1	BEFREE
      842	CASP9	0.458	0.808	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2002	2018	   3	   0	CTD_human;RGD
      842	CASP9	0.458	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.03	1	2013	2020	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.10	0.973	2001	2020	  37	   1	BEFREE
      842	CASP9	0.458	0.808	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.03	0.667	2017	2018	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.09	0.889	2001	2018	   9	   1	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.06	1	2012	2018	   6	   0	BEFREE
      842	CASP9	0.458	0.808	C0029531	Other cataract	disease	C11	Disease or Syndrome	0.20	1	2013	2013	   1	   0	RGD
      842	CASP9	0.458	0.808	C0029866	Other ureteric obstruction	phenotype	C13;C12	Anatomical Abnormality	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C0029882	Otitis Media	disease	C09	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.07	1	2001	2018	   7	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0031090	Periodontal Diseases	group	C07	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0031099	Periodontitis	disease	C07	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0031106	Aggressive Periodontitis	disease	C07	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0032463	Polycythemia Vera	disease	C04;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2007	   2	   0	BEFREE;CTD_human
      842	CASP9	0.458	0.808	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0036211	Sarcoma 180	disease	C04	Neoplastic Process; Experimental Model of Disease	0.02	1	2017	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.02	1	2018	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.02	1	2004	2013	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0038013	Ankylosing spondylitis	disease	C05	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0038436	Post-Traumatic Stress Disorder	disease	F03	Mental or Behavioral Dysfunction	0.20	1	2014	2014	   1	   0	RGD
      842	CASP9	0.458	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.02	1	2011	2013	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0038525	Subarachnoid Hemorrhage	disease	C23;C10;C14	Disease or Syndrome	0.23	0.75	2015	2019	   4	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0040028	Thrombocythemia, Essential	disease	C15	Disease or Syndrome	0.01	1	2019	2019	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0041296	Tuberculosis	disease	C01	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0042341	Varicocele	disease	C12;C14	Disease or Syndrome	0.21	1	2009	2017	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0042571	Vertigo	phenotype	C23;C10;C09	Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0042963	Vomiting	phenotype	C23	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.10	0.986	2007	2020	  72	   0	BEFREE
      842	CASP9	0.458	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2005	2007	   2	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.03	0.667	2006	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0153690	Secondary malignant neoplasm of bone	disease	C23;C04;C05	Neoplastic Process	0.02	1	2011	2013	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0155626	Acute myocardial infarction	disease	C23;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0157946	Osteoarthrosis, localized, not specified whether primary or secondary	disease	C05	Disease or Syndrome	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C0158266	Intervertebral Disc Degeneration	disease	C05	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.21	1	2010	2015	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0175699	Saethre-Chotzen Syndrome	disease	C16;C05	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0178664	Glomerulosclerosis (disorder)	disease	C13;C12;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.03	1	2018	2018	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0201976	Creatinine measurement, serum (procedure)	phenotype		Laboratory Procedure	0.10	1	2016	2016	   1	   1	GWASCAT
      842	CASP9	0.458	0.808	C0202239	Uric acid measurement (procedure)	phenotype		Laboratory Procedure	0.10	1	2019	2019	   1	   1	GWASCAT
      842	CASP9	0.458	0.808	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C0220613	Adult Soft Tissue Sarcoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0220641	Lip and Oral Cavity Carcinoma	disease	C04;C07	Neoplastic Process	0.02	1	2014	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0220645	Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0220668	Congenital contractural arachnodactyly	disease	C16;C05	Congenital Abnormality	0.02	1	2015	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0221775	Lumbar disc disease	disease	C23;C05	Disease or Syndrome	0.02	1	2011	2011	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0233514	Abnormal behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.03	1	2010	2015	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0236734	Caffeine related disorders	group		Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0238421	Selenium deficiency	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0242006	Myelofibrosis due to another disorder	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.07	1	2006	2019	   7	   2	BEFREE
      842	CASP9	0.458	0.808	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.20	1	2016	2016	   1	   0	RGD
      842	CASP9	0.458	0.808	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.22	1	2004	2017	   3	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0262401	Carcinoma of ampulla of Vater	disease	C06;C04;C19	Neoplastic Process	0.01	0	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0264714	Acute heart failure	disease	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0271568	Laron Syndrome	disease	C16;C05;C19	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0274294	Chronic mountain sickness	disease	C23;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0276138	Viral myocarditis	disease	C01;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.05	1	2002	2018	   5	   0	BEFREE
      842	CASP9	0.458	0.808	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0279014	Childhood Germ Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.03	1	2012	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.01	1	2010	2010	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2013	2013	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0280141	Acute Undifferentiated Leukemia	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.05	1	2002	2018	   5	   0	BEFREE
      842	CASP9	0.458	0.808	C0281899	Prolapsed lumbar disc	disease	C23;C05	Acquired Abnormality	0.01	1	2011	2011	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0302142	Deformity	group	C23;C16	Anatomical Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0334664	Mast Cell Neoplasm	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0342257	Complications of Diabetes Mellitus	group	C19	Disease or Syndrome	0.20	1	2014	2014	   1	   0	RGD
      842	CASP9	0.458	0.808	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.21	1	2018	2019	   2	   0	BEFREE;RGD
      842	CASP9	0.458	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.02	1	2010	2015	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0349566	Squamous cell carcinoma of tongue	disease	C04;C07	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.01	0	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.909	2001	2017	  11	   2	BEFREE;CTD_human
      842	CASP9	0.458	0.808	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.20	1	2013	2013	   1	   0	RGD
      842	CASP9	0.458	0.808	C0376670	Pancreatitis, Alcoholic	disease	C06;C25	Disease or Syndrome	0.10	1	2018	2018	   1	   1	GWASCAT
      842	CASP9	0.458	0.808	C0392885	High density lipoprotein measurement	phenotype		Laboratory Procedure	0.10	1	2012	2012	   1	   1	GWASDB
      842	CASP9	0.458	0.808	C0393591	AICARDI-GOUTIERES SYNDROME	disease	C16;C20;C10	Disease or Syndrome	0.02	0.5	2008	2015	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0428472	Serum HDL cholesterol measurement	phenotype		Laboratory Procedure	0.10	1	2012	2012	   1	   1	GWASDB
      842	CASP9	0.458	0.808	C0432283	Osteoglophonic dwarfism	disease	C16;C05	Congenital Abnormality	0.02	1	2017	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0521652	Caffeine withdrawal	disease		Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.02	1	2004	2013	   2	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C0549523	Oropharynx (excludes nasopharynx)	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.06	1	2012	2018	   6	   0	BEFREE
      842	CASP9	0.458	0.808	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.05	1	2001	2014	   5	   0	BEFREE
      842	CASP9	0.458	0.808	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.10	0.9	2001	2017	  10	   2	BEFREE
      842	CASP9	0.458	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.10	1	2008	2019	  10	   2	BEFREE
      842	CASP9	0.458	0.808	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.08	1	2006	2019	   8	   2	BEFREE
      842	CASP9	0.458	0.808	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2011	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.03	1	2009	2017	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.09	0.889	2001	2018	   9	   1	BEFREE
      842	CASP9	0.458	0.808	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.02	1	2018	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.20	1	2016	2016	   1	   0	RGD
      842	CASP9	0.458	0.808	C0742343	Acute Chest Syndrome	disease	C16;C08;C15	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
      842	CASP9	0.458	0.808	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0752308	Hypoxia-Ischemia, Brain	disease	C10;C14	Disease or Syndrome	0.20	1	2013	2013	   1	   0	RGD
      842	CASP9	0.458	0.808	C0796070	MICROPHTHALMIA, SYNDROMIC 7	disease	C16;C11;C17	Disease or Syndrome; Congenital Abnormality	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.20	1	2017	2017	   1	   0	RGD
      842	CASP9	0.458	0.808	C0856169	Endothelial dysfunction	phenotype		Disease or Syndrome	0.02	1	2016	2018	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0877015	Pelvic Organ Prolapse	disease	C23	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0917801	Sleeplessness	phenotype	C10;F03	Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.04	1	2016	2019	   4	   0	BEFREE
      842	CASP9	0.458	0.808	C1096184	West Nile viral infection	disease	C01;C10	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.04	1	2016	2019	   4	   0	BEFREE
      842	CASP9	0.458	0.808	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.03	1	2000	2019	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C1261473	Sarcoma	group	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.09	1	2004	2019	   9	   0	BEFREE
      842	CASP9	0.458	0.808	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	1	2001	2019	  21	   5	BEFREE
      842	CASP9	0.458	0.808	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.07	1	2006	2019	   7	   2	BEFREE
      842	CASP9	0.458	0.808	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1332949	Childhood Brain Meningioma	disease	C04;C10	Neoplastic Process	0.01	0	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.02	1	2017	2018	   2	   1	BEFREE
      842	CASP9	0.458	0.808	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.06	1	2012	2018	   6	   0	BEFREE
      842	CASP9	0.458	0.808	C1336527	Carcinoma of urinary bladder, superficial	disease	C04;C13;C12	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1378511	Undifferentiated leukemia	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1445957	Serum total cholesterol measurement	phenotype		Laboratory Procedure	0.10	1	2012	2012	   1	   1	GWASDB
      842	CASP9	0.458	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.02	1	2001	2006	   2	   0	BEFREE;LHGDN
      842	CASP9	0.458	0.808	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.02	1	2010	2020	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C1541923	Infective endocarditis	disease	C14	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.07	1	2002	2018	   7	   0	BEFREE
      842	CASP9	0.458	0.808	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1739135	Progression of prostate cancer	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1853926	NONAKA MYOPATHY	disease	C16;C05;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1862112	BRACHYDACTYLY, TYPE B1	disease	C16;C05	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C1963961	Testosterone deficiency	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C2004493	Leukemia, B-Cell	disease	C04;C20;C15	Neoplastic Process	0.03	1	2013	2019	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.28	1	2004	2019	   9	   1	BEFREE;LHGDN;RGD
      842	CASP9	0.458	0.808	C2242987	Benign Mastocytoma	disease	C04;C17	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C2676033	Hepatoblastoma Caused By Somatic Mutation	disease	C06;C04	Neoplastic Process	0.20	1	2018	2018	   1	   0	RGD
      842	CASP9	0.458	0.808	C2827407	Infectious Otitis Media	disease	C09	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.03	1	2018	2019	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.20	1	2017	2017	   1	   0	RGD
      842	CASP9	0.458	0.808	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
      842	CASP9	0.458	0.808	C3714514	Infection	group	C01	Pathologic Function	0.02	1	2004	2008	   2	   0	LHGDN
      842	CASP9	0.458	0.808	C3854222	Human immunodeficiency virus (HIV) II infection category B1	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C3888864	Fistulising Crohn's disease	disease		Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C3898127	Non-Metastatic Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C3900101	Adult Germ Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.01	0	2002	2002	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.09	0.889	2001	2018	   9	   1	BEFREE
      842	CASP9	0.458	0.808	C4087397	Mammary gland tumor	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4285789	Systemic viral infection	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4529962	Fatty Liver Disease	disease		Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4551687	Sarcoma of soft tissue	group	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4551722	Encephalocele	disease	C23;C16;C13;C10	Congenital Abnormality	0.01	0	2017	2017	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4703473	Atherosclerotic lesion	disease	C14	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
      842	CASP9	0.458	0.808	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.04	1	2016	2019	   4	   0	BEFREE
      842	CASP9	0.458	0.808	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
      842	CASP9	0.458	0.808	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0000737	Abdominal Pain	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.03	1	2012	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.948	1983	2020	 327	   4	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0001430	Adenoma	group	C04	Neoplastic Process	0.40	0.944	1991	2020	  90	   2	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0001816	Agnosia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0002448	Ameloblastoma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0002793	Anaplasia	disease	C23;C04	Neoplastic Process	0.03	1	2003	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0002871	Anemia	disease	C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0002878	Anemia, Hemolytic	disease	C15	Disease or Syndrome	0.11	1	2018	2018	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0003081	Anisometropia	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003467	Anxiety	disease	F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003486	Aortic Aneurysm	disease	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0003492	Aortic coarctation	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003507	Aortic Valve Stenosis	disease	C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003537	Aphasia	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0003857	Congenital arteriovenous malformation	disease	C16;C14	Congenital Abnormality	0.04	1	2018	2019	   4	   2	BEFREE
     3845	KRAS	0.32	0.923	C0003962	Ascites	phenotype	C23	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.32	1	2007	2013	   3	   0	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0004135	Ataxia Telangiectasia	disease	C16;C18;C20;C10;C14	Disease or Syndrome	0.02	1	2015	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.03	1	2011	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0004604	Back Pain	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0004763	Barrett Esophagus	disease	C06;C04	Disease or Syndrome	0.02	1	1996	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.02	1	2002	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0004997	Benign Ovarian Neoplasm	disease	C04;C13;C19	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.70	1	2000	2019	  11	   2	BEFREE;CLINVAR;CTD_human;UNIPROT
     3845	KRAS	0.32	0.923	C0005689	Bladder Exstrophy	disease	C16;C13;C12	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	1	2001	2019	  12	   0	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0005699	Blast Phase	disease	C23;C04;C15	Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0005744	Blepharophimosis	disease	C16;C11	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0005745	Blepharoptosis	disease	C11	Disease or Syndrome	0.10				   0	   2	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0005866	Bluetongue infection	disease	C01;C22	Disease or Syndrome	0.02	1	2016	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0005937	Bone Cysts	disease	C04;C05	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.04	1	2010	2015	   4	   2	BEFREE
     3845	KRAS	0.32	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.70	0.947	2005	2020	  38	   4	BEFREE;CGI;CLINVAR;CTD_human
     3845	KRAS	0.32	0.923	C0006160	Brenner Tumor	disease	C04;C13;C19	Neoplastic Process	0.02	1	2014	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.60	0.972	1987	2020	 429	   8	BEFREE;CGI;CTD_human
     3845	KRAS	0.32	0.923	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	0.969	1984	2020	 130	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.50	0.981	1991	2019	 154	   5	BEFREE;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.10	0.9	1997	2019	  20	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007113	Rectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.975	1987	2019	  40	   1	BEFREE
     3845	KRAS	0.32	0.923	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.37	1	2012	2016	   7	   0	BEFREE;CGI
     3845	KRAS	0.32	0.923	C0007120	Bronchioloalveolar Adenocarcinoma	disease	C04	Neoplastic Process	0.39	1	1998	2015	  10	   0	BEFREE;HPO;LHGDN;RGD
     3845	KRAS	0.32	0.923	C0007121	Bronchogenic Carcinoma	disease	C04;C08	Neoplastic Process	0.02	1	1997	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007129	Merkel cell carcinoma	disease	C04;C01	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007130	Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.10	1	1999	2020	  26	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.70	0.979	1989	2020	 529	  12	BEFREE;CGI;CLINVAR;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0007133	Carcinoma, Papillary	disease	C04	Neoplastic Process	0.04	1	1995	2018	   4	   1	BEFREE
     3845	KRAS	0.32	0.923	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.05	1	2010	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	1985	2019	  41	   2	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0007140	Carcinosarcoma	disease	C04	Neoplastic Process	0.03	1	2010	2019	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.13	1	2013	2018	   3	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0007528	Cecal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0007772	Intracranial Arteriovenous Malformation	disease	C16;C10;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
     3845	KRAS	0.32	0.923	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0007847	Malignant tumor of cervix	disease	C04;C13	Neoplastic Process	0.34	1	2001	2019	   4	   0	BEFREE;CGI
     3845	KRAS	0.32	0.923	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.31	1	2015	2015	   1	   0	BEFREE;CGI
     3845	KRAS	0.32	0.923	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.04	1	2007	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0008340	Choledochal Cyst	disease	C16;C06;C04	Congenital Abnormality	0.01	1	1993	1993	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.01	1	2002	2002	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0008487	Chordoma	disease	C04	Neoplastic Process	0.01	0	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0008626	Congenital chromosomal disease	group	C16	Congenital Abnormality	0.09	0.778	1986	2015	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0009207	Cockayne Syndrome	disease	C16;C18;C05;C10	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0009319	Colitis	disease	C06	Disease or Syndrome	0.02	1	2016	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.05	1	1991	2012	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0009373	Colonic Diseases	group	C06	Disease or Syndrome	0.01	1	1987	1987	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.40	0.971	1987	2018	  35	   1	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0009376	Colonic Polyps	phenotype	C23	Anatomical Abnormality	0.02	1	2011	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.60	0.963	1990	2020	1007	  13	BEFREE;CTD_human;UNIPROT
     3845	KRAS	0.32	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.50	0.983	1990	2019	 117	  12	BEFREE;CLINVAR;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0009806	Constipation	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0010038	Corneal Opacity	phenotype	C11	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0010278	Craniosynostosis	disease	C16;C05	Disease or Syndrome	0.03	1	2012	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.11	1	2009	2009	   1	   2	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0010631	Cystadenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010633	Cystadenoma	disease	C04	Neoplastic Process	0.02	1	1993	2004	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010635	Cystadenoma, Mucinous	disease	C04	Neoplastic Process	0.02	0.5	2007	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010674	Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.01	1	1994	1994	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010709	Cyst	disease	C23;C04	Disease or Syndrome	0.02	1	2013	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0010964	Dandy-Walker Syndrome	disease	C16;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0011168	Deglutition Disorders	group	C06;C09	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011311	Dengue Fever	disease	C01	Disease or Syndrome	0.03	1	1997	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.11	1	2016	2016	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0011644	Scleroderma	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011649	Dermoid Cyst	disease	C04	Neoplastic Process	0.03	1	2013	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011847	Diabetes	disease	C19	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.12	1	2015	2019	   2	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0011991	Diarrhea	phenotype	C23	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0013274	Patent ductus arteriosus	disease	C16;C14	Congenital Abnormality	0.20	1	2009	2019	  16	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.11	1	2007	2007	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0013362	Dysarthria	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0013384	Dyskinetic syndrome	disease	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0013528	Echolalia	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0014057	Japanese Encephalitis	disease	C01;C10	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0014116	Endocardial Cushion Defects	group	C16;C14	Congenital Abnormality	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.04	1	2001	2014	   4	   0	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0014173	Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.05	1	2001	2019	   5	   0	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.60	0.917	2005	2019	  12	   1	BEFREE;CTD_human;LHGDN;MGD
     3845	KRAS	0.32	0.923	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0014588	Epispadias	group	C16;C13;C12	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0014599	Epithelial hyperplasia	disease	C23	Disease or Syndrome	0.01	1	2003	2003	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0014647	Giant Cell Epulis	disease	C23;C05;C07	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0014850	Esophageal Atresia	disease	C16;C06	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.04	1	1995	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0015230	Exanthema	phenotype	C17	Sign or Symptom	0.02	1	2010	2011	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0015300	Exophthalmos	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0015424	Eyelid Neoplasms	group	C04;C11	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0015644	Muscular fasciculation	phenotype	C23;C10	Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0015672	Fatigue	phenotype	C23	Sign or Symptom	0.11	0	2012	2012	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0015967	Fever	phenotype	C23	Sign or Symptom	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0016842	Congenital pectus excavatum	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0016977	Gall Bladder Diseases	group	C06	Disease or Syndrome	0.01	1	1998	1998	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0016978	gallbladder neoplasm	disease	C06;C04	Neoplastic Process	0.31	1	1996	2014	   2	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0017152	Gastritis	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017154	Gastritis, Atrophic	disease	C06	Disease or Syndrome	0.11	1	1999	1999	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0017168	Gastroesophageal reflux disease	disease	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017178	Gastrointestinal Diseases	group	C06	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0017185	Gastrointestinal Neoplasms	group	C06;C04	Neoplastic Process	0.03	1	2015	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017525	Giant Cell Tumors	group	C04	Neoplastic Process	0.01	1	1997	1997	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.06	1	2004	2019	   6	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0017638	Glioma	disease	C04	Neoplastic Process	0.04	1	2005	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0017653	Glomus Tumor	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0018206	granulosa cell tumor	disease	C04;C13;C19	Neoplastic Process	0.02	1	2012	2017	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0018524	Hallucinations	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0018790	Cardiac Arrest	disease	C14	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0018817	Atrial Septal Defects	group	C16;C14	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0018818	Ventricular Septal Defects	group	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0018916	Hemangioma	disease	C04	Neoplastic Process	0.11	1	2007	2007	   1	   0	HPO;LHGDN
     3845	KRAS	0.32	0.923	C0018920	Hemangioma, Cavernous	disease	C04;C15;C14	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.64	1	1997	2016	   9	   2	BEFREE;CGI;CLINVAR;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0018939	Hematological Disease	group	C15	Disease or Syndrome	0.01	1	1986	1986	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0018989	Hemiparesis	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0018991	Hemiplegia	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0019163	Hepatitis B	disease	C06;C01	Disease or Syndrome	0.02	1	2006	2018	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.10	0.988	1995	2019	  80	   0	BEFREE
     3845	KRAS	0.32	0.923	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0019214	Hepatosplenomegaly	phenotype	C23;C06;C15	Sign or Symptom	0.11	1	2018	2018	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0019340	Herpes NOS	disease	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0019623	Malignant histiocytosis	disease	C04;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0019625	Sinus histiocytosis	disease	C15	Disease or Syndrome	0.02	1	2017	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0020224	Polyhydramnios	phenotype	C13	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0020255	Hydrocephalus	disease	C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0020295	Hydronephrosis	disease	C13;C12	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.03	1	2003	2008	   3	   0	LHGDN
     3845	KRAS	0.32	0.923	C0020534	Orbital separation excessive	phenotype	C16;C05	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0020757	Ichthyoses	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.03	1	2016	2019	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.05	1	2004	2018	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0021847	Intestinal Pseudo-Obstruction	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0022107	Irritable Mood	phenotype	F01	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0022346	Icterus	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0022603	Seborrheic keratosis	disease	C17	Neoplastic Process	0.01	1	2014	2014	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.21	1	1996	2019	   2	   0	BEFREE;RGD
     3845	KRAS	0.32	0.923	C0023051	Laryngeal Diseases	group	C08;C09	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023221	Leg Length Inequality	phenotype	C23;C05	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0023267	Fibroid Tumor	disease	C04	Neoplastic Process	0.02	1	2003	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023269	leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023418	leukemia	disease	C04	Neoplastic Process	0.20	0.9	1987	2020	  10	   1	BEFREE;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.13	1	1991	2016	   4	   4	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.05	0.4	2004	2018	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.06	0.667	2004	2018	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.03	1	1989	2013	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.70	0.939	1987	2020	  33	   8	BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0023470	Myeloid Leukemia	disease	C04	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.06	1	2008	2016	   6	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0023480	Leukemia, Myelomonocytic, Chronic	disease	C04;C15	Neoplastic Process	0.06	1	2006	2017	   6	   1	BEFREE
     3845	KRAS	0.32	0.923	C0023484	Leukemia, Plasma Cell	disease	C04;C20	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.03	1	1992	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023488	Leukemia, Radiation-Induced	disease	C04;C26	Neoplastic Process	0.01	0	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023492	Leukemia, T-Cell	disease	C04;C20;C15	Neoplastic Process	0.01	1	2008	2008	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0023518	Leukocytosis	phenotype	C23;C15	Disease or Syndrome	0.31	1	2016	2016	   2	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0023530	Leukopenia	disease	C15	Disease or Syndrome	0.03	0.333	2012	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023531	Leukoplakia	disease	C23;C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023652	Lichen Sclerosus et Atrophicus	disease	C17	Disease or Syndrome	0.01	1	2007	2007	   1	   0	LHGDN
     3845	KRAS	0.32	0.923	C0023787	Lipodystrophy	disease	C18;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0023798	Lipoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0023801	Lipomatosis	disease	C18;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023804	Lipomatosis, Multiple Symmetrical	disease	C18;C17	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.02	1	2014	2014	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0023897	Liver Diseases, Parasitic	group	C06;C01	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.66	1	1993	2017	   9	   0	BEFREE;CTD_human;HPO;RGD
     3845	KRAS	0.32	0.923	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.01	0	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.02	0.5	2016	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.60	0.974	1991	2019	 117	   2	BEFREE;CGI;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.02	1	2010	2017	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0024225	Lymphangitis	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0024236	Lymphedema	disease	C15	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0024282	Lymphocytosis	disease	C15	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.44	1	1997	2013	   5	   1	BEFREE;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.02	1	2018	2019	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0024314	Lymphoproliferative Disorders	group	C20;C15	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0024523	Malabsorption Syndrome	group	C06;C18	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.50	1	1987	2019	  31	   2	BEFREE;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0024624	Malignant neoplasm of upper lobe, bronchus or lung	disease	C04;C08	Neoplastic Process	0.20	1	2001	2014	   6	   0	MGD
     3845	KRAS	0.32	0.923	C0024814	Marinesco-Sjogren syndrome	disease	C16;C10	Disease or Syndrome	0.08	1	2002	2018	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C0024899	Mastocytosis	disease	C04;C17;C20	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.20	1	2001	2020	  25	   4	BEFREE;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	1988	1988	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.02	1	2000	2007	   2	   0	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0025568	Metaplasia	phenotype	C23	Cell or Molecular Dysfunction	0.01	1	2003	2003	   1	   0	LHGDN
     3845	KRAS	0.32	0.923	C0025990	Micrognathism	disease	C16;C05;C07	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026010	Microphthalmos	disease	C16;C11	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026267	Mitral Valve Prolapse Syndrome	disease	C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026277	Mixed Salivary Gland Tumor	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0026470	Monoclonal Gammopathy of Undetermined Significance	disease	C20;C15	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0026499	Monosomy	group	C23	Congenital Abnormality	0.02	1	2017	2019	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.31	1	2009	2019	   2	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.50	1	2001	2019	  15	   5	BEFREE;CGI;CLINVAR
     3845	KRAS	0.32	0.923	C0026826	Muscle Hypertonia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026827	Muscle hypotonia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026837	Muscle Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026838	Muscle Spasticity	phenotype	C23;C05;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026884	Mutism	phenotype	C23;C10;F03	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
     3845	KRAS	0.32	0.923	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.03	1	2012	2019	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0027092	Myopia	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0027498	Nausea and vomiting	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.01	1	1990	1990	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.952	1991	2020	 207	   7	BEFREE;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	0.953	1983	2020	1448	  13	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1997	2015	   5	   0	CTD_human
     3845	KRAS	0.32	0.923	C0027672	Neoplastic Syndromes, Hereditary	group	C16;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.06	1	2010	2017	   6	   1	BEFREE
     3845	KRAS	0.32	0.923	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.45	1	2006	2017	   6	   2	BEFREE;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0027831	Neurofibromatosis 1	disease	C16;C04;C10	Neoplastic Process	0.05	0.8	2005	2018	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0027859	Acoustic Neuroma	disease	C04;C10;C09	Neoplastic Process	0.01	0	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0027947	Neutropenia	disease	C15	Disease or Syndrome	0.13	0.333	2012	2017	   3	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0027962	Melanocytic nevus	disease	C04	Neoplastic Process	0.11	1	2001	2001	   1	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0028259	Nodule	phenotype		Acquired Abnormality	0.05	1	2000	2019	   5	   2	BEFREE
     3845	KRAS	0.32	0.923	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	1.00	0.985	1993	2019	  68	  17	BEFREE;CLINGEN;CLINVAR;CTD_human;GENOMICS_ENGLAND;LHGDN;MGD;ORPHANET
     3845	KRAS	0.32	0.923	C0028738	Nystagmus	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.04	0.75	2009	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0028880	Odontogenic Tumors	group	C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0029124	Optic Atrophy	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0029429	Osteochondrosis	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.04	1	1988	2018	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.47	1	1986	2013	   7	   0	BEFREE;CGI;HPO
     3845	KRAS	0.32	0.923	C0030215	Palatal Neoplasms	disease	C04;C05;C07	Neoplastic Process	0.01	1	2019	2019	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0030283	Pancreatic Cyst	disease	C06;C04	Disease or Syndrome	0.07	0.857	1999	2018	   7	   0	BEFREE
     3845	KRAS	0.32	0.923	C0030286	Pancreatic Diseases	group	C06	Disease or Syndrome	0.02	1	1998	2008	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.70	0.974	1997	2019	  39	   1	BEFREE;CGI;CTD_human;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.07	1	2001	2018	   7	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0030312	Pancytopenia	disease	C15	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0030354	Papilloma	disease	C04	Neoplastic Process	0.04	1	2011	2019	   4	   3	BEFREE
     3845	KRAS	0.32	0.923	C0030421	Paraganglioma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0030554	Paresthesia	phenotype	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0030793	Pelvic Neoplasms	group	C04	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0030849	Penile Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0030920	Peptic Ulcer	disease	C06	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0031036	Polyarteritis Nodosa	disease	C17;C14	Disease or Syndrome	0.02	1	2015	2020	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0031039	Pericardial effusion	disease	C14	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0031269	Peutz-Jeghers Syndrome	disease	C16;C06;C04;C17	Disease or Syndrome	0.02	1	2013	2014	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0032000	Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0032227	Pleural effusion disorder	group	C08	Disease or Syndrome	0.02	1	2015	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	0.10	0.949	1986	2020	  39	   2	BEFREE
     3845	KRAS	0.32	0.923	C0032584	polyps	phenotype	C23	Anatomical Abnormality	0.10	1	1995	2020	  32	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0032897	Prader-Willi Syndrome	disease	C16;C18;C10	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.09	0.778	1991	2019	   9	   1	BEFREE
     3845	KRAS	0.32	0.923	C0033036	Atrial Premature Complexes	disease	C23;C14	Disease or Syndrome	0.09	0.778	2000	2019	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0033377	Ptosis	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.50	1	2018	2018	   1	   0	CTD_human;MGD
     3845	KRAS	0.32	0.923	C0033822	Pseudomyxoma Peritonei	disease	C04	Neoplastic Process	0.05	1	2001	2020	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0033844	Pseudotumor	disease	C23	Acquired Abnormality	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0034372	Quadriplegia	disease	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0034885	Rectal Neoplasms	group	C06;C04	Neoplastic Process	0.18	0.875	2006	2020	   8	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0035309	Retinal Diseases	group	C11	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0035335	Retinoblastoma	disease	C04;C11	Neoplastic Process	0.06	1	1996	2019	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.04	1	2010	2018	   4	   1	BEFREE
     3845	KRAS	0.32	0.923	C0036216	Sarcoma, Experimental	disease	C04	Neoplastic Process; Experimental Model of Disease	0.20	1	2001	2001	   1	   0	RGD
     3845	KRAS	0.32	0.923	C0036220	Kaposi Sarcoma	disease	C04;C01	Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0036439	Scoliosis, unspecified	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0036631	Seminoma	disease	C04	Neoplastic Process	0.05	1	1993	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0036857	Severe intellectual disability	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.01	1	2011	2011	   1	   2	BEFREE
     3845	KRAS	0.32	0.923	C0037116	Silicosis	disease	C08;C24	Disease or Syndrome	0.01	1	2000	2000	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0037284	Skin lesion	group	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2016	2016	   1	   0	CTD_human;HPO
     3845	KRAS	0.32	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.46	1	2000	2015	   8	   2	BEFREE;CLINVAR;CTD_human;LHGDN
     3845	KRAS	0.32	0.923	C0038379	Strabismus	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0038478	Struma Ovarii	disease	C04	Neoplastic Process	0.02	1	2012	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0039538	Teratoma	disease	C04	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0039585	Androgen-Insensitivity Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0040100	Thymoma	disease	C04;C15	Neoplastic Process	0.02	1	2009	2014	   2	   2	BEFREE
     3845	KRAS	0.32	0.923	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.68	1	1988	2016	  14	   8	BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0040137	Thyroid Nodule	disease	C04;C19	Neoplastic Process	0.05	1	2014	2019	   5	   2	BEFREE
     3845	KRAS	0.32	0.923	C0040427	Tooth Abnormalities	group	C16;C07	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0040962	Tricuspid Valve Prolapse	disease	C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0041341	Tuberous Sclerosis	disease	C16;C04;C10	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0041408	Turner Syndrome	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0041409	Turner Syndrome, Male	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2007	2007	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0042076	Urologic Neoplasms	group	C04;C13;C12	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0042133	Uterine Fibroids	group	C04	Neoplastic Process	0.03	1	2003	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0042138	Uterine Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0042769	Virus Diseases	group	C01	Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0042798	Low Vision	disease	C23;C11;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0042929	Polyp of vocal cord	disease	C23;C08;C09	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0043325	Xanthomatosis	disease	C18	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.02	1	2003	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	1997	2019	   3	   5	BEFREE
     3845	KRAS	0.32	0.923	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2003	2003	   1	   0	LHGDN
     3845	KRAS	0.32	0.923	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.01	1	2011	2011	   1	   2	BEFREE
     3845	KRAS	0.32	0.923	C0080032	Pleural Effusion, Malignant	disease	C04;C08	Disease or Syndrome	0.06	1	2012	2019	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C0085183	Neoplasms, Second Primary	phenotype	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0085281	Addictive Behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.04	1	2012	2018	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0085669	Acute leukemia	disease	C23;C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0085702	Monocytosis	disease	C23;C15	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2000	2016	   2	   0	CTD_human
     3845	KRAS	0.32	0.923	C0086795	Pfaundler-Hurler Syndrome	disease	C16;C18;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.01	1	1995	1995	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.10	1	1997	2018	  14	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0149632	Abnormality of the bladder	phenotype	C13;C12	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0149678	Epstein-Barr Virus Infections	group	C01	Disease or Syndrome	0.02	1	2011	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.43	1	2014	2019	   4	   2	BEFREE;CGI;CLINVAR
     3845	KRAS	0.32	0.923	C0149793	Amaurosis Fugax	phenotype	C23;C11;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0149826	Gastric adenoma	disease	C06;C04	Neoplastic Process	0.02	1	1997	2013	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.05	1	2001	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0149978	Adenocarcinoma of rectum	disease	C06;C04	Neoplastic Process	0.06	1	1987	2019	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.30	1	1988	1988	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0151526	Premature Birth	phenotype	C13	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151611	Electroencephalogram abnormal	phenotype	C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151650	Renal fibrosis	disease	C23;C13;C12	Disease or Syndrome	0.20	1	2012	2012	   1	   0	RGD
     3845	KRAS	0.32	0.923	C0151669	Increased antibody level in blood	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151699	Intracranial Hemorrhage	group	C23;C10;C14	Pathologic Function	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0151723	Hypomagnesemia	phenotype	C18	Disease or Syndrome	0.03	1	2011	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0151740	Intracranial Hypertension	disease	C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.12	1	2001	2016	   3	   2	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0151786	Muscle Weakness	phenotype	C23;C05;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151811	Subcutaneous nodule	phenotype	C04;C17;C05	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151857	Pleocytosis	disease	C23;C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0151860	Acquired porencephaly	disease	C16;C05;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151889	Hyperreflexia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0151908	Dry skin	phenotype	C17	Sign or Symptom	0.12	1	2012	2016	   2	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.70	0.967	1990	2020	 302	   3	BEFREE;CGI;CLINVAR;CTD_human
     3845	KRAS	0.32	0.923	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.17	1	1992	2019	   8	   1	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0152235	Congenital genu recurvatum	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0152419	Interrupted aortic arch	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0152421	Macrotia	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.33	1	2009	2011	   4	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0153382	Malignant neoplasm of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153437	Malignant neoplasm of cecum	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0153446	Malignant neoplasm of anus	disease	C06;C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.40	1	2004	2019	  13	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0153467	Malignant tumor of peritoneum	disease	C06;C04;C17	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153491	Malignant neoplasm of middle lobe, bronchus or lung	disease	C04;C08	Neoplastic Process	0.20	1	2001	2014	   6	   0	MGD
     3845	KRAS	0.32	0.923	C0153492	Malignant neoplasm of lower lobe, bronchus or lung	disease	C04;C08	Neoplastic Process	0.20	1	2001	2014	   6	   0	MGD
     3845	KRAS	0.32	0.923	C0153493	Malignant neoplasm of other parts of bronchus or lung	disease	C04;C08	Neoplastic Process	0.20	1	2001	2014	   6	   0	MGD
     3845	KRAS	0.32	0.923	C0153567	Uterine Cancer	disease	C04;C13	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0153574	Malignant Uterine Corpus Neoplasm	disease	C04;C13	Neoplastic Process	0.10	1	2016	2016	   1	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0153601	Malignant neoplasm of penis	disease	C04;C12	Neoplastic Process	0.31	1	2008	2008	   1	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.03	1	2010	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153676	Secondary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.929	1987	2020	  28	   1	BEFREE
     3845	KRAS	0.32	0.923	C0153678	Secondary malignant neoplasm of pleura	disease	C04;C08	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153687	Secondary malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0153690	Secondary malignant neoplasm of bone	disease	C23;C04;C05	Neoplastic Process	0.08	1	2007	2018	   8	   1	BEFREE
     3845	KRAS	0.32	0.923	C0156147	Crohn's disease of large bowel	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0156369	Uterine Polyp	disease	C23;C04;C13	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0158465	Acquired cubitus valgus	disease		Acquired Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0158486	Acquired genu recurvatum	phenotype	C05	Acquired Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0158731	Congenital pectus carinatum	disease	C16;C17;C05	Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0158761	Radioulnar Synostosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0162429	Malnutrition	disease	C18	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0162565	Acute intermittent porphyria	disease	C16;C06;C18;C17	Disease or Syndrome	0.02	1	2011	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0162678	Neurofibromatoses	group	C16;C04;C10	Neoplastic Process	0.03	0.667	2010	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0162834	Hyperpigmentation	phenotype	C17	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0162835	Hypopigmentation disorder	disease	C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0175691	Dubowitz syndrome	disease	C23;C16;C17;C05;C10;F03;F01	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0175701	Aarskog syndrome	disease	C16;C05;C19;C14	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0175704	LEOPARD Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.31	1	2011	2011	   1	   0	BEFREE;CLINGEN
     3845	KRAS	0.32	0.923	C0175754	Agenesis of corpus callosum	disease	C23;C16;C10	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.10	0.976	1999	2019	  42	   1	BEFREE
     3845	KRAS	0.32	0.923	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2001	2010	   3	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.31	1	1999	2010	   4	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2001	2010	   3	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2001	2010	   3	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2001	2010	   3	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1996	2015	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.31	1	1996	2015	   5	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	1996	2015	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1996	2015	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1996	2015	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1996	2015	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205695	Carcinoid, Goblet Cell	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	2010	   2	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.36	1	1996	2018	   8	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.32	1	1999	2016	   4	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1999	2010	   2	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.04	1	1990	2012	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0205854	Glandular Neoplasms	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0205969	Thymic Carcinoma	disease	C04;C15	Neoplastic Process	0.02	1	2009	2014	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0206620	Lymphangioma, Cystic	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0206623	Adenosquamous carcinoma	disease	C04	Neoplastic Process	0.04	1	2011	2020	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.21	1	1993	2006	   2	   0	BEFREE;RGD
     3845	KRAS	0.32	0.923	C0206627	Mixed Tumor, Mullerian	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206629	Pulmonary Blastoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206631	Lipomatous neoplasm	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206656	Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	1989	2018	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0206659	Embryonal Carcinoma	disease	C04	Neoplastic Process	0.01	1	1987	1987	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206663	Neuroectodermal Tumor, Primitive	disease	C04	Neoplastic Process	0.01	1	1992	1992	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206664	Teratocarcinoma	disease	C04	Neoplastic Process	0.02	1	1990	2002	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206669	Hepatocellular Adenoma	disease	C06;C04	Neoplastic Process	0.21	1	1993	2006	   2	   0	BEFREE;RGD
     3845	KRAS	0.32	0.923	C0206674	Adenoma, Villous	disease	C04	Neoplastic Process	0.04	1	2001	2012	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206677	Adenomatous Polyps	disease	C04	Neoplastic Process	0.04	1	2011	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206681	Adenocarcinoma, Clear Cell	disease	C04	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.36	1	2007	2017	   7	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0206683	Papillary and follicular adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0206684	Sebaceous Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206685	Acinar Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206687	Carcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.10	0.909	2001	2020	  11	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206693	Medullary carcinoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206694	Mucoepidermoid Carcinoma	disease	C04	Neoplastic Process	0.02	1	2000	2009	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206695	Carcinoma, Neuroendocrine	disease	C04	Neoplastic Process	0.05	1	2015	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206696	Carcinoma, Signet Ring Cell	disease	C04	Neoplastic Process	0.03	1	2012	2019	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.40	1	1995	2019	  18	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0206699	Cystadenocarcinoma, Mucinous	disease	C04	Neoplastic Process	0.01	0	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206701	Cystadenocarcinoma, Serous	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0206704	Carcinoma, Large Cell	disease	C04	Neoplastic Process	0.05	1	2003	2018	   5	   1	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0206709	Cystadenoma, Serous	disease	C04	Neoplastic Process	0.02	1	2004	2014	   2	   0	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C0206721	Inverted Papilloma	disease	C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206733	Strawberry nevus of skin	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0206740	Calcifying Odontogenic Cyst	disease	C04;C05;C07	Anatomical Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.05	1	2003	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220611	Childhood Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2013	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0220613	Adult Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	1999	2010	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220620	Gastrointestinal Carcinoid Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220621	Childhood Acute Myeloid Leukemia	disease	C04	Neoplastic Process	0.01	1	1990	1990	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220645	Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	1999	2010	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220650	Metastatic malignant neoplasm to brain	disease	C23;C04;C10	Neoplastic Process	0.10	0.95	2011	2019	  20	   0	BEFREE
     3845	KRAS	0.32	0.923	C0220668	Congenital contractural arachnodactyly	disease	C16;C05	Congenital Abnormality	0.04	0.75	2011	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0221023	Cyclic neutropenia	disease	C15	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0221170	Muscular stiffness	phenotype	C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0221217	Neck webbing	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0221219	Ectopic pancreas	disease	C16	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0221263	Cafe-au-Lait Spots	phenotype	C23;C17	Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0221353	Horseshoe Kidney	disease	C16;C13;C12	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0221354	Frontal bossing	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0221357	Brachydactyly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0232462	Decrease in appetite	phenotype	C06;C10;F03	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0232466	Feeding difficulties	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0234132	Pyramidal sign	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0234144	Dysgraphia	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0235752	Port-Wine Stain	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0235782	Gallbladder Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	1996	2019	  15	   1	BEFREE
     3845	KRAS	0.32	0.923	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2019	2019	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.70	0.983	1985	2020	 242	   4	BEFREE;CGI;CLINVAR;MGD
     3845	KRAS	0.32	0.923	C0238003	Adenocarcinoma of appendix	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0238052	Xanthomatosis, Cerebrotendinous	disease	C16;C18	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0238137	Gallbladder adenoma	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.48	1	2009	2016	   9	   1	BEFREE;CGI;CLINVAR
     3845	KRAS	0.32	0.923	C0238397	Pulmonary artery stenosis	disease	C14	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.15	0.8	2008	2016	   5	   3	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.40	1	2007	2019	  17	   5	BEFREE;ORPHANET
     3845	KRAS	0.32	0.923	C0239181	Intermittent diarrhea	phenotype	C23	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0239234	Low set ears	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0239676	High forehead	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0239803	Red hair	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0240063	Coloboma of iris	disease	C16;C11	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0240225	Liver mass	phenotype		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0240635	Byzanthine arch palate	disease	C16;C05;C10;C07	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0241074	Hyperextensible skin	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0241654	Abnormal heart valve morphology	phenotype	C16;C14	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0241880	Endometriosis of pelvis	disease	C13	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0242292	McCune-Albright Syndrome	disease	C05	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0242363	Islet Cell Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.70	0.974	1990	2020	 344	   4	BEFREE;CGI;CTD_human;UNIPROT
     3845	KRAS	0.32	0.923	C0242584	Autoimmune thrombocytopenia	disease	C20;C15	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0242596	Neoplasm, Residual	phenotype	C23;C04	Neoplastic Process	0.01	1	2014	2014	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0242621	Isochromosomes	phenotype	C23	Acquired Abnormality	0.02	1	2017	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2001	2003	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0262401	Carcinoma of ampulla of Vater	disease	C06;C04;C19	Neoplastic Process	0.02	1	2015	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.03	1	2011	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0263490	Brittle hair	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0265205	Robinow Syndrome	disease	C16;C13;C05;C12;C19	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.01	1	1988	1988	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0265319	Fibrous skin tumor of tuberous sclerosis	disease	C16;C04;C10	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.09	1	1993	2018	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0265329	Organoid Nevus Phakomatosis	disease	C16;C04;C10	Disease or Syndrome	0.75	1	2012	2019	   5	   3	BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;ORPHANET
     3845	KRAS	0.32	0.923	C0265529	Plagiocephaly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0265534	Scaphycephaly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0265535	Trigonocephaly	disease	C16;C05	Congenital Abnormality	0.10				   0	   2	CLINVAR
     3845	KRAS	0.32	0.923	C0265783	Congenital hypoplasia of lung	disease	C16;C08	Congenital Abnormality	0.02	1	2008	2014	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0265962	Ichthyosis linearis circumflexa	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0266011	Accessory nipple	disease	C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0266153	Ectopic gastric tissue	disease	C16	Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0266526	Norrie disease	disease	C23;C16;C11;C10	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0266544	Microcornea	disease	C16;C11	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0266551	Congenital coloboma of iris	disease	C16;C11	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0267756	Abscess of peritoneum	phenotype	C23;C06;C01	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0267963	Exocrine pancreatic insufficiency	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0268074	Indian childhood cirrhosis	disease	C23;C06;C08	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     3845	KRAS	0.32	0.923	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0269106	Endosalpingiosis	disease	C23;C13	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0270685	Cerebral calcification	phenotype	C18;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0270972	Cornelia De Lange Syndrome	disease	C16;C10	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0271561	Somatotropin deficiency	disease	C16;C05;C10;C19	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0271618	Delayed female puberty	phenotype	C19	Pathologic Function	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0276289	Zika Virus Infection	disease	C01	Disease or Syndrome	0.04	1	2017	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0277959	Coarse hair	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0278479	Stage II Colon Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2010	2015	   2	   2	BEFREE
     3845	KRAS	0.32	0.923	C0278480	Stage III Colon Cancer	disease	C06;C04	Neoplastic Process	0.09	1	2000	2019	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278484	Malignant neoplasm of colon stage IV	disease	C06;C04	Neoplastic Process	0.07	1	2009	2017	   7	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278488	Carcinoma breast stage IV	disease		Neoplastic Process	0.02	1	2016	2020	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278505	Non-small cell lung cancer stage II	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278506	Non-small cell lung cancer stage III	disease		Neoplastic Process	0.03	0.667	2010	2015	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0278512	Metastatic osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278517	Non-small cell lung cancer recurrent	disease	C04;C08	Neoplastic Process	0.02	1	2009	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278535	Rectal cancer stage I	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278556	Anal cancer recurrent	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278579	Cervix carcinoma recurrent	disease	C04;C13	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278592	Adult Angiosarcoma	disease	C04	Neoplastic Process	0.02	1	1997	2016	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0278607	Adult Leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.11	1	2016	2019	   2	   2	BEFREE;CLINVAR
     3845	KRAS	0.32	0.923	C0278801	Endometrial neoplasm malignant metastatic	disease	C04;C13	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278803	Adenocarcinoma of small intestine	disease	C06;C04	Neoplastic Process	0.03	1	2013	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278804	Adenocarcinoma of duodenum	disease	C06;C04	Neoplastic Process	0.02	1	2013	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278877	Adult Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	1988	1988	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.04	1	2011	2019	   4	   1	BEFREE
     3845	KRAS	0.32	0.923	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.04	1	2003	2017	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278983	Non-small cell lung cancer stage IIIA	disease		Neoplastic Process	0.02	1	1995	1995	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.08	1	2010	2018	   8	   1	BEFREE
     3845	KRAS	0.32	0.923	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279550	Adult Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2013	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0279557	Adenosquamous cell lung cancer	disease	C04;C08	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279612	Childhood Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.07	1	2008	2020	   7	   1	BEFREE
     3845	KRAS	0.32	0.923	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.02	1	2016	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279637	Anal carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279651	Gallbladder adenocarcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279671	Cervical Squamous Cell Carcinoma	disease	C04;C13	Neoplastic Process	0.03	1	2007	2015	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0279672	Cervical Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.03	1	1994	2007	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.42	1	2001	2019	   3	   1	BEFREE;CGI;CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0279682	Bladder Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.06	1	2011	2019	   6	   1	BEFREE
     3845	KRAS	0.32	0.923	C0279748	Undifferentiated carcinoma of nasopharynx	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279763	endometrial adenoacanthoma	disease		Neoplastic Process	0.20	1	1999	1999	   1	   0	RGD
     3845	KRAS	0.32	0.923	C0279986	Childhood Leiomyosarcoma	disease	C04	Neoplastic Process	0.01	1	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0279988	Childhood Angiosarcoma	disease	C04	Neoplastic Process	0.02	1	1997	2016	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0280089	Carcinoid tumor of lung	disease	C04;C08	Neoplastic Process	0.01	0	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.09	1	2009	2019	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280131	Ovarian Teratoma	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280217	stage, non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.03	1	2009	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280222	stage, pancreatic cancer	phenotype	C06;C04;C19	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280313	Squamous cell carcinoma of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280317	Squamous cell carcinoma of tonsil	disease	C04;C07;C09	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280324	Laryngeal Squamous Cell Carcinoma	disease	C04;C08;C09	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.04	1	2011	2019	   4	   1	BEFREE
     3845	KRAS	0.32	0.923	C0280781	Adult Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2007	2009	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0281361	Adenocarcinoma of pancreas	disease	C06;C04;C19	Neoplastic Process	0.20	1	1991	2019	  28	   2	BEFREE;CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0302592	Cervix carcinoma	disease	C04;C13	Neoplastic Process	0.35	1	2001	2019	   5	   0	BEFREE;CGI
     3845	KRAS	0.32	0.923	C0332877	Congenital premature fusion	disease		Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0332890	Congenital hemihypertrophy	disease	C23;C16;C13	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0333068	Flexion contracture	disease	C05	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0333516	Tumor necrosis	phenotype	C23	Neoplastic Process	0.03	0.667	2008	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0333983	Hyperplastic Polyp	disease	C23	Neoplastic Process	0.10	1	2003	2016	  13	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334037	Intestinal metaplasia	phenotype		Disease or Syndrome	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334067	Non-Ossifying Fibroma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334082	NEVUS, EPIDERMAL (disorder)	disease	C04	Disease or Syndrome	0.41	1	2010	2010	   1	   1	BEFREE;CLINVAR;GENOMICS_ENGLAND;HPO
     3845	KRAS	0.32	0.923	C0334108	Multiple polyps	disease	C23	Neoplastic Process	0.02	0.5	2018	2019	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0334192	Atrophic endometrium	phenotype	C23;C13	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334233	Pleomorphic carcinoma	disease	C04	Neoplastic Process	0.03	1	1996	2004	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334254	Lymphoepithelial carcinoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334268	Schneiderian papilloma	disease	C04	Neoplastic Process	0.01	0	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334276	Adenocarcinoma in Situ	phenotype	C23;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334277	Adenocarcinoma, metastatic	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334279	Adenocarcinoma, intestinal type	disease	C04	Neoplastic Process	0.02	0.5	1996	2018	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0334287	Fibrolamellar Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334292	Tubular adenoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334294	Multiple adenomatous polyps	disease	C04	Neoplastic Process	0.02	1	2006	2008	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334307	Tubulovillous adenoma	disease	C04	Neoplastic Process	0.04	1	2011	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334345	Apocrine adenoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334350	Eccrine papillary adenoma	disease	C04;C17	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334355	Serous cystadenoma, borderline malignancy	disease	C04	Neoplastic Process	0.07	1	2007	2019	   7	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334448	Cellular Blue Nevus	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334463	Malignant Fibrous Histiocytoma	disease	C04	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334494	Proliferating Brenner Tumor	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334533	Arteriovenous hemangioma	disease	C16;C04;C14	Neoplastic Process	0.03	1	2018	2019	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0334565	Adenoameloblastoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.62	1	2007	2013	   3	   2	BEFREE;CGI;CLINVAR;CTD_human
     3845	KRAS	0.32	0.923	C0334586	Pleomorphic Xanthoastrocytoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0334663	Histiocytic sarcoma	disease	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0334664	Mast Cell Neoplasm	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0338106	Adenocarcinoma of colon	disease	C06;C04	Neoplastic Process	0.10	1	2000	2019	  17	   1	BEFREE
     3845	KRAS	0.32	0.923	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.06	1	1995	2011	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0345392	Congenital kyphoscoliosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0345613	Neoplasm of minor salivary gland	disease	C06;C04;C07	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.52	1	1993	2020	   5	   0	BEFREE;CTD_human;RGD
     3845	KRAS	0.32	0.923	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.60	0.957	1994	2019	  23	   1	BEFREE;CTD_human;MGD
     3845	KRAS	0.32	0.923	C0345907	Angiosarcoma of liver	disease	C06;C04;C14	Neoplastic Process	0.04	1	1991	2002	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0345960	Giant cell carcinoma of lung	disease	C04	Neoplastic Process	0.01	1	1984	1984	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0345964	Adenoma of lung	disease	C04	Neoplastic Process	0.04	1	2000	2008	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346053	Atypical fibroxanthoma of skin	disease	C04	Neoplastic Process	0.01	0	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346099	Nevus spilus	disease	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.01	0	2012	2012	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0346163	Endometrioid carcinoma ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346360	Malignant melanoma of conjunctiva	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346398	Mixed follicular and papillary thyroid carcinoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346619	Malignant neoplasm of cardioesophageal junction of stomach	disease	C06;C04	Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.60	0.985	1985	2020	 268	   3	BEFREE;CGI;CTD_human
     3845	KRAS	0.32	0.923	C0346648	Malignant tumor of exocrine pancreas	disease	C06;C04;C19	Neoplastic Process	0.05	1	1999	2003	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346957	Disseminated Malignant Neoplasm	phenotype	C04	Neoplastic Process	0.03	1	2011	2018	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C0346976	Secondary malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.03	1	2011	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346989	Secondary malignant neoplasm of peritoneum	disease		Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
     3845	KRAS	0.32	0.923	C0347509	Benign neoplasm of central nervous system	group	C04;C10	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0347915	Congenital malformation syndromes associated with short stature	disease	C16;C05;C19	Disease or Syndrome	0.20	1	2014	2014	   1	   0	MGD
     3845	KRAS	0.32	0.923	C0348801	Group B streptococcal pneumonia	disease	C01;C08	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0349579	Atypical Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.02	1	2001	2002	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0349588	Short stature	phenotype		Finding	0.10	1	2006	2011	   3	   2	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	1.00	1	1994	2019	  24	   4	BEFREE;CLINVAR;CTD_human;HPO;LHGDN;MGD;ORPHANET;UNIPROT
     3845	KRAS	0.32	0.923	C0362030	Verrucous epidermal nevus	disease	C16;C04;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0375206	Hemiplegia/hemiparesis	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.60	1	2005	2018	  13	   0	BEFREE;CTD_human;MGD
     3845	KRAS	0.32	0.923	C0376544	Hematopoietic Neoplasms	group	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.02	1	2014	2014	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0398368	Lymphatic Abnormalities	group	C16;C15	Anatomical Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0398650	Immune thrombocytopenic purpura	disease	C23;C20;C15	Disease or Syndrome	0.11	1	2018	2018	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0398738	Leukocyte adhesion deficiency type 1	disease	C16;C20	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0406484	Sebaceous hyperplasia	disease	C23;C17	Disease or Syndrome	0.02	1	2007	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0406612	Encephalocraniocutaneous lipomatosis	disease	C16;C18;C11;C17;C10	Congenital Abnormality	0.31	1	2016	2016	   1	   1	BEFREE;ORPHANET
     3845	KRAS	0.32	0.923	C0406803	Syringocystadenoma Papilliferum	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0410528	Skeletal dysplasia	disease	C16	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0423110	Downward slant of palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0423112	Short palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0423113	Telecanthus	phenotype	C16;C05	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0423867	Fine hair	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.16	1	2005	2017	   6	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0424503	Dysmorphic facies	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0424939	Learning difficulties	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C0427543	Increased blood monocyte number	phenotype		Laboratory or Test Result	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0431097	Malignant melanoma - category	group		Neoplastic Process	0.01	1	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0431371	Absence of septum pellucidum	disease	C16;C10	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0431391	Hemimegalencephaly	disease	C16;C05;C10	Disease or Syndrome	0.40				   0	   0	GENOMICS_ENGLAND;HPO
     3845	KRAS	0.32	0.923	C0431448	Absent eyebrow	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0431478	Posteriorly rotated ear	disease		Congenital Abnormality	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0431527	Laryngeal hypoplasia	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0432103	Submucous cleft of hard palate	disease	C16;C08;C07;C09	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0432122	Interfrontal craniofaciosynostosis	disease	C16;C05	Congenital Abnormality	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0432123	Sagittal craniosynostosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0432163	Defect of vertebral segmentation	disease	C05	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0432230	Langer Mesomelic Dysplasia Syndrome	disease	C23;C16;C05	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0432333	Abnormal dermatoglyphic pattern	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0432408	Trisomy 12	phenotype	C23;C16;C04;C20;C15	Disease or Syndrome	0.01	0	1991	1991	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0442874	Neuropathy	group	C10	Disease or Syndrome	0.01	0	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0456070	Growth delay	phenotype		Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0473574	Inflammatory linear verrucous epidermal nevus	disease	C16;C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0476073	Papillary neoplasm	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.10	0.981	1992	2019	  54	   0	BEFREE
     3845	KRAS	0.32	0.923	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	1	2001	2020	  65	   1	BEFREE
     3845	KRAS	0.32	0.923	C0496779	Malignant neoplasm of appendix	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     3845	KRAS	0.32	0.923	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     3845	KRAS	0.32	0.923	C0497156	Lymphadenopathy	phenotype	C15	Disease or Syndrome	0.12	1	2016	2018	   2	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C0518656	Chronic fatigue	phenotype	C23	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.02	1	1995	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0520739	Hereditary pyropoikilocytosis	disease	C16;C15	Disease or Syndrome	0.02	1	2011	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0521158	Recurrent tumor	phenotype		Neoplastic Process	0.09	1	2006	2019	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0521525	Short neck	phenotype		Finding	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0521573	Coloboma of eyelid	phenotype	C16;C11	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0522224	Paralysed	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0524801	Retinal Neoplasms	group	C04;C11	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0524910	Hepatitis C, Chronic	disease	C06;C01	Disease or Syndrome	0.04	1	1995	2013	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0541764	Delayed bone age	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0541912	Duodenal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0542476	Forgetful	phenotype	C23;C10;F03;F01	Sign or Symptom	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0544886	Somatic mutation	phenotype		Cell or Molecular Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.05	1	1995	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0546964	Genu recurvatum	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.59	1	1988	2016	  10	   0	BEFREE;CGI;CTD_human
     3845	KRAS	0.32	0.923	C0549523	Oropharynx (excludes nasopharynx)	disease		Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0549608	VEINS/LYMPHATICS	phenotype	C14	Disease or Syndrome	0.01	0	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0553723	Squamous cell carcinoma of skin	disease	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0555278	Cerebral metastasis	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.10	1	2006	2011	   3	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0558165	Curly hair (finding)	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0574143	Liver calculus	disease		Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0575081	Gait abnormality	group	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0575158	Kyphoscoliosis deformity of spine	disease	C05	Anatomical Abnormality	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C0576093	Knee joint valgus deformity	disease	C05	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0581342	Redundant skin	phenotype	C16;C17	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.03	1	1988	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0586358	Biliary Intraepithelial Neoplasia	disease	C06	Disease or Syndrome	0.03	0.667	2013	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.60	1	2006	2018	  12	   1	BEFREE;CLINGEN;CTD_human
     3845	KRAS	0.32	0.923	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.959	1990	2020	 268	   3	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0597984	Biliary stricture	disease	C06	Anatomical Abnormality	0.02	1	1998	2000	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0598766	Leukemogenesis	disease	C23;C04	Neoplastic Process	0.03	1	1991	2014	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0598935	Tumor Initiation	phenotype	C23;C04	Neoplastic Process	0.10	1	1997	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C0600033	Acquired Kyphoscoliosis	disease	C05	Acquired Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.10	1	2009	2018	  12	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.02	1	2010	2011	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.08	1	2008	2014	   8	   1	BEFREE
     3845	KRAS	0.32	0.923	C0677898	invasive cancer	phenotype	C04	Neoplastic Process	0.02	1	2007	2011	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677932	Progressive Neoplastic Disease	phenotype		Neoplastic Process	0.10	0.9	1998	2020	  10	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677936	Refractory cancer	phenotype	C04	Neoplastic Process	0.03	1	2010	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677948	Stage II Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2012	2013	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677949	Stage III Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0677950	Stage IV Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.05	1	2014	2018	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.95	1987	2020	  40	   3	BEFREE;CGI;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0678230	Congenital Epicanthus	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.70	0.98	1985	2020	 255	   6	BEFREE;CGI;CLINVAR;UNIPROT
     3845	KRAS	0.32	0.923	C0685938	Malignant neoplasm of gastrointestinal tract	disease	C06;C04	Neoplastic Process	0.08	1	1990	2019	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C0686377	CNS metastases	phenotype	C04;C10	Neoplastic Process	0.02	0.5	2015	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.10	0.963	2007	2019	  27	   3	BEFREE
     3845	KRAS	0.32	0.923	C0699753	Cancer Relapse	disease		Neoplastic Process	0.01	0	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.985	1983	2019	 135	   5	BEFREE
     3845	KRAS	0.32	0.923	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.967	1987	2019	  30	   6	BEFREE;UNIPROT
     3845	KRAS	0.32	0.923	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.09	1	2001	2019	   9	   0	BEFREE
     3845	KRAS	0.32	0.923	C0699889	Malignant Female Reproductive System Neoplasm	disease	C04;C13	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.04	1	2006	2016	   4	   2	BEFREE
     3845	KRAS	0.32	0.923	C0740277	Bile duct carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0740345	Germ Cell Cancer	disease	C04	Neoplastic Process	0.01	1	1990	1990	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0741250	aspirin sensitivity	phenotype		Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0741899	Poorly differentiated carcinoma	phenotype		Neoplastic Process	0.02	1	2016	2017	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C0744620	Metastatic Head and Neck Squamous Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0745730	Multiple lipomata	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.08	1	2002	2020	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C0751008	Intracranial Arteriovenous Malformation, Ruptured	disease	C16;C10;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
     3845	KRAS	0.32	0.923	C0751075	Cancer of Digestive System	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.04	0.5	2004	2018	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0751688	Malignant Squamous Cell Neoplasm	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.03	1	2009	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0751783	Lafora Disease	disease	C16;C10	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0796003	Juberg-Marsidi syndrome	disease	C23;C16;C10;C19;C09	Disease or Syndrome	0.01	1	2019	2019	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0796074	MOHR-TRANEBJAERG SYNDROME	disease	C23;C16;C11;C10;F03;C09;F01	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0848558	Hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0850666	Infection caused by Helicobacter pylori	disease	C01	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0851140	Carcinoma in situ of uterine cervix	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
     3845	KRAS	0.32	0.923	C0853105	Penis carcinoma	disease	C04;C12	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854178	Metastases to adrenals	disease	C04;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854750	Colorectal cancer recurrent	disease	C06;C04	Neoplastic Process	0.03	1	2012	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854776	Pancreatic carcinoma non-resectable	disease	C06;C04;C19	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854917	Rhabdoid Tumor of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.02	1	2008	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854985	Adenocarcinoma of lung, stage I	disease		Neoplastic Process	0.03	1	1994	2014	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0854988	Adenocarcinoma of lung, stage IV	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0855002	Recurrent Lung Carcinoma Cell Type Unspecified	disease		Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0855740	Abnormal platelet function	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.41	0	2019	2019	   1	   1	BEFREE;CGI;CLINVAR
     3845	KRAS	0.32	0.923	C0861727	Pancreatic adenocarcinoma metastatic	disease		Neoplastic Process	0.01	0	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0862506	Borderline ovarian tumour	disease		Neoplastic Process	0.02	1	1999	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0868908	Pancolitis	disease	C06	Disease or Syndrome	0.01	1	1997	1997	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0878500	Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.03	1	2004	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     3845	KRAS	0.32	0.923	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.33	1	1997	2019	   5	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C0917804	Arteriovenous Malformations, Cerebral	group	C16;C10;C14	Congenital Abnormality	0.43	1	2018	2019	   4	   2	BEFREE;CLINVAR;CTD_human;HPO
     3845	KRAS	0.32	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.70	0.903	1991	2019	  31	   4	BEFREE;CGI;CLINVAR;CTD_human;HPO;LHGDN
     3845	KRAS	0.32	0.923	C0920184	Fundic gland polyp	disease	C23	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0936223	Metastatic Prostate Carcinoma	disease	C04;C12	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0940937	precancerous lesions	phenotype		Neoplastic Process	0.04	0.75	2015	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C0941051	Diagnosis for colon	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C0948209	Intestinal adenocarcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2014	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C0949059	Polyp of large intestine	disease	C23;C06;C04	Neoplastic Process	0.02	1	2011	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C0949541	Hurthle Cell Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C0973461	Dysphasia	disease	C23;C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1096184	West Nile viral infection	disease	C01;C10	Disease or Syndrome	0.02	1	2018	2020	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
     3845	KRAS	0.32	0.923	C1112160	Gastrooesophageal cancer	disease		Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2017	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1136084	Plasma cell dyscrasia	disease	C20;C15	Disease or Syndrome	0.02	1	2015	2017	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.70	0.909	1986	2019	  22	   2	BEFREE;CGI;CTD_human;HPO
     3845	KRAS	0.32	0.923	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.24	1	1993	1999	   5	   0	BEFREE;RGD
     3845	KRAS	0.32	0.923	C1167791	Skin toxicity	disease		Disease or Syndrome	0.07	1	2008	2016	   7	   2	BEFREE
     3845	KRAS	0.32	0.923	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.10	0.7	2002	2017	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.06	1	1997	2018	   6	   1	BEFREE
     3845	KRAS	0.32	0.923	C1257915	Intestinal Polyposis	disease	C06	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
     3845	KRAS	0.32	0.923	C1261473	Sarcoma	group	C04	Neoplastic Process	0.10	0.818	1999	2018	  11	   2	BEFREE
     3845	KRAS	0.32	0.923	C1262477	Weight decreased	phenotype	C23	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1263857	Peripheral axonal neuropathy	disease	C10	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1265996	Large cell neuroendocrine carcinoma	disease	C04	Neoplastic Process	0.04	1	2015	2018	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C1266005	Basaloid squamous cell carcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1266025	Traditional Serrated Adenoma	disease	C04	Neoplastic Process	0.10	1	2012	2019	  10	   0	BEFREE
     3845	KRAS	0.32	0.923	C1266051	Papillary microcarcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	0.985	2006	2020	  65	   4	BEFREE
     3845	KRAS	0.32	0.923	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	0.80	1	1993	2019	  35	  10	BEFREE;CLINGEN;CLINVAR;CTD_human;GENOMICS_ENGLAND;ORPHANET
     3845	KRAS	0.32	0.923	C1279945	Acute interstitial pneumonia	disease	C08	Disease or Syndrome	0.02	1	2011	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1282496	Metastasis from malignant tumor of prostate	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	0	2006	2006	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.03	1	2012	2016	   3	   2	BEFREE
     3845	KRAS	0.32	0.923	C1298180	Single tumor	phenotype		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1301034	Pancreatic intraepithelial neoplasia	disease	C04	Neoplastic Process	0.10	1	2002	2019	  21	   1	BEFREE
     3845	KRAS	0.32	0.923	C1301194	Salivary duct carcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   3	BEFREE
     3845	KRAS	0.32	0.923	C1302401	Adenoma of large intestine	disease	C06;C04	Neoplastic Process	0.10	1	1991	2019	  19	   0	BEFREE
     3845	KRAS	0.32	0.923	C1306050	Primary malignant neoplasm of appendix	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.977	1987	2020	 352	   7	BEFREE
     3845	KRAS	0.32	0.923	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.979	1993	2020	 241	   4	BEFREE
     3845	KRAS	0.32	0.923	C1306574	Botryoid rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1306710	Facial asymmetry	phenotype	C23	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1318485	Liver regeneration disorder	phenotype	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.40	0.95	1993	2019	  20	   0	BEFREE;CGI
     3845	KRAS	0.32	0.923	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.03	1	2011	2018	   3	   2	BEFREE
     3845	KRAS	0.32	0.923	C1328931	Multiple lentigines	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1332153	acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	1997	1997	   1	   5	BEFREE
     3845	KRAS	0.32	0.923	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2008	2013	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1332243	Adenocarcinoma of ampulla of Vater	disease	C04	Neoplastic Process	0.03	1	2015	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332460	Barrett's Adenocarcinoma	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332866	Adenocarcinoma of cecum	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332899	Cerebellar Glioblastoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.08	0.875	1996	2020	   8	   1	BEFREE
     3845	KRAS	0.32	0.923	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2008	2013	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.03	1	1988	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1332995	Childhood Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2007	2009	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1333001	Childhood Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1333015	Childhood Kidney Wilms Tumor	disease	C16;C04;C13;C12	Neoplastic Process	0.02	1	2011	2017	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1333081	Colloid Carcinoma of the Pancreas	disease	C04	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1333116	Colorectal Traditional Serrated Adenoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1333190	Cystic Neoplasm	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1333308	Distal Bile Duct Carcinoma	disease		Neoplastic Process	0.01	1	1998	1998	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.40	0.917	1996	2017	  12	   0	BEFREE;ORPHANET
     3845	KRAS	0.32	0.923	C1334008	High Grade Sarcoma	disease		Neoplastic Process	0.02	1	2014	2015	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334015	High Grade Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.02	1	2004	2014	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334260	Intramuscular Myxoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334274	Invasive Carcinoma	phenotype	C04	Neoplastic Process	0.02	1	1997	2006	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334455	Pulmonary Sclerosing Hemangioma	disease	C04;C08	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334811	Mucinous neoplasm	disease		Neoplastic Process	0.03	1	2016	2017	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1334920	Adenocarcinoma of the nasal cavity	disease	C04	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1335167	Ovarian Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1335177	Ovarian Serous Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2003	2004	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.10	0.988	1998	2020	  85	   1	BEFREE
     3845	KRAS	0.32	0.923	C1335377	periampullary adenocarcinoma	disease	C06;C04	Neoplastic Process	0.02	0.5	1995	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1335475	Primary Carcinoma	phenotype	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1335729	Refractory Neoplasm	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336026	Solid Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336076	Sporadic Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	1998	1998	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336137	Stage IB Lung Adenocarcinoma AJCC v7	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336861	Undifferentiated Pancreatic Carcinoma	disease		Neoplastic Process	0.02	1	2013	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1336905	Endometrial Endometrioid Adenocarcinoma	disease	C04;C13;C19	Neoplastic Process	0.20	1	1999	1999	   1	   0	RGD
     3845	KRAS	0.32	0.923	C1337011	Well Differentiated Pancreatic Endocrine Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.03	1	2011	2014	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1368816	Sebaceous adenoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   2	BEFREE
     3845	KRAS	0.32	0.923	C1368898	Adult Teratoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1368910	Mature Teratoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1369136	Anal cancer metastatic	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1370419	Ovarian Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1384494	Metastatic Carcinoma	group	C23;C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.01	1	1998	1998	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1402294	Primary Lesion	phenotype		Disease or Syndrome	0.03	1	2013	2017	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C1412036	Anal squamous cell carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2012	2016	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.35	1	2010	2017	   5	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C1511789	Desmoplastic	disease		Disease or Syndrome	0.02	1	2013	2019	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1512127	HER2 gene amplification	disease		Disease or Syndrome	0.10	0.917	2001	2019	  12	   0	BEFREE
     3845	KRAS	0.32	0.923	C1512409	Hepatocarcinogenesis	disease	C23;C04	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1512981	Mammary Tumorigenesis	phenotype	C23;C04	Neoplastic Process	0.02	1	2001	2006	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1516490	Cholangiolocellular Carcinoma	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1519086	Pilomyxoid astrocytoma	disease	C04	Neoplastic Process	0.30	1	2007	2012	   4	   0	ORPHANET
     3845	KRAS	0.32	0.923	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.02	1	2009	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1519680	Tumor Immunity	phenotype	C23	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1527349	Ductal Breast Carcinoma	disease	C04	Neoplastic Process	0.06	1	1997	2018	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C1527404	Female Pseudo-Turner Syndrome	disease	C16;C17;C05;C14	Congenital Abnormality	0.30	1	2007	2007	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C1531647	Cerebral ventriculomegaly	phenotype	C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1535510	ADENOMAS AND ADENOCARCINOMAS	group	C04	Neoplastic Process	0.02	1	2011	2013	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1569637	Adenocarcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.04	1	2012	2020	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.10	0.958	1996	2019	  24	   0	BEFREE
     3845	KRAS	0.32	0.923	C1611743	Familial (FPAH)	disease		Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.15	1	2011	2019	   5	   1	BEFREE;HPO
     3845	KRAS	0.32	0.923	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.02	1	2012	2014	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1704375	Hypophosphatemic Rickets	disease	C18;C05	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1704453	Oncocytic Schneiderian papilloma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1707440	Colorectal Signet Ring Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1707444	Columnar Cell Change of the Breast	phenotype		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.40	1	2000	2001	   2	   1	CLINVAR;CTD_human
     3845	KRAS	0.32	0.923	C1708747	Low grade appendiceal mucinous neoplasm	disease		Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1709780	Pyloric Gland Adenoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1720430	Papillary carcinoma, clear cell	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C1762616	Meningioma, benign, no ICD-O subtype	disease	C04;C10	Neoplastic Process	0.01	1	1988	1988	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.01	1	2002	2002	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1827524	Wide spaced nipples	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1827820	Fast acetylator due to N-acetyltransferase enzyme variant	disease		Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1832348	Slow-growing hair	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.10	0.985	2009	2020	 133	   2	BEFREE
     3845	KRAS	0.32	0.923	C1835884	Triangular face	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1836047	Long face	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1836542	Depressed nasal bridge	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1836830	Developmental regression	disease	F03	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1836940	Thickened nuchal skin fold	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1837732	Thickened helices	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1837770	Sparse hair	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1838329	APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS	disease	C16;C04;C17	Disease or Syndrome	0.33	1	2015	2019	   4	   2	BEFREE;ORPHANET
     3845	KRAS	0.32	0.923	C1839739	Thick lower lip vermilion	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1839767	Tented upper lip vermilion	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1840077	Anteverted nostril	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1840264	IMMUNE SUPPRESSION	phenotype		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1840382	Abnormality of the ureter	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1842408	increased risk of pancreatic cancer	phenotype	C04	Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1842881	Dilated aortic root	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1843108	Short palm	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1843181	Noonan syndrome-like disorder with loose anagen hair	disease	C23;C17	Disease or Syndrome	0.30				   0	   0	CLINGEN
     3845	KRAS	0.32	0.923	C1843367	Poor school performance	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1845847	Coarse facial features	phenotype	C23	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1846821	Abnormality of coagulation	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1848701	Elevated hepatic transaminase	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1849089	Broad forehead	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1849157	Resistance to Insulin-Like Growth Factor I	disease	C23;C16	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1849265	Overgrowth	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1849340	Long palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1849538	Delayed eruption of primary teeth	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1849699	Progesterone Resistance	disease	C13	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1850049	Clinodactyly of the 5th finger	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	disease	C15	Disease or Syndrome	0.03	1	2017	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1851710	LATERAL MENINGOCELE SYNDROME	disease	C23;C16;C10	Disease or Syndrome	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1851841	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	disease	C16;C17;C05;C07	Disease or Syndrome	0.03	1	2013	2015	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C1853237	Isolated cases	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1853242	Midface retrusion	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1853737	Prominent occiput	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1854114	Short nose	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1854418	Biparietal narrowing	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1854978	Monosomy 7 of Bone Marrow	disease	C23;C16;C04;C15	Disease or Syndrome	0.01	1	1994	1994	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1855728	Low posterior hairline	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1857486	Low-set, posteriorly rotated ears	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1857539	Deep palmar crease	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1858430	Death in infancy	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1858969	Decreased lymphocyte apoptosis	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1860236	Irregular hyperpigmentation	phenotype	C17	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1860245	Cranial asymmetry	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1860991	NOONAN SYNDROME 3	disease	C16;C17;C05;C14	Disease or Syndrome	0.90	1	2006	2014	  15	  11	CLINVAR;CTD_human;GENOMICS_ENGLAND;MGD;UNIPROT
     3845	KRAS	0.32	0.923	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1861866	Aplasia/Hypoplasia of the corpus callosum	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1861869	Underdeveloped supraorbital ridges	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1861975	Cafe au lait spots, multiple	disease	C23;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1863753	LIMB-MAMMARY SYNDROME	disease	C16;C05	Disease or Syndrome	0.01	1	1999	1999	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1865014	Long philtrum	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1865597	Hypoplastic nasal bridge	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1865916	Bilateral ptosis	phenotype	C11	Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C1866231	Full cheeks	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1866934	Reduced tendon reflexes	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1867616	Dermoid choristoma of eye proper	disease	C11	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1867873	Failure to thrive in infancy	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1868085	Craniofacial hyperostosis	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.02	1	1991	1997	   2	   3	BEFREE
     3845	KRAS	0.32	0.923	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	2017	2017	   1	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C1879344	Biliary papillomatosis	disease	C06;C04	Neoplastic Process	0.02	1	1993	2018	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1881254	Inverted Squamous Cell Papilloma	disease	C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C1947968	Carcinoma Metastatic to the Skin	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1956257	Pulmonary Stenosis	disease	C14	Disease or Syndrome	0.10				   0	   1	CLINVAR;HPO
     3845	KRAS	0.32	0.923	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	0.5	2014	2016	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.04	1	2008	2018	   4	   0	BEFREE;LHGDN
     3845	KRAS	0.32	0.923	C1962966	Retinopathy, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1963094	Dry Skin, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1963165	Malabsorption, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1963167	Memory Impairment, CTCAE 3.0	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C1963184	Nystagmus, CTCAE 3.0	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2145472	Urothelial Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.92	1985	2020	  25	   4	BEFREE;CLINVAR;CTD_human;HPO;RGD
     3845	KRAS	0.32	0.923	C2315100	Pediatric failure to thrive	disease	C23;C18;F03	Disease or Syndrome	0.10	1	2006	2011	   3	   2	CLINVAR
     3845	KRAS	0.32	0.923	C2347761	Childhood Myelodysplastic Syndrome	disease	C15	Neoplastic Process	0.03	1	1988	2004	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C2347762	Childhood Teratoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2349952	Oropharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2613439	Extramedullary Hematopoiesis (disorder)	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2674608	Feeding difficulties in infancy	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2674723	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	disease	C16;C04;C20;C15	Disease or Syndrome	0.63	1	2006	2019	   8	   6	BEFREE;CLINVAR;GENOMICS_ENGLAND;ORPHANET
     3845	KRAS	0.32	0.923	C2674737	Abnormality of finger	phenotype	C05	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2674738	Abnormality of toe	group	C05	Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2675021	Narrow palpebral fissure	phenotype		Finding	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C2675111	Abnormal eyelash morphology	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2676033	Hepatoblastoma Caused By Somatic Mutation	disease	C06;C04	Neoplastic Process	0.20	1	1993	1993	   1	   0	RGD
     3845	KRAS	0.32	0.923	C2697636	Hyperdiploid B Acute Lymphoblastic Leukemia	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2700617	Irritation - emotion	phenotype	F01	Mental Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2712711	Benign endometrial hyperplasia	disease	C13	Disease or Syndrome	0.01	1	2002	2002	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C2721606	Bladder dysplasia	disease		Disease or Syndrome	0.01	1	1996	1996	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2732618	Sessile Serrated Adenoma/Polyp	disease		Neoplastic Process	0.02	1	2004	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C2732838	Neoplasm of skeletal system	disease		Neoplastic Process	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2751260	Macrothrombocytopenia	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2751492	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	disease	C16;C18;C10	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2752147	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	disease	C16;C04;C18;C17	Disease or Syndrome; Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2826323	Refractory Cytopenia of Childhood	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2919142	Short Stature, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C2931038	Pancreatic carcinoma, familial	disease	C06;C04;C19	Neoplastic Process	0.31	1	2015	2019	   2	   0	BEFREE;ORPHANET
     3845	KRAS	0.32	0.923	C2931201	Urachal adenocarcinoma	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2931202	Urachal cancer	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2931658	Phacomatosis pigmentokeratotica	disease	C04;C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.34	0.8	2009	2015	   5	   1	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C2938924	Oestrogen receptor positive breast cancer	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.10	0.945	1991	2020	  91	   3	BEFREE
     3845	KRAS	0.32	0.923	C2973725	Pulmonary arterial hypertension	disease	C08;C14	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C2986682	Locally Recurrent Malignant Neoplasm	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2987120	Intramucosal Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C2987191	Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type	disease	C06;C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3146250	Stage III Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3146251	Stage IV Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.05	1	2014	2018	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C3146252	Stage II Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3146254	Stage III Colon Cancer AJCC v7	disease		Neoplastic Process	0.08	1	2005	2019	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C3146257	Stage II Colon Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2010	2015	   2	   2	BEFREE
     3845	KRAS	0.32	0.923	C3149631	MELORHEOSTOSIS, ISOLATED	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3160815	Intraductal papillary mucinous neoplasm	disease		Neoplastic Process	0.04	1	2007	2016	   4	   1	BEFREE
     3845	KRAS	0.32	0.923	C3164374	Abnormality of pulmonary valve	disease		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3179502	Linear Verrucous Epidermal Nevus	disease	C16;C04;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3257924	Non-advanced adenomas	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3266123	Serrated polyp	disease	C23	Anatomical Abnormality	0.03	0.667	2004	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.03	1	2016	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C3272607	Colorectal Neuroendocrine Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3272793	Filiform Serrated Adenoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3272809	Colorectal Serrated Adenocarcinoma	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3272841	MUTYH-Associate Polyposis	disease	C16;C04	Neoplastic Process	0.06	1	2007	2015	   6	   1	BEFREE
     3845	KRAS	0.32	0.923	C3278923	Dilated ventricles (finding)	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3279222	Aplasia/Hypoplasia of the cerebellum	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3281200	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	disease	C16;C04;C18;C10	Disease or Syndrome	0.02	1	2018	2019	   2	   1	BEFREE
     3845	KRAS	0.32	0.923	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.37	1	1988	2017	   8	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C3472623	Serrated adenocarcinoma	disease		Neoplastic Process	0.02	1	2011	2013	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3489413	Lipomatosis, Multiple	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   1	BEFREE
     3845	KRAS	0.32	0.923	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C3501846	Noonan-Like Syndrome With Loose Anagen Hair	disease	C23;C16;C17;C05;C14	Disease or Syndrome	0.30				   0	   0	CLINGEN
     3845	KRAS	0.32	0.923	C3536983	Familial Hypophosphatemic Rickets	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3539781	Progressive cGVHD	disease		Disease or Syndrome	0.10	0.9	1998	2020	  10	   0	BEFREE
     3845	KRAS	0.32	0.923	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.36	1	2010	2019	   6	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C3544205	Ovarian clear cell carcinoma	disease		Neoplastic Process	0.06	1	2010	2018	   6	   0	BEFREE
     3845	KRAS	0.32	0.923	C3551426	Dystrophic fingernails	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3551431	Sparse or absent eyelashes	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3553764	Joint hyperflexibility	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3639956	Functional intestinal obstruction	phenotype	C06	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3642345	Luminal A Breast Carcinoma	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3647143	Secondary malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3714524	Fibromyxosarcoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3714651	Follicular Variant Thyroid Gland Papillary Carcinoma	disease	C04;C19	Neoplastic Process	0.03	1	2015	2018	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C3714745	Malabsorption	phenotype	C06	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.34	1	1994	2015	   6	   0	BEFREE;CTD_human
     3845	KRAS	0.32	0.923	C3805574	Increased fracture rate	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3809005	CARDIOFACIOCUTANEOUS SYNDROME 2	disease		Disease or Syndrome	0.60	1	2006	2014	  11	   9	CLINVAR;GENOMICS_ENGLAND;UNIPROT
     3845	KRAS	0.32	0.923	C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3839184	Low grade serous carcinoma	disease		Neoplastic Process	0.05	1	2013	2017	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C3839280	High grade serous carcinoma	disease		Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3839868	Cytogenetically normal acute myeloid leukemia	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3854181	Nevus sebaceous	disease	C04	Neoplastic Process	0.43	1	2012	2017	   4	   1	BEFREE;CLINVAR;HPO;ORPHANET
     3845	KRAS	0.32	0.923	C3854222	Human immunodeficiency virus (HIV) II infection category B1	disease		Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3887641	Recurrent hepatitis	disease	C06	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3887654	POLYARTERITIS NODOSA, CHILDHOOD-ONSET	disease	C17;C14	Disease or Syndrome	0.02	1	2015	2020	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3887875	Visual field defects	group	C23;C11;C10	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C3888194	MIXED LINEAGE LEUKEMIA	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3888391	Nonnuclear polymorphic congenital cataract	disease		Congenital Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3896578	Familial Colorectal Cancer Type X	disease	C16;C06;C04;C18	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3896673	Familial Nonmedullary Thyroid Gland Carcinoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3898127	Non-Metastatic Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.02	1	1999	2010	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3898473	Malignant biliary obstruction	disease		Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3898709	Intestinal-Type Sinonasal Adenocarcinoma	disease		Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C3899645	Childhood Pleomorphic Xanthoastrocytoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3900097	Adult Penile Carcinoma	disease	C04;C12	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C3900098	Adult Myelodysplastic Syndrome	disease	C15	Neoplastic Process	0.02	1	1988	1991	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4014733	Follicular hyperplasia	phenotype	C15	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4016403	BLADDER CANCER, TRANSITIONAL CELL, SOMATIC	disease		Neoplastic Process	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C4016796	COLORECTAL CANCER WITH CHROMOSOMAL INSTABILITY	disease		Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4020962	Enlarged thorax	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4020965	Cardiac diverticulum	disease		Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4021242	Hypoplasia of the zygomatic bone	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4021956	Aplasia/Hypoplasia of the eyebrow	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4021977	Visceral angiomatosis	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4022012	Death in early adulthood	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4022025	Asymmetric growth	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4022755	Functional abnormality of the gastrointestinal tract	phenotype		Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4023018	Subcortical cerebral atrophy	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4023385	Aplasia of the semicircular canal	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4023397	Abnormal hair quantity	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4023401	Abnormality of hair density	disease		Anatomical Abnormality	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C4023551	Abnormality of dental color	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4023909	Aplasia/Hypoplasia of the abdominal wall musculature	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4024737	Aplasia/Hypoplasia of the skin	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4024878	Generalized hyperpigmentation	phenotype	C17	Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4024890	Excessive wrinkled skin	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4025662	Abnormality of the ulna	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4025680	Abnormal cartilage morphology	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4025749	Abnormality of the spleen	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4025835	Abnormal nasolacrimal system morphology	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4025846	Abnormality of vision	disease		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.04	1	2001	2019	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C4048329	Immunosuppression	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4049272	Tumour budding	disease		Neoplastic Process	0.06	1	2007	2018	   6	   2	BEFREE
     3845	KRAS	0.32	0.923	C4049796	Abnormality of cardiovascular system morphology	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4082172	Porencephalic cyst	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.04	1	2006	2016	   4	   2	BEFREE
     3845	KRAS	0.32	0.923	C4087504	Peritoneal dissemination	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4282128	PATENT DUCTUS ARTERIOSUS 1	disease	C16;C14	Congenital Abnormality	0.10	1	2009	2019	  16	   1	BEFREE
     3845	KRAS	0.32	0.923	C4283978	Primary adenocarcinoma of lower third of esophagus due to Barrett esophagus	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.09	1	1994	2018	   9	   1	BEFREE
     3845	KRAS	0.32	0.923	C4296896	Hyperplastic polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4302356	Primary low grade serous adenocarcinoma of ovary	disease		Neoplastic Process	0.10				   0	   1	CLINVAR
     3845	KRAS	0.32	0.923	C4324656	Non-squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.02	1	2015	2019	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4476553	Atrial septal dilatation	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4509816	Squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.03	1	2013	2019	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C4511687	Pancreatic Intraductal Papillary Mucinous Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.10	1	2003	2019	  13	   1	BEFREE
     3845	KRAS	0.32	0.923	C4518333	Clear cell papillary renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4520718	Stage I Rectal Cancer AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     3845	KRAS	0.32	0.923	C4522160	Invasive Mucinous Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.01	0	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4523846	MSI-high	disease		Neoplastic Process	0.08	0.875	2008	2018	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C4524257	MSI-low	disease		Neoplastic Process	0.05	0.8	2006	2016	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C4524268	Advanced lung cancer	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4525119	Stage II Colon Cancer AJCC v8	disease		Neoplastic Process	0.02	1	2010	2015	   2	   2	BEFREE
     3845	KRAS	0.32	0.923	C4525124	Stage III Colon Cancer AJCC v8	disease		Neoplastic Process	0.08	1	2005	2019	   8	   0	BEFREE
     3845	KRAS	0.32	0.923	C4525133	Stage I Rectal Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4525297	Stage 0 Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.10	1	2004	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C4525300	Stage IIA Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.10	1	2004	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C4525301	Stage IIB Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.10	1	2004	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C4525302	Stage III Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.10	1	2004	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C4525305	Stage IV Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.10	1	2004	2019	  10	   1	BEFREE
     3845	KRAS	0.32	0.923	C4528668	Acute myeloid leukaemia refractory	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4531084	Mucinous colorectal carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.02	1	2013	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551506	Paroxysmal Nonkinesigenic Dyskinesia 1	disease	C23;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551583	Cerebral cortical atrophy	disease		Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4551593	Surface epithelial-stromal tumor	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551602	Noonan Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2007	2007	   4	   0	CTD_human
     3845	KRAS	0.32	0.923	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4551683	Adrenal Gland Pheochromocytoma	disease	C04;C19	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.10	0.8	1999	2018	  10	   2	BEFREE
     3845	KRAS	0.32	0.923	C4551687	Sarcoma of soft tissue	group	C04	Neoplastic Process	0.02	1	1999	2010	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4551915	Gait Disturbance, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C4552097	Nevus Sebaceus of Jadassohn	disease	C16;C04;C10	Disease or Syndrome	0.62	1	2012	2017	   2	   2	BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;HPO
     3845	KRAS	0.32	0.923	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.04	0.75	2011	2017	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C4552810	Irritability, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4553743	Spasticity, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4553765	Memory Impairment, CTCAE 5.0	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4554036	Nystagmus, CTCAE 5.0	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4684879	Metastatic Bile Duct Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4684880	Advanced Bile Duct Carcinoma	disease		Neoplastic Process	0.04	1	2015	2017	   4	   0	BEFREE
     3845	KRAS	0.32	0.923	C4688308	Advanced Lung Non-Squamous Non-Small Cell Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4688318	Refractory Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2010	2017	   3	   1	BEFREE
     3845	KRAS	0.32	0.923	C4703633	Increased level of L-fucose in urine	phenotype		Finding	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3845	KRAS	0.32	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
     3845	KRAS	0.32	0.923	C4721411	Osteolysis	phenotype	C05	Pathologic Function	0.10				   0	   0	HPO
     3845	KRAS	0.32	0.923	C4721505	Sarcoma, Myeloid	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.10	0.98	2007	2020	 492	   4	BEFREE
     3845	KRAS	0.32	0.923	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.20	0.923	1986	2019	  26	   2	BEFREE;HPO
     3845	KRAS	0.32	0.923	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.11	1	2016	2016	   1	   0	BEFREE;HPO
     3845	KRAS	0.32	0.923	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.10	0.974	1991	2020	 459	   6	BEFREE
     3845	KRAS	0.32	0.923	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.05	1	2010	2019	   5	   0	BEFREE
     3845	KRAS	0.32	0.923	C4727070	Advanced Carcinoma	disease		Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4727838	Advanced Melanoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     3845	KRAS	0.32	0.923	C4744444	Metastatic Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
     3845	KRAS	0.32	0.923	C4744564	Metastatic Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.952	2009	2017	  21	   0	BEFREE
     3845	KRAS	0.32	0.923	C4744565	Metastatic Colon Carcinoma	disease		Neoplastic Process	0.02	1	2005	2012	   2	   0	BEFREE
     3845	KRAS	0.32	0.923	C4745063	Biliary Tract Carcinoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085281	Addictive Behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.10	0.909	2004	2019	  11	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085293	Hepatitis E	disease	C06;C01	Disease or Syndrome	0.01	1	2008	2008	   1	   0	LHGDN
     1956	EGFR	0.295	0.885	C0085390	Li-Fraumeni Syndrome	disease	C16;C04;C18	Disease or Syndrome	0.04	1	2013	2018	   4	   3	BEFREE
     1956	EGFR	0.295	0.885	C0085413	Polycystic Kidney, Autosomal Dominant	disease	C16;C13;C12	Disease or Syndrome	0.04	1	2003	2019	   4	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0085437	Meningitis, Bacterial	group	C01;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	0.32	1	1998	2010	   3	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0085605	Liver Failure	disease	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085624	Burning sensation	phenotype	C23;C10	Sign or Symptom	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085669	Acute leukemia	disease	C23;C04	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2013	2020	   2	   0	BEFREE;PSYGENET
     1956	EGFR	0.295	0.885	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0086543	Cataract	disease	C11	Acquired Abnormality	0.02	1	1999	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.05	1	1996	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0149516	Chronic sinusitis	disease	C01;C08;C09	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.03	1	1994	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0149630	Bicuspid aortic valve	disease	C14	Congenital Abnormality	0.01	1	2016	2016	   1	   2	BEFREE
     1956	EGFR	0.295	0.885	C0149678	Epstein-Barr Virus Infections	group	C01	Disease or Syndrome	0.01	1	1995	1995	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.20	1	2003	2003	   1	   0	RGD
     1956	EGFR	0.295	0.885	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.50	0.98	2007	2019	  51	   7	BEFREE;CGI;CLINVAR
     1956	EGFR	0.295	0.885	C0149911	Humoral hypercalcemia of malignancy (disorder)	disease	C04;C18	Disease or Syndrome	0.02	1	2007	2009	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.40	0.985	1990	2019	  68	   6	BEFREE;CTD_human;LHGDN
     1956	EGFR	0.295	0.885	C0149978	Adenocarcinoma of rectum	disease	C06;C04	Neoplastic Process	0.02	1	2010	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0150055	Chronic pain	phenotype	C23	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151449	Primary Sjögren's syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151546	Oral Cavity Carcinoma	disease	C06;C04;C07	Neoplastic Process	0.03	1	2011	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151650	Renal fibrosis	disease	C23;C13;C12	Disease or Syndrome	0.04	1	2013	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151664	Gastrointestinal perforation	disease	C06	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151723	Hypomagnesemia	phenotype	C18	Disease or Syndrome	0.08	1	2016	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.02	1	2008	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0151908	Dry skin	phenotype	C17	Sign or Symptom	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.70	0.978	1990	2020	1148	  26	BEFREE;CGI;CLINVAR;CTD_human
     1956	EGFR	0.295	0.885	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.50	1	1988	2019	  43	   0	BEFREE;CGI;CLINVAR
     1956	EGFR	0.295	0.885	C0152021	Congenital heart disease	group	C16;C14	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0152069	Echinococcus multilocularis infection	disease	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153349	Malignant neoplasm of tongue	disease	C04;C07	Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.10	1	1989	2020	  30	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153382	Malignant neoplasm of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.05	1	2007	2018	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153392	Malignant neoplasm of nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.02	1	2008	2019	   2	   1	BEFREE
     1956	EGFR	0.295	0.885	C0153446	Malignant neoplasm of anus	disease	C06;C04	Neoplastic Process	0.03	0.667	2015	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.36	1	2010	2019	   7	   1	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0153579	Malignant neoplasm of fallopian tube	group	C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153594	Malignant neoplasm of testis	disease	C04;C12;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153601	Malignant neoplasm of penis	disease	C04;C12	Neoplastic Process	0.03	1	2013	2016	   3	   3	BEFREE
     1956	EGFR	0.295	0.885	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.40	1	2004	2019	  10	   0	BEFREE;CGI
     1956	EGFR	0.295	0.885	C0153653	Malignant tumor of parathyroid gland	disease	C04;C19	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153676	Secondary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	1	1999	2019	  32	   3	BEFREE
     1956	EGFR	0.295	0.885	C0153678	Secondary malignant neoplasm of pleura	disease	C04;C08	Neoplastic Process	0.03	1	2011	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0153690	Secondary malignant neoplasm of bone	disease	C23;C04;C05	Neoplastic Process	0.10	0.933	2007	2020	  30	   3	BEFREE
     1956	EGFR	0.295	0.885	C0153942	Benign neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1956	EGFR	0.295	0.885	C0154059	Carcinoma in situ of esophagus	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1956	EGFR	0.295	0.885	C0154084	Stage 0 Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0155490	Middle Ear Cholesteatoma	disease	C17;C09	Disease or Syndrome	0.02	1	1993	1994	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0158266	Intervertebral Disc Degeneration	disease	C05	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162359	Christ-Siemens-Touraine syndrome	disease	C16;C17	Disease or Syndrome	0.01	1	1996	1996	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162429	Malnutrition	disease	C18	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162534	Prion Diseases	group	C01;C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162678	Neurofibromatoses	group	C16;C04;C10	Neoplastic Process	0.04	1	2005	2017	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162830	Dermatitis, Phototoxic	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162848	Lichenoid Eruptions	group	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.02	0.5	1998	1999	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0175754	Agenesis of corpus callosum	disease	C23;C16;C10	Congenital Abnormality	0.09	1	2001	2018	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.10	0.967	1992	2020	 184	   5	BEFREE
     1956	EGFR	0.295	0.885	C0205622	Microinvasive tumor	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1989	2016	   5	   0	CTD_human
     1956	EGFR	0.295	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	1989	2016	   5	   0	CTD_human
     1956	EGFR	0.295	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	1989	2016	   5	   0	CTD_human
     1956	EGFR	0.295	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	1989	2016	   5	   0	CTD_human
     1956	EGFR	0.295	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.33	1	1989	2018	   8	   3	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.31	1	2004	2008	   2	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.34	1	2004	2019	   5	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.32	1	2004	2011	   3	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.31	1	2004	2013	   2	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205748	Dysplastic Nevus	disease	C16;C04	Neoplastic Process	0.01	1	1992	1992	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0205874	Papilloma, Squamous Cell	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0205875	Papillomatosis	disease	C04	Neoplastic Process	0.31	1	1995	2017	   2	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0205944	Sarcoma, Epithelioid	disease	C04	Neoplastic Process	0.02	1	2010	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0205969	Thymic Carcinoma	disease	C04;C15	Neoplastic Process	0.10	0.923	2002	2019	  13	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206061	Pneumonia, Interstitial	disease	C08	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206062	Lung Diseases, Interstitial	group	C08	Disease or Syndrome	0.10	1	2006	2019	  23	   1	BEFREE
     1956	EGFR	0.295	0.885	C0206093	Neuroectodermal Tumors	disease	C04	Neoplastic Process	0.01	1	1989	1989	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206138	CREST Syndrome	disease	C06;C18;C17;C14	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206139	Lichen Planus, Oral	disease	C17;C07	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206180	Ki-1+ Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0206623	Adenosquamous carcinoma	disease	C04	Neoplastic Process	0.10	0.962	2007	2019	  26	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.04	1	2009	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206629	Pulmonary Blastoma	disease	C04	Neoplastic Process	0.02	1	2007	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206630	Endometrial Stromal Sarcoma	disease	C04;C13	Neoplastic Process	0.02	1	2007	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206633	Angiomyolipoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206638	Giant Cell Tumor of Bone	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206647	Dermatofibrosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206650	Fibroadenoma	disease	C04	Neoplastic Process	0.01	1	1995	1995	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206651	Clear Cell Sarcoma of Soft Tissue	disease	C04	Neoplastic Process	0.02	1	2004	2007	   2	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206655	Alveolar rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206656	Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206658	Smooth Muscle Tumor	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206659	Embryonal Carcinoma	disease	C04	Neoplastic Process	0.03	1	1994	2010	   3	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206663	Neuroectodermal Tumor, Primitive	disease	C04	Neoplastic Process	0.03	1	1994	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.03	1	2010	2014	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206681	Adenocarcinoma, Clear Cell	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.02	1	2014	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206684	Sebaceous Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206685	Acinar Cell Carcinoma	disease	C04	Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.34	1	2009	2013	   4	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0206687	Carcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.02	1	2010	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206693	Medullary carcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206694	Mucoepidermoid Carcinoma	disease	C04	Neoplastic Process	0.10	1	2001	2019	  17	   4	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206695	Carcinoma, Neuroendocrine	disease	C04	Neoplastic Process	0.10	0.8	1992	2020	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206696	Carcinoma, Signet Ring Cell	disease	C04	Neoplastic Process	0.02	0.5	2017	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.40	1	2002	2019	  29	   0	BEFREE;CTD_human;LHGDN
     1956	EGFR	0.295	0.885	C0206701	Cystadenocarcinoma, Serous	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206704	Carcinoma, Large Cell	disease	C04	Neoplastic Process	0.10	0.909	2003	2016	  11	   3	BEFREE
     1956	EGFR	0.295	0.885	C0206706	Verrucous carcinoma	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	LHGDN
     1956	EGFR	0.295	0.885	C0206708	Cervical Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.01	1	1990	1990	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206716	Ganglioglioma	disease	C04	Neoplastic Process	0.02	1	1992	2008	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206721	Inverted Papilloma	disease	C04	Neoplastic Process	0.06	1	2008	2020	   6	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0206726	gliosarcoma	disease	C04	Neoplastic Process	0.31	1	2008	2013	   3	   0	BEFREE;ORPHANET
     1956	EGFR	0.295	0.885	C0206727	Nerve Sheath Tumors	group	C04;C10	Neoplastic Process	0.01	1	2008	2008	   1	   0	LHGDN
     1956	EGFR	0.295	0.885	C0206728	Plexiform Neurofibroma	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206734	Hemangioblastoma	disease	C04	Neoplastic Process	0.03	1	1995	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206743	Rhabdoid Tumor	disease	C04	Neoplastic Process	0.04	1	2001	2015	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206750	Coronavirus Infections	group	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.06	1	2003	2019	   6	   1	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0220611	Childhood Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.07	1	1996	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220613	Adult Soft Tissue Sarcoma	disease		Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220615	Adult Acute Myeloblastic Leukemia	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220620	Gastrointestinal Carcinoid Tumor	disease	C06;C04;C19	Neoplastic Process	0.05	0.8	2001	2018	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.08	1	2011	2020	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.02	1	2001	2013	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.04	1	2012	2016	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220641	Lip and Oral Cavity Carcinoma	disease	C04;C07	Neoplastic Process	0.10	1	1989	2020	  28	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220645	Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220650	Metastatic malignant neoplasm to brain	disease	C23;C04;C10	Neoplastic Process	0.10	0.982	1989	2020	 222	   4	BEFREE
     1956	EGFR	0.295	0.885	C0220654	Meningeal Carcinomatosis	disease	C04;C10	Neoplastic Process	0.10	0.9	1999	2017	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220656	Malignant ascites	disease	C23;C06;C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0220668	Congenital contractural arachnodactyly	disease	C16;C05	Congenital Abnormality	0.10	1	2011	2020	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C0221228	Comedone	disease	C17	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0221239	Rapidly progressive glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0221270	Acanthosis	phenotype	C23	Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C0221353	Horseshoe Kidney	disease	C16;C13;C12	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0221406	Pituitary-dependent Cushing's disease	disease	C10;C19	Disease or Syndrome	0.06	1	2011	2020	   6	   1	BEFREE
     1956	EGFR	0.295	0.885	C0221505	Lesion of brain	group		Disease or Syndrome	0.06	1	2013	2018	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C0232462	Decrease in appetite	phenotype	C06;C10;F03	Sign or Symptom	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0235653	Malignant neoplasm of female breast	disease	C04;C17	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0235782	Gallbladder Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2006	2019	  13	   1	BEFREE
     1956	EGFR	0.295	0.885	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.10	0.991	1986	2019	 107	   0	BEFREE
     1956	EGFR	0.295	0.885	C0236734	Caffeine related disorders	group		Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238031	Breast Phyllodes Tumor	disease	C04;C17	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238033	Carcinoma of Male Breast	disease	C04;C17	Neoplastic Process	0.03	1	2009	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238122	Fallopian Tube Carcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.10	1	2004	2018	  12	   1	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0238258	Lymphangitis carcinomatosa	disease	C04	Neoplastic Process	0.04	1	2011	2020	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238301	Cancer of Nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.32	1	2008	2019	   3	   1	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0238348	Squamous cell carcinoma of penis	disease	C04;C12	Neoplastic Process	0.09	0.889	2011	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0238461	Anaplastic thyroid carcinoma	disease	C04	Neoplastic Process	0.10	1	2000	2019	  10	   1	BEFREE
     1956	EGFR	0.295	0.885	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.10	1	1997	2017	  10	   1	BEFREE
     1956	EGFR	0.295	0.885	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.10	1	1990	2018	  15	   1	BEFREE
     1956	EGFR	0.295	0.885	C0239816	Hand eczema	disease	C17	Disease or Syndrome	0.01	1	2016	2016	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.07	1	2008	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0240164	Squamous Papilloma of the Larynx	disease	C04	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0241157	pustule	phenotype	C17	Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C0242216	Biliary calculi	phenotype	C23;C06	Body Substance	0.02	1	2006	2008	   2	   0	LHGDN
     1956	EGFR	0.295	0.885	C0242363	Islet Cell Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.60	0.983	1988	2020	1494	  27	BEFREE;CGI;CTD_human
     1956	EGFR	0.295	0.885	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.20	1	2005	2005	   1	   0	RGD
     1956	EGFR	0.295	0.885	C0242510	Drug usage	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0242787	Malignant neoplasm of male breast	disease	C04;C17;C19	Neoplastic Process	0.03	1	2009	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0242852	Proliferative vitreoretinopathy	disease	C11	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0243038	Carcinoma, Lewis Lung	disease	C04	Neoplastic Process; Experimental Model of Disease	0.04	1	2006	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0259817	Xerosis	disease	C06;C10	Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0260037	Multiple tumors	phenotype	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0262401	Carcinoma of ampulla of Vater	disease	C06;C04;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.08	1	2007	2017	   8	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0262591	Pelvic adhesions	disease	C23	Disease or Syndrome	0.01	1	1994	1994	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0263313	Pemphigus Foliaceus	disease	C17;C20	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0263420	Hyperkeratosis lenticularis perstans	disease	C17	Disease or Syndrome	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0263641	Epithelial hyperplasia of skin	disease	C23	Disease or Syndrome	0.02	1	2001	2006	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0264490	Acute respiratory failure	disease	C23;C18;C08	Disease or Syndrome	0.02	1	2016	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265110	Cerebral Vasospasm	disease	C10;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265306	Greig cephalopolysyndactyly syndrome	disease	C16;C05	Congenital Abnormality	0.01	1	1991	1991	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.03	1	2017	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265344	Donohue Syndrome	disease	C16;C18;C05;C19	Disease or Syndrome	0.02	1	1989	1992	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265783	Congenital hypoplasia of lung	disease	C16;C08	Congenital Abnormality	0.04	1	2007	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0265979	Fibrous Hamartoma of Infancy	disease	C16;C04;C17	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0266568	Persistent Hyperplastic Primary Vitreous	disease	C16;C11	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0266574	Ablepharon	disease	C16;C11	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0266789	Velamentous insertion of umbilical cord (disorder)	disease	C13	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0266929	Chronic Periodontitis	disease	C07	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0267026	Actinic cheilitis	disease	C07	Disease or Syndrome	0.03	1	2004	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0268138	Xeroderma Pigmentosum, Complementation Group D	disease	C16;C04;C18;C17	Disease or Syndrome	0.01	1	2011	2011	   1	   5	BEFREE
     1956	EGFR	0.295	0.885	C0268398	Familial lichen amyloidosis	disease	C16;C18;C17	Disease or Syndrome	0.04	1	1996	2014	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0268800	Simple renal cyst	disease	C23;C16;C04;C13;C12	Disease or Syndrome	0.01	1	1998	1998	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0268837	Cystitis glandularis	disease	C13;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.32	1	1994	2011	   3	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0270922	Peripheral demyelinating neuropathy	disease	C20;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0271844	Parathyroid hyperplasia	disease	C23;C18;C19	Disease or Syndrome	0.03	1	2004	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0272138	Erythroblastosis	disease		Disease or Syndrome	0.07	1	1986	2020	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0276447	Rhinovirus infection	disease	C01	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0277527	Epidemic diarrhea	disease	C06;C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278480	Stage III Colon Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278484	Malignant neoplasm of colon stage IV	disease	C06;C04	Neoplastic Process	0.03	1	2008	2019	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C0278488	Carcinoma breast stage IV	disease		Neoplastic Process	0.10	1	2004	2020	  31	   3	BEFREE
     1956	EGFR	0.295	0.885	C0278493	Breast cancer recurrent	disease	C04;C17	Neoplastic Process	0.02	1	2011	2012	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278498	Malignant neoplasm of stomach stage IV	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278504	Non-small cell lung cancer stage I	disease		Neoplastic Process	0.05	1	2004	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278506	Non-small cell lung cancer stage III	disease		Neoplastic Process	0.09	1	2010	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.07	1	2001	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278512	Metastatic osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278517	Non-small cell lung cancer recurrent	disease	C04;C08	Neoplastic Process	0.10	1	2005	2019	  25	   3	BEFREE
     1956	EGFR	0.295	0.885	C0278556	Anal cancer recurrent	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278579	Cervix carcinoma recurrent	disease	C04;C13	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278595	Adult Fibrosarcoma	disease	C04	Neoplastic Process	0.02	1	1991	2016	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278601	Inflammatory Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.10	1	2007	2019	  20	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278608	Adult Liposarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278622	Adult Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.02	1	2009	2013	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278660	Adult Synovial Sarcoma	disease	C04	Neoplastic Process	0.03	1	2005	2011	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.04	1	2005	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278726	Small cell lung cancer extensive stage	disease	C04;C08	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278764	Adult Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.02	1	1991	2016	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278802	Recurrent Endometrial Cancer	disease	C04;C13	Neoplastic Process	0.01	1	2012	2012	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0278803	Adenocarcinoma of small intestine	disease	C06;C04	Neoplastic Process	0.05	0.8	2013	2018	   5	   3	BEFREE
     1956	EGFR	0.295	0.885	C0278838	Prostate cancer recurrent	disease	C04;C12	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278846	Thymoma malignant invasive	disease	C04;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278874	Adult Ependymoma	disease	C04	Neoplastic Process	0.05	0.8	1992	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.06	1	2003	2018	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278877	Adult Meningioma	disease	C04;C10	Neoplastic Process	0.03	0.667	2009	2014	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.10	0.979	1988	2020	 334	   1	BEFREE
     1956	EGFR	0.295	0.885	C0278879	Childhood Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.02	1	1991	2016	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.03	1	2000	2019	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C0278884	Melanoma recurrent	phenotype	C04;C17	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278983	Non-small cell lung cancer stage IIIA	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278984	Non-small cell lung cancer stage IIIB	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.10	0.96	2005	2020	 126	   3	BEFREE
     1956	EGFR	0.295	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.60	0.965	1989	2019	  86	   0	BEFREE;CGI;CTD_human
     1956	EGFR	0.295	0.885	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.08	1	2011	2020	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279068	Childhood Solid Neoplasm	phenotype		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279070	Adult Oligodendroglioma	disease	C04	Neoplastic Process	0.05	1	1992	2014	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279530	Malignant Bone Neoplasm	disease	C04;C05	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279545	Adult Epithelioid Sarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279550	Adult Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.06	1	1996	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279557	Adenosquamous cell lung cancer	disease	C04;C08	Neoplastic Process	0.06	1	2014	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279565	Invasive Lobular Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279606	Childhood Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279607	Adult Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279612	Childhood Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279613	Childhood Alveolar Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.70	1	1994	2020	  72	   6	BEFREE;CGI;CLINVAR;CTD_human
     1956	EGFR	0.295	0.885	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.10	1	2006	2018	  11	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279633	intestinal adenocarcinoma of the stomach	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279637	Anal carcinoma	disease	C06;C04	Neoplastic Process	0.03	0.667	2015	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279651	Gallbladder adenocarcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279671	Cervical Squamous Cell Carcinoma	disease	C04;C13	Neoplastic Process	0.09	1	2003	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279672	Cervical Adenocarcinoma	disease	C04;C13	Neoplastic Process	0.02	1	1991	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.05	1	1991	2018	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279682	Bladder Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279698	Squamous cell carcinoma of nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.10	0.933	1989	2019	  45	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279705	Thymoma, type B3	disease	C04;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279746	Adenocarcinoma of salivary gland	disease	C04;C07	Neoplastic Process	0.01	1	1985	1985	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279748	Undifferentiated carcinoma of nasopharynx	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279751	Adenoid cystic carcinoma of salivary gland	disease	C04;C07	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279763	endometrial adenoacanthoma	disease		Neoplastic Process	0.10	1	2012	2012	   1	   1	CLINVAR
     1956	EGFR	0.295	0.885	C0279982	Childhood Synovial Sarcoma	disease	C04	Neoplastic Process	0.03	1	2005	2011	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279984	Childhood Liposarcoma	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279987	Childhood Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.02	1	2009	2013	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0279989	Childhood Epithelioid Sarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280089	Carcinoid tumor of lung	disease	C04;C08	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280099	Adult Solid Neoplasm	group		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.10	0.958	1995	2020	  71	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280217	stage, non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.10	1	2006	2019	  19	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280222	stage, pancreatic cancer	phenotype	C06;C04;C19	Neoplastic Process	0.01	0	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280252	stage, colon cancer	phenotype	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280313	Squamous cell carcinoma of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.07	1	2007	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280317	Squamous cell carcinoma of tonsil	disease	C04;C07;C09	Neoplastic Process	0.02	1	2009	2010	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280321	Squamous cell carcinoma of the hypopharynx	disease		Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280324	Laryngeal Squamous Cell Carcinoma	disease	C04;C08;C09	Neoplastic Process	0.10	1	2001	2019	  18	   3	BEFREE
     1956	EGFR	0.295	0.885	C0280325	Glottic Squamous Cell Carcinoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280333	Squamous cell carcinoma of the nasal cavity	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.10	0.979	1988	2020	 333	   1	BEFREE
     1956	EGFR	0.295	0.885	C0280475	Childhood Oligodendroglioma	disease	C04	Neoplastic Process	0.05	1	1992	2014	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280483	Adult Anaplastic Astrocytoma	disease	C04	Neoplastic Process	0.07	1	2001	2015	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280630	Uterine Carcinosarcoma	disease	C04;C13	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280781	Adult Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.05	1	1996	2014	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280790	Adult Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.03	1	1996	2011	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0280856	Squamous cell carcinoma of vulva	disease	C04;C13	Neoplastic Process	0.04	1	2008	2016	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0281361	Adenocarcinoma of pancreas	disease	C06;C04;C19	Neoplastic Process	0.07	1	2003	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.09	1	2001	2018	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.02	1	1994	2006	   2	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0302142	Deformity	group	C23;C16	Anatomical Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0302592	Cervix carcinoma	disease	C04;C13	Neoplastic Process	0.10	1	1999	2019	  38	   3	BEFREE
     1956	EGFR	0.295	0.885	C0314719	Dryness of eye	phenotype	C11	Sign or Symptom	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0332563	Papule	phenotype	C23	Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C0333047	Recession	disease		Anatomical Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0333293	Healing ulcer	disease	C23	Acquired Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0333516	Tumor necrosis	phenotype	C23	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0333873	Squamous intraepithelial lesion	phenotype	C23;C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0333875	High-Grade Squamous Intraepithelial Lesions	phenotype	C23;C04;C13	Neoplastic Process	0.02	1	2008	2014	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0333983	Hyperplastic Polyp	disease	C23	Neoplastic Process	0.01	1	2012	2012	   1	   3	BEFREE
     1956	EGFR	0.295	0.885	C0334037	Intestinal metaplasia	phenotype		Disease or Syndrome	0.01	1	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334082	NEVUS, EPIDERMAL (disorder)	disease	C04	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334233	Pleomorphic carcinoma	disease	C04	Neoplastic Process	0.07	1	2006	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334240	Combined small cell carcinoma	disease	C04	Neoplastic Process	0.02	1	2007	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334245	Intraepithelial Squamous Cell Carcinoma	disease	C23;C04;C13	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334246	Squamous cell carcinoma, metastatic	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334254	Lymphoepithelial carcinoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334268	Schneiderian papilloma	disease	C04	Neoplastic Process	0.02	1	2015	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334276	Adenocarcinoma in Situ	phenotype	C23;C04	Neoplastic Process	0.10	1	2007	2018	  12	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334277	Adenocarcinoma, metastatic	disease	C04	Neoplastic Process	0.04	0.75	2005	2020	   4	   3	BEFREE
     1956	EGFR	0.295	0.885	C0334279	Adenocarcinoma, intestinal type	disease	C04	Neoplastic Process	0.02	1	2009	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334287	Fibrolamellar Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2006	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334299	Carcinoid tumor no ICD-O subtype	phenotype	C04	Neoplastic Process	0.02	1	2009	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334344	Sweat gland adenocarcinoma	disease	C04;C17	Neoplastic Process	0.02	1	2010	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334409	Leydig cell tumor, benign	disease	C04;C12;C19	Neoplastic Process	0.01	1	2001	2001	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334463	Malignant Fibrous Histiocytoma	disease	C04	Neoplastic Process	0.04	1	2004	2009	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334488	Clear cell sarcoma of kidney	disease	C04;C13;C12	Neoplastic Process	0.03	1	2005	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334520	Teratoma, Malignant	disease	C04	Neoplastic Process	0.02	1	1994	2010	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.10	1	1992	2015	  18	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.04	1	1993	2012	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334586	Pleomorphic Xanthoastrocytoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.50	1	2009	2015	   5	   0	CTD_human;ORPHANET
     1956	EGFR	0.295	0.885	C0334590	Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.06	1	1996	2011	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0338078	Non-Functioning Pituitary Gland Neoplasm	disease	C04;C10;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0338106	Adenocarcinoma of colon	disease	C06;C04	Neoplastic Process	0.05	1	2000	2018	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0339573	Glaucoma, Primary Open Angle	disease	C11	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0339962	Pulmonary mucormycosis	disease	C01	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0340288	Stable angina	disease	C23;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0342190	C-cell hyperplasia of thyroid	disease	C23;C19	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0342384	Idiopathic hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.10	1	2001	2020	  16	   0	BEFREE
     1956	EGFR	0.295	0.885	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.07	1	2011	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0344460	Carcinoma ex pleomorphic adenoma	disease	C04;C07	Neoplastic Process	0.03	1	2007	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	1	2011	2020	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.40	1	2007	2018	  11	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.05	0.8	2008	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0345960	Giant cell carcinoma of lung	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.37	1	2005	2019	   8	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0346027	Eccrine epithelioma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346109	Malignant Mesothelioma of Peritoneum	disease	C04;C08	Neoplastic Process	0.08	0.75	2009	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346154	Malignant phyllodes tumor of breast	disease	C04;C17	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346163	Endometrioid carcinoma ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     1956	EGFR	0.295	0.885	C0346202	Cervical Adenosquamous Carcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346429	Multiple malignancy	phenotype	C04	Neoplastic Process	0.07	1	2012	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346619	Malignant neoplasm of cardioesophageal junction of stomach	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	0.991	1986	2019	 112	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0346957	Disseminated Malignant Neoplasm	phenotype	C04	Neoplastic Process	0.07	1	2006	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346976	Secondary malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.04	0.75	2017	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.01	1	2011	2011	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0348374	Malignant Central Nervous System Neoplasm	disease	C04;C10	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0349458	Cervical intraepithelial neoplasia grade 1	disease	C04;C13	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0349459	Cervical intraepithelial neoplasia grade 2	disease	C04;C13	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0349530	Early gastric cancer	disease	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0349543	Brain Glioblastoma	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0349566	Squamous cell carcinoma of tongue	disease	C04;C07	Neoplastic Process	0.38	1	2007	2017	   8	   0	BEFREE;CGI
     1956	EGFR	0.295	0.885	C0349649	Pulmonary lymphangioleiomyomatosis	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0374997	Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site	disease		Disease or Syndrome	0.05	1	2001	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0375023	Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	disease		Disease or Syndrome	0.03	1	2005	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0375071	Malignant neoplasm of vulva	disease	C04;C13	Neoplastic Process	0.02	1	2007	2014	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.972	1994	2019	 106	   3	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.03	1	2000	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0391826	Lhermitte-Duclos disease	disease	C16;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C0392784	Dermatofibrosarcoma Protuberans	disease	C04	Neoplastic Process	0.03	1	2012	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0393559	Troyer syndrome	disease	C16;C10	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0393706	Early infantile epileptic encephalopathy with suppression bursts	disease	C10	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0398359	Trousseau's syndrome	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0398623	Thrombophilia	disease	C15	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0398738	Leukocyte adhesion deficiency type 1	disease	C16;C20	Disease or Syndrome	0.05	1	2014	2020	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0399440	Hereditary gingival fibromatosis	disease	C16;C07	Disease or Syndrome	0.02	1	2008	2014	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0399474	Dysplastic oral leukoplakia	disease	C23;C04;C07	Neoplastic Process	0.02	1	1999	1999	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.04	1	2017	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0403416	Idiopathic crescentic glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0403529	Anti-Glomerular Basement Membrane Disease	disease	C13;C12;C08;C20	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0403592	Chronic rejection of renal transplant	disease	C13;C12	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0406484	Sebaceous hyperplasia	disease	C23;C17	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.03	1	2012	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0410207	Tubular Aggregate Myopathy	disease	C05;C10	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0410702	Adolescent idiopathic scoliosis	disease	C05	Anatomical Abnormality	0.10	1	2018	2018	   1	   1	GWASCAT
     1956	EGFR	0.295	0.885	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.10	1	2000	2020	  14	   0	BEFREE
     1956	EGFR	0.295	0.885	C0431129	Adamantinous Craniopharyngioma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0432230	Langer Mesomelic Dysplasia Syndrome	disease	C23;C16;C05	Disease or Syndrome	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0432526	Desmoplastic trichoepithelioma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.40	0.967	1991	2018	  30	   2	BEFREE;CGI
     1956	EGFR	0.295	0.885	C0476273	Respiratory distress	phenotype	C23;C08	Sign or Symptom	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.10	1	1995	2019	  29	   4	BEFREE
     1956	EGFR	0.295	0.885	C0497156	Lymphadenopathy	phenotype	C15	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0520459	Necrotizing Enterocolitis	disease	C06	Disease or Syndrome	0.01	1	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0520571	Fibrosis of bile duct	disease	C06	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0520679	Sleep Apnea, Obstructive	disease	C08;C10	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0520739	Hereditary pyropoikilocytosis	disease	C16;C15	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0521158	Recurrent tumor	phenotype		Neoplastic Process	0.10	1	2003	2019	  18	   1	BEFREE
     1956	EGFR	0.295	0.885	C0521585	Gastrointestinal mucositis	disease	C06;C07	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0521607	Peritoneal Fibrosis	disease	C23;C06	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0521707	Bilateral cataracts (disorder)	disease	C11	Disease or Syndrome	0.01	1	1999	1999	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.02	1	2003	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0524910	Hepatitis C, Chronic	disease	C06;C01	Disease or Syndrome	0.01	1	2017	2017	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0544886	Somatic mutation	phenotype		Cell or Molecular Dysfunction	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.60	1	1988	2020	  40	   0	BEFREE;CGI;CTD_human
     1956	EGFR	0.295	0.885	C0549379	Recurrent Carcinoma	disease	C04	Neoplastic Process	0.01	0	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.10	0.944	2005	2018	  18	   4	BEFREE
     1956	EGFR	0.295	0.885	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0553694	Oropharyngeal disorders	group	C06;C08;C07;C09	Disease or Syndrome	0.05	1	1999	2014	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0553723	Squamous cell carcinoma of skin	disease	C04;C17	Neoplastic Process	0.10	0.95	2001	2019	  20	   0	BEFREE
     1956	EGFR	0.295	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.10	0.969	1987	2018	  64	   0	BEFREE
     1956	EGFR	0.295	0.885	C0555278	Cerebral metastasis	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0558353	Tongue Carcinoma	disease	C04;C07	Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0558355	Tonsillar Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.03	1	2007	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0559260	Congenital scoliosis	disease	C05	Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0566602	Primary sclerosing cholangitis	disease	C06	Disease or Syndrome	0.02	1	2015	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0574143	Liver calculus	disease		Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0585362	Squamous cell carcinoma of mouth	disease	C06;C04;C07	Neoplastic Process	0.08	1	1992	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.10	0.974	1997	2019	  39	   0	BEFREE
     1956	EGFR	0.295	0.885	C0595989	Carcinoma of larynx	disease	C04;C08;C09	Neoplastic Process	0.08	1	1992	2015	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.10	0.967	1986	2020	 360	   5	BEFREE
     1956	EGFR	0.295	0.885	C0598766	Leukemogenesis	disease	C23;C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0598935	Tumor Initiation	phenotype	C23;C04	Neoplastic Process	0.07	0.857	2006	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.10	0.972	1994	2019	 108	   3	BEFREE
     1956	EGFR	0.295	0.885	C0677055	CARCINOMA OF VULVA	disease	C04;C13	Neoplastic Process	0.03	1	2007	2014	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0677865	Brain Stem Glioma	disease	C04;C10	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
     1956	EGFR	0.295	0.885	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.10	1	2005	2019	  18	   1	BEFREE
     1956	EGFR	0.295	0.885	C0677898	invasive cancer	phenotype	C04	Neoplastic Process	0.04	1	1999	2010	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0677932	Progressive Neoplastic Disease	phenotype		Neoplastic Process	0.10	1	2005	2020	  70	   4	BEFREE
     1956	EGFR	0.295	0.885	C0677936	Refractory cancer	phenotype	C04	Neoplastic Process	0.10	1	2009	2020	  12	   0	BEFREE
     1956	EGFR	0.295	0.885	C0677944	Sentinel node (disorder)	disease		Disease or Syndrome	0.01	1	2011	2011	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0677948	Stage II Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0677949	Stage III Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2017	2020	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0677950	Stage IV Colorectal Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0678213	Complete hydatidiform mole	disease	C04;C13	Neoplastic Process	0.03	1	2000	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.974	1987	2020	 570	  12	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.50	0.985	1988	2020	1300	  28	BEFREE;CGI;CLINVAR
     1956	EGFR	0.295	0.885	C0684337	Ewings sarcoma-primitive neuroectodermal tumor (PNET)	disease	C04	Neoplastic Process	0.02	1	2004	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0684550	Secondary malignant neoplasm of vertebral column	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0684686	Secondary malignant neoplasm of soft tissues	group	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0685938	Malignant neoplasm of gastrointestinal tract	disease	C06;C04	Neoplastic Process	0.09	1	2006	2018	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0686377	CNS metastases	phenotype	C04;C10	Neoplastic Process	0.10	0.972	2009	2020	  36	   3	BEFREE
     1956	EGFR	0.295	0.885	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.10	0.943	1990	2020	  87	   3	BEFREE
     1956	EGFR	0.295	0.885	C0694550	Recurrent pneumonia	disease	C01;C08	Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.98	1989	2019	 102	   5	BEFREE
     1956	EGFR	0.295	0.885	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.989	1986	2019	  91	   6	BEFREE
     1956	EGFR	0.295	0.885	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.10	1	1989	2020	  70	   1	BEFREE
     1956	EGFR	0.295	0.885	C0699893	Skin carcinoma	disease	C04;C17	Neoplastic Process	0.03	1	1989	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0699949	airway disease	disease	C23;C08	Disease or Syndrome	0.02	1	2011	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.10	1	1988	2019	  19	   1	BEFREE
     1956	EGFR	0.295	0.885	C0729233	Dissecting aneurysm of the thoracic aorta	disease	C14	Disease or Syndrome	0.02	1	2007	2020	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0729531	Viral respiratory infection	group	C01;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0730328	Central Serous Chorioretinopathy	disease	C11	Disease or Syndrome	0.04	1	2016	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0740277	Bile duct carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2006	2017	   4	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C0740345	Germ Cell Cancer	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.01	1	2020	2020	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.09	1	1988	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C0742132	cervical cancer metastasis	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0742343	Acute Chest Syndrome	disease	C16;C08;C15	Disease or Syndrome	0.01	0	2008	2008	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C0742468	Central nervous system lesion	disease		Disease or Syndrome	0.03	1	2009	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0744619	Head and neck cancer metastatic	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0744620	Metastatic Head and Neck Squamous Cell Carcinoma	disease	C04	Neoplastic Process	0.03	1	2010	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
     1956	EGFR	0.295	0.885	C0747845	early pregnancy	phenotype		Disease or Syndrome	0.02	1	2014	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.10	1	2005	2018	  13	   1	BEFREE
     1956	EGFR	0.295	0.885	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.05	1	1999	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
     1956	EGFR	0.295	0.885	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751297	Leptomeningeal Neoplasms	disease	C04;C10	Neoplastic Process	0.05	1	2015	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751396	Well Differentiated Oligodendroglioma	disease	C04	Neoplastic Process	0.10	1	1992	2014	  17	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751560	Malignant neoplasm tonsil	disease	C04;C07;C09	Neoplastic Process	0.02	1	2007	2007	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751569	Genitourinary Cancer	disease	C04;C13;C12	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751674	Lymphangioleiomyomatosis	disease	C04;C20;C15	Neoplastic Process	0.02	1	2015	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751688	Malignant Squamous Cell Neoplasm	disease	C04	Neoplastic Process	0.08	0.875	2007	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751689	Peripheral Nerve Sheath Neoplasm	disease	C04;C10	Neoplastic Process	0.02	1	2007	2007	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.10	0.941	2002	2019	  17	   0	BEFREE
     1956	EGFR	0.295	0.885	C0795818	Chromosome 7 ring syndrome	disease	C23;C16	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0795839	Chromosome 10, monosomy 10q	disease	C23	Disease or Syndrome	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0796611	Newly Diagnosed Childhood Ependymoma	disease	C04	Neoplastic Process	0.05	0.8	1992	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0810364	Cleft Lip with or without Cleft Palate	disease		Congenital Abnormality	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0812413	Malignant Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.10	1	2005	2019	  19	   0	BEFREE
     1956	EGFR	0.295	0.885	C0813148	Metastatic Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0849640	skin damage	phenotype		Sign or Symptom	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0850666	Infection caused by Helicobacter pylori	disease	C01	Disease or Syndrome	0.02	1	2006	2009	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0850741	Smoker's lung	disease	C01;C08	Disease or Syndrome	0.05	1	2012	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0851135	In situ cancer	phenotype		Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0851140	Carcinoma in situ of uterine cervix	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0852667	Vulval cancer metastatic	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0853105	Penis carcinoma	disease	C04;C12	Neoplastic Process	0.06	1	2013	2017	   6	   3	BEFREE
     1956	EGFR	0.295	0.885	C0853879	Invasive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.10	0.941	1991	2018	  17	   0	BEFREE
     1956	EGFR	0.295	0.885	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854178	Metastases to adrenals	disease	C04;C19	Neoplastic Process	0.02	1	2009	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854750	Colorectal cancer recurrent	disease	C06;C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854796	Hepatoblastoma non-resectable	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854917	Rhabdoid Tumor of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854924	Papillary serous endometrial carcinoma	disease	C04;C13	Neoplastic Process	0.03	1	2009	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854963	Metastatic Penile Cancer	disease	C04;C12	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854983	Lung adenocarcinoma recurrent	disease	C04	Neoplastic Process	0.05	1	2012	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854985	Adenocarcinoma of lung, stage I	disease		Neoplastic Process	0.08	1	2011	2017	   8	   1	BEFREE
     1956	EGFR	0.295	0.885	C0854987	Adenocarcinoma of lung, stage III	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0854988	Adenocarcinoma of lung, stage IV	disease		Neoplastic Process	0.10	0.909	2011	2019	  22	   6	BEFREE
     1956	EGFR	0.295	0.885	C0855002	Recurrent Lung Carcinoma Cell Type Unspecified	disease		Neoplastic Process	0.05	1	2005	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0855005	Stage IV Lung Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0856169	Endothelial dysfunction	phenotype		Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0856825	Acute GVH disease	disease	C20	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0858004	Influenza A virus infection	disease	C01;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.04	0.75	2009	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C0860594	Malignant melanoma, metastatic	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0861727	Pancreatic adenocarcinoma metastatic	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0862793	Adenocarcinoma of lung stage IIIB	disease		Neoplastic Process	0.03	1	2018	2018	   3	   3	BEFREE
     1956	EGFR	0.295	0.885	C0862802	Recurrent lung cancer	disease		Neoplastic Process	0.05	1	2005	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0870082	Hyperkeratosis	disease	C23;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0872084	Sarcopenia	phenotype	C23;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0877008	Enzyme inhibition disorder	phenotype		Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0877430	Asthma chronic	disease		Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0878500	Intraepithelial Neoplasia	disease	C04	Neoplastic Process	0.02	1	2001	2002	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.03	1	2010	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C0879615	Stromal Neoplasm	disease	C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
     1956	EGFR	0.295	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.40	1	1995	2019	  63	   3	BEFREE;CTD_human;LHGDN
     1956	EGFR	0.295	0.885	C0919659	Oropharyngeal candidiasis	disease	C01	Disease or Syndrome	0.02	1	2017	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0936223	Metastatic Prostate Carcinoma	disease	C04;C12	Neoplastic Process	0.07	1	2007	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C0940937	precancerous lesions	phenotype		Neoplastic Process	0.02	1	2013	2016	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0947622	Cholecystolithiasis	disease	C06	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.01	1	2008	2008	   1	   1	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C0948680	Adenocarcinoma of liver	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0948750	Salivary gland carcinoma	disease	C04;C07	Neoplastic Process	0.05	1	2008	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C0949541	Hurthle Cell Tumor	disease	C04	Neoplastic Process	0.02	1	1998	2012	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C0950121	Denys-Drash Syndrome	disease	C16;C04;C13;C12;C19	Disease or Syndrome	0.01	1	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C1112160	Gastrooesophageal cancer	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1112356	Bronchial dysplasia	disease		Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.08	0.75	1990	2018	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C1135194	Chronic systolic heart failure	disease	C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1135868	Gestational Trophoblastic Neoplasms	group	C04;C13	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.40	0.982	1990	2019	  57	   3	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C1145670	Respiratory Failure	disease	C08	Disease or Syndrome	0.02	1	1997	2011	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.33	1	1995	2011	   3	   0	BEFREE;CGI
     1956	EGFR	0.295	0.885	C1167791	Skin toxicity	disease		Disease or Syndrome	0.10	0.971	2004	2020	  35	   1	BEFREE
     1956	EGFR	0.295	0.885	C1168327	High-Grade Prostatic Intraepithelial Neoplasia	disease	C04;C12	Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1168328	Low Grade Prostatic Intraepithelial Neoplasia	disease	C04;C12	Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.50	0.982	1992	2020	 277	  15	BEFREE;CGI;CLINVAR
     1956	EGFR	0.295	0.885	C1175175	Severe Acute Respiratory Syndrome	disease	C01;C08	Disease or Syndrome	0.02	1	2017	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.04	1	2010	2015	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2013	   6	   0	CTD_human
     1956	EGFR	0.295	0.885	C1258104	Diffuse Scleroderma	disease	C17	Disease or Syndrome	0.01	1	1990	1990	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1260325	Dendritic Cell Sarcoma, Follicular	disease	C04;C15	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1260873	Aortic valve disorder	disease	C14	Disease or Syndrome	0.20				   0	   0	MGD
     1956	EGFR	0.295	0.885	C1261473	Sarcoma	group	C04	Neoplastic Process	0.10	0.938	1990	2019	  32	   1	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C1265996	Large cell neuroendocrine carcinoma	disease	C04	Neoplastic Process	0.03	1	2014	2017	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C1266002	Non-small cell carcinoma	disease	C04	Neoplastic Process	0.05	1	2013	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266025	Traditional Serrated Adenoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266065	Eccrine porocarcinoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266088	Adenocarcinoma with neuroendocrine differentiation	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266091	Thymoma, type A	disease	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266129	Atypical Lipoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266158	Nongerminomatous Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.02	1	2001	2003	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1266184	Atypical Teratoid Rhabdoid Tumor	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2007	2017	   3	   0	BEFREE;PSYGENET
     1956	EGFR	0.295	0.885	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	0.971	1994	2020	 341	   8	BEFREE
     1956	EGFR	0.295	0.885	C1272516	Small cell glioblastoma	disease	C04	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1275122	Familial multiple trichoepitheliomata	disease	C16;C04;C17	Neoplastic Process	0.03	1	2012	2017	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C1275155	Multiple basal cell papillomata	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1279945	Acute interstitial pneumonia	disease	C08	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1282496	Metastasis from malignant tumor of prostate	disease		Neoplastic Process	0.07	1	2007	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C1290854	Disorder of skull	group	C05	Disease or Syndrome	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1290884	Inflammatory disorder	group	C23	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1298180	Single tumor	phenotype		Neoplastic Process	0.07	1	2005	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C1301034	Pancreatic intraepithelial neoplasia	disease	C04	Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1301194	Salivary duct carcinoma	disease	C04	Neoplastic Process	0.03	1	2009	2014	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1302401	Adenoma of large intestine	disease	C06;C04	Neoplastic Process	0.05	1	2011	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1302773	Low Grade Squamous Intraepithelial Neoplasia	disease	C23;C04;C13	Neoplastic Process	0.02	1	2013	2014	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1306068	After-cataract	disease	C11	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1306214	ACTH-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.05	1	2004	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.982	1990	2020	 950	  14	BEFREE
     1956	EGFR	0.295	0.885	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.985	1988	2020	1270	  26	BEFREE
     1956	EGFR	0.295	0.885	C1306573	Botryoid-Type Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1318485	Liver regeneration disorder	phenotype	C06	Disease or Syndrome	0.09	1	2005	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C1319018	Asthmatic bronchitis	disease	C01;C08;C20	Disease or Syndrome	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.40	0.923	1993	2018	  13	   1	BEFREE;CGI
     1956	EGFR	0.295	0.885	C1319317	Squamous cell carcinoma of pharynx	disease	C04;C07;C09	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1321546	Anaplastic large B-cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2014	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1328504	Hormone refractory prostate cancer	disease	C04;C12	Neoplastic Process	0.10	0.933	2004	2019	  15	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332166	Adenocarcinoma of the gastroesophageal junction	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332182	Adult Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332183	Adult Astrocytic Tumor	disease	C04	Neoplastic Process	0.01	1	1993	1993	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332187	Adult Brain Glioblastoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332198	Adult Clear Cell Sarcoma of Soft Parts	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2012	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332218	Adult Type Ovarian Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332243	Adenocarcinoma of ampulla of Vater	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332460	Barrett's Adenocarcinoma	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332564	Small cell neuroendocrine carcinoma of bladder	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332833	Calcifying Fibrous Pseudotumor	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332899	Cerebellar Glioblastoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332922	Cervical Squamous Intraepithelial Neoplasia	disease	C23;C04;C13	Neoplastic Process	0.01	1	1990	1990	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332942	Childhood Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332943	Childhood Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.03	1	1996	2011	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332964	Childhood Clear Cell Sarcoma of Soft Parts	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332965	Congenital Mesoblastic Nephroma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.02	1	2010	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2012	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.10	0.974	1997	2019	  39	   0	BEFREE
     1956	EGFR	0.295	0.885	C1332995	Childhood Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333015	Childhood Kidney Wilms Tumor	disease	C16;C04;C13;C12	Neoplastic Process	0.05	1	1989	2010	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333125	combined type small cell lung cancer	disease	C04;C08	Neoplastic Process	0.02	1	2018	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333443	Esophageal Basaloid Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333472	Ethmoid Sinus Adenocarcinoma	disease		Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333768	Gastric Gastrointestinal Stromal Tumor	disease	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333977	Hepatitis B Virus-Related Hepatocellular Carcinoma	disease		Neoplastic Process	0.02	1	2013	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.02	1	2012	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334003	Barretts esophagus with high grade dysplasia	disease	C06;C04	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334008	High Grade Sarcoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334177	Infiltrating Cervical Carcinoma	disease		Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334272	Invasive Apocrine Breast Carcinoma	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334274	Invasive Carcinoma	phenotype	C04	Neoplastic Process	0.03	1	2007	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334281	Infiltrating Bladder Urothelial Carcinoma	disease		Neoplastic Process	0.01	1	1994	1994	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334603	Malignant Mixed Mesodermal (Mullerian) Tumor	disease	C04	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334615	Malignant Phyllodes Tumor of Prostate	disease	C04;C12	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334708	Metaplastic carcinoma of breast	disease		Neoplastic Process	0.03	1	2008	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1334953	Neuroblastic tumors	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.10	0.947	2004	2020	  19	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335363	Mucoepidermoid carcinoma of parotid gland	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335377	periampullary adenocarcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335409	Prostate Phyllodes Tumor	disease	C04;C12	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335475	Primary Carcinoma	phenotype	C04	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1335703	Recurrent Head and Neck Carcinoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336026	Solid Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336030	Solid pseudopapillary tumour of the pancreas	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C1336076	Sporadic Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336082	Thymic Squamous Cell Carcinoma	disease	C04;C15	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336084	Squamous Lung Dysplasia	disease	C04;C08	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336117	Stage IA Lung Adenocarcinoma AJCC v7	disease		Neoplastic Process	0.01	1	2017	2017	   1	   3	BEFREE
     1956	EGFR	0.295	0.885	C1336137	Stage IB Lung Adenocarcinoma AJCC v7	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336536	Supratentorial Glioblastoma	disease	C04;C10	Neoplastic Process	0.02	1	1992	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336538	Supratentorial Embryonal Tumor, Not Otherwise Specified	disease	C04;C10	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1336905	Endometrial Endometrioid Adenocarcinoma	disease	C04;C13;C19	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1337011	Well Differentiated Pancreatic Endocrine Tumor	disease	C06;C04;C19	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1337013	Differentiated Thyroid Gland Carcinoma	disease		Neoplastic Process	0.02	1	2005	2006	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1367774	Eccrine Papillary Adenocarcinoma	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1367789	Digital papillary eccrine carcinoma of skin	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1367859	Pineal parenchymal tumor of intermediate differentiation	disease	C04;C10	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1368404	Hypopharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.03	1	1995	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.10	1	1992	2019	  24	   0	BEFREE
     1956	EGFR	0.295	0.885	C1368910	Mature Teratoma	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1369136	Anal cancer metastatic	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1370419	Ovarian Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1370889	Liposarcoma, well differentiated	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1377610	Peritoneal Mesothelioma	disease	C06;C04	Neoplastic Process	0.04	0.75	2012	2015	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1377913	Pleural Mesothelioma	disease	C04;C08	Neoplastic Process	0.02	1	2012	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1377919	Stage IV Nasopharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.10	1	1988	2019	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C1384494	Metastatic Carcinoma	group	C23;C04	Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1397307	Cardiac fibrosis	disease		Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1402294	Primary Lesion	phenotype		Disease or Syndrome	0.04	0.75	2015	2019	   4	   3	BEFREE
     1956	EGFR	0.295	0.885	C1402315	Vascular lesions	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1412036	Anal squamous cell carcinoma	disease	C06;C04	Neoplastic Process	0.06	0.833	2009	2016	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C1444680	Posterior capsule opacification	disease	C11	Disease or Syndrome	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.33	1	2008	2019	   4	   1	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C1455705	Pulmonary Histiocytosis X	disease	C08;C15	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	0.988	1990	2019	  85	   1	BEFREE;CTD_human;LHGDN
     1956	EGFR	0.295	0.885	C1510420	Cavitation	disease		Anatomical Abnormality	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1512127	HER2 gene amplification	disease		Disease or Syndrome	0.10	0.902	1991	2020	  61	   3	BEFREE
     1956	EGFR	0.295	0.885	C1512409	Hepatocarcinogenesis	disease	C23;C04	Neoplastic Process	0.04	1	2009	2016	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1512981	Mammary Tumorigenesis	phenotype	C23;C04	Neoplastic Process	0.03	1	2015	2016	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C1514422	Glioblastoma, IDH-Wildtype	disease	C04	Neoplastic Process	0.08	1	2001	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C1514428	Primary peritoneal carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2005	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1515286	Testicular Intratubular Germ Cell Neoplasia, Unclassified	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1518005	Low Grade Cervical Squamous Intraepithelial Neoplasia	disease	C23;C04;C13	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519214	Glioblastoma, IDH-Mutant	disease	C04	Neoplastic Process	0.02	1	1996	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519346	Skin Carcinogenesis	disease	C23;C04	Neoplastic Process	0.03	1	2001	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519353	Skin Papule	phenotype	C17	Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C1519666	Tumor-Associated Vasculature	disease		Acquired Abnormality	0.03	1	2011	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519670	Tumor Angiogenesis	phenotype	C23	Neoplastic Process	0.10	1	2001	2019	  17	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519680	Tumor Immunity	phenotype	C23	Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1519689	Tumor Promotion	phenotype	C23;C04	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1527336	Sjogren's Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.02	1	2014	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1527349	Ductal Breast Carcinoma	disease	C04	Neoplastic Process	0.05	1	2005	2019	   5	   1	BEFREE
     1956	EGFR	0.295	0.885	C1527358	Phototoxicity	disease	C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.07	1	1988	2018	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C1533161	Eccrine Poroma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.10	1	2010	2019	  13	   0	BEFREE
     1956	EGFR	0.295	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1569637	Adenocarcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.10	0.933	1989	2019	  30	   0	BEFREE
     1956	EGFR	0.295	0.885	C1611743	Familial (FPAH)	disease		Disease or Syndrome	0.03	1	2014	2016	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.50	0.973	1988	2020	 562	   6	BEFREE;CTD_human;GWASCAT
     1956	EGFR	0.295	0.885	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.02	0.5	2008	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1654637	androgen independent prostate cancer	disease		Neoplastic Process	0.10	0.9	2002	2017	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C1658953	tumor vasculature	phenotype		Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1699634	HER-2 positive breast cancer	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1704231	Metastatic Malignant Neoplasm to the Leptomeninges	disease	C10	Neoplastic Process	0.10	1	1999	2020	  44	   5	BEFREE
     1956	EGFR	0.295	0.885	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.05	1	1996	2006	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1704376	Uterine Corpus Carcinosarcoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1707291	NUT midline carcinoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1707444	Columnar Cell Change of the Breast	phenotype		Neoplastic Process	0.02	1	2013	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.31	1	2005	2012	   4	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C1708550	Intimal sarcoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1708778	mucoepidermoid carcinoma of lung	disease	C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1708781	Sarcomatoid carcinoma of the lung	disease	C04;C08	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1709246	Non-Neoplastic Disorder	disease	C23	Disease or Syndrome	0.01	1	1990	1990	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1710016	Satellite Nodule	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1710096	Sinonasal undifferentiated carcinoma	disease	C04;C08;C09	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1711276	carcinosarcoma of lung	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1719528	Other stomatitis and mucositis (ulcerative)	disease		Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1735635	Progression of adenocarcinoma	disease		Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1737250	Progression of non-small cell lung cancer	disease		Neoplastic Process	0.05	1	2010	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1739135	Progression of prostate cancer	disease		Neoplastic Process	0.05	1	2005	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1762616	Meningioma, benign, no ICD-O subtype	disease	C04;C10	Neoplastic Process	0.03	0.667	2009	2014	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.04	1	2006	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1827293	Carcinoma of urinary bladder, invasive	disease	C04;C13;C12	Neoplastic Process	0.04	1	2011	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.10	1	2007	2020	  30	   0	BEFREE
     1956	EGFR	0.295	0.885	C1833921	Familial medullary thyroid carcinoma	disease	C16;C04;C19	Neoplastic Process	0.02	1	1997	2009	   2	   1	BEFREE
     1956	EGFR	0.295	0.885	C1833929	THYROID CARCINOMA, SPORADIC MEDULLARY	disease		Neoplastic Process	0.01	1	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1834582	MYELOPROLIFERATIVE SYNDROME, TRANSIENT	disease	C16;C10;C15	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1834711	CEREBELLOPARENCHYMAL DISORDER VI	disease	C16;C04;C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C1834712	Cerebellar Granule Cell Hypertrophy and Megalencephaly	disease	C16;C04;C10	Disease or Syndrome	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C1837461	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3	disease		Finding	0.10	1	2018	2018	   1	   1	GWASCAT
     1956	EGFR	0.295	0.885	C1840264	IMMUNE SUPPRESSION	phenotype		Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1840311	Laryngeal cleft	disease	C16	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1840560	Hidradenitis suppurativa, familial	disease	C01;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1845055	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	disease	C16;C10;C15	Disease or Syndrome	0.03	0.667	2017	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1848296	DOSAGE-SENSITIVE SEX REVERSAL	disease	C16;C13;C12;C19	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1849157	Resistance to Insulin-Like Growth Factor I	disease	C23;C16	Disease or Syndrome	0.05	1	2011	2017	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1851584	Childhood Ependymoma	disease	C04	Neoplastic Process	0.05	0.8	1992	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	disease	C15	Disease or Syndrome	0.10	1	2008	2019	  21	   3	BEFREE
     1956	EGFR	0.295	0.885	C1851841	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	disease	C16;C17;C05;C07	Disease or Syndrome	0.02	1	2012	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1853193	Recurrent skin infections	phenotype	C01;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1853195	Prostate Cancer, Hereditary, 7	disease	C04;C12	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1853738	Long eyelashes	phenotype		Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C1853926	NONAKA MYOPATHY	disease	C16;C05;C10	Disease or Syndrome	0.01	1	2011	2011	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.01	0	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1859101	Vertebral chordoma	disease	C04	Neoplastic Process	0.02	1	2018	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1859598	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	disease	C23;C10;C15;F01	Disease or Syndrome	0.02	1	2009	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1859972	ADRENOCORTICAL CARCINOMA, HEREDITARY	disease	C04;C19	Neoplastic Process	0.02	1	2017	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1860392	Renal hemangioblastoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.03	0.667	2014	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1861305	TARSAL-CARPAL COALITION SYNDROME	disease	C16;C05	Disease or Syndrome	0.05	1	1993	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C1862382	SVEINSSON CHORIORETINAL ATROPHY	disease	C16;C11	Disease or Syndrome	0.04	0.75	2008	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1862866	Ankyloblepharon filiforme adnatum and cleft palate	disease	C16;C11;C05;C07	Congenital Abnormality	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1866376	Pten Hamartoma Tumor Syndrome With Granular Cell Tumor	disease	C16;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C1866398	Proteus-Like Syndrome (disorder)	disease	C16;C04;C05	Disease or Syndrome	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C1867441	Pterygium Of Conjunctiva And Cornea	disease	C11	Disease or Syndrome	0.02	1	2005	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.03	1	2014	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C1868810	Neutrophilic panniculitis	disease	C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1881254	Inverted Squamous Cell Papilloma	disease	C04	Neoplastic Process	0.04	1	2008	2020	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.02	1	2016	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1959582	PTEN Hamartoma Tumor Syndrome	disease	C16;C04	Neoplastic Process	0.10				   0	   1	CLINVAR
     1956	EGFR	0.295	0.885	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.10	1	2010	2019	  36	   0	BEFREE
     1956	EGFR	0.295	0.885	C1960925	Epidermal growth factor receptor positive non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.07	1	2010	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1969372	Tubulointerstitial fibrosis	phenotype		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C1997217	Low grade glioma	disease	C04	Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2012072	Glassy cell carcinoma of the cervix	disease	C04;C13	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2062441	Influenza A	disease		Disease or Syndrome	0.02	1	2010	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C2112532	Postmenopausal endometrium	disease		Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2145472	Urothelial Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.09	1	2006	2018	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.985	1985	2020	 131	   0	BEFREE;CTD_human;LHGDN
     1956	EGFR	0.295	0.885	C2316810	Chronic kidney disease stage 5	disease	C13;C12	Disease or Syndrome	0.04	1	2003	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C2349952	Oropharyngeal Carcinoma	disease	C04;C07;C09	Neoplastic Process	0.10	1	2007	2019	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C2350019	Solitary Pulmonary Nodule	disease	C08	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2350236	Idiopathic Interstitial Pneumonias	disease	C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2362320	Subacute cutaneous lupus	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2364135	Discomfort	phenotype		Sign or Symptom	0.01	1	2020	2020	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2609319	Papulopustular Rash	phenotype	C17	Sign or Symptom	0.03	1	2017	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2001	2003	   2	   0	CTD_human;RGD
     1956	EGFR	0.295	0.885	C2674218	SPHEROCYTOSIS, TYPE 1 (disorder)	disease	C16;C15	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2698045	Merkel Cell Polyomavirus Infection	disease	C01	Disease or Syndrome	0.02	1	2014	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.07	1	2014	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C2713442	Polyposis, Adenomatous Intestinal	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C2713443	Familial Intestinal Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1956	EGFR	0.295	0.885	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.06	0.833	2002	2018	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C2717981	Poroma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2718092	Acrospiroma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2747802	Bile acid malabsorption	disease	C06;C18	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2828150	HPV positive oropharyngeal squamous cell carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2919426	Apocrine intraductal carcinoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2931202	Urachal cancer	disease	C04;C13;C12	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2931618	Gestational trophoblastic disease	disease	C04;C13	Disease or Syndrome	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2931783	Amelogenesis imperfecta nephrocalcinosis	disease	C16;C18;C13;C12;C07	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.10	0.897	1995	2019	  39	   2	BEFREE
     1956	EGFR	0.295	0.885	C2936904	Opitz GBBB Syndrome, X-Linked	disease	C16;C13;C05;C12;C07	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2937421	Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.01	1	2006	2006	   1	   0	LHGDN
     1956	EGFR	0.295	0.885	C2938924	Oestrogen receptor positive breast cancer	disease		Neoplastic Process	0.07	1	2008	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.10	0.948	1988	2020	 135	   4	BEFREE
     1956	EGFR	0.295	0.885	C2959547	Endometrial sarcoma	disease	C04;C13	Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2960634	Reactivation of hepatitis B viral hepatitis	disease	C06;C01	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2981344	Stage I Lung Cancer AJCC v6	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2981352	Stage IV Lung Cancer AJCC v6	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2986665	Early-Stage Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2987120	Intramucosal Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C2987252	Esophageal Spindle Cell Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3146250	Stage III Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2017	2020	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3146251	Stage IV Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.02	1	2015	2017	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3146252	Stage II Colorectal Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3160815	Intraductal papillary mucinous neoplasm	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3163943	Combined large cell neuroendocrine carcinoma	disease		Neoplastic Process	0.02	1	2014	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.10	0.929	1994	2019	  14	   0	BEFREE
     1956	EGFR	0.295	0.885	C3267003	Vascular endothelial growth factor overexpression	disease		Disease or Syndrome	0.02	1	2008	2015	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3463897	HYDATIDIFORM MOLE, RECURRENT, 1	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3495798	Periodontal inflammation	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3495917	Advanced breast cancer	disease		Neoplastic Process	0.03	1	2015	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C3495949	Locally advanced breast cancer	disease		Neoplastic Process	0.04	1	2005	2015	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C3539781	Progressive cGVHD	disease		Disease or Syndrome	0.10	1	2005	2020	  70	   4	BEFREE
     1956	EGFR	0.295	0.885	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.10	0.956	2008	2020	 181	   4	BEFREE
     1956	EGFR	0.295	0.885	C3544205	Ovarian clear cell carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3549742	Breast cancer, lobular	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3642345	Luminal A Breast Carcinoma	disease		Neoplastic Process	0.07	1	2014	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C3642346	Luminal B Breast Carcinoma	disease		Neoplastic Process	0.04	1	2017	2019	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C3642347	Basal-Like Breast Carcinoma	disease		Neoplastic Process	0.10	1	2007	2018	  17	   0	BEFREE
     1956	EGFR	0.295	0.885	C3665419	intracranial glioma	disease	C04;C10	Neoplastic Process	0.04	1	2002	2011	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C3665444	Neutrophilia (disorder)	disease	C23;C15	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3665918	Neutrophilic folliculitis	disease		Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3693482	Giant Cell Fibroblastoma	disease	C04	Neoplastic Process	0.03	1	2012	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C3714514	Infection	group	C01	Pathologic Function	0.05	1	2005	2009	   5	   0	LHGDN
     1956	EGFR	0.295	0.885	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.09	1	2017	2019	   9	   0	BEFREE
     1956	EGFR	0.295	0.885	C3714644	Thymus Neoplasms	group	C04;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE;LHGDN
     1956	EGFR	0.295	0.885	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3714796	Isolated somatotropin deficiency	disease		Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3714948	PACHYONYCHIA CONGENITA 3	disease		Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.36	1	2007	2018	   7	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C3809250	ESTROGEN RESISTANCE	disease		Disease or Syndrome	0.05	1	2005	2016	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	C04	Neoplastic Process	0.08	1	2008	2019	   8	   0	BEFREE
     1956	EGFR	0.295	0.885	C3839280	High grade serous carcinoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3854222	Human immunodeficiency virus (HIV) II infection category B1	disease		Disease or Syndrome	0.03	1	2008	2016	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C3854329	Primary mucoepidermoid carcinoma of lung	disease		Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3873341	Primary adenocarcinoma of lung	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3875321	Inflammatory dermatosis	disease	C17	Disease or Syndrome	0.04	1	2013	2020	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.40	0.954	1989	2019	  87	   0	BEFREE;CGI
     1956	EGFR	0.295	0.885	C3887499	Renal cyst	phenotype	C23;C04;C13;C12	Disease or Syndrome	0.01	1	1998	1998	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3887678	Central Nervous System Embryonal Tumor, Not Otherwise Specified	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3887938	Deuteranomaly	disease	C23;C11;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3888504	HER-2 protein overexpression	disease		Disease or Syndrome	0.02	1	2004	2009	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C3888789	Pancreatic toxicity	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3897752	Recurrent Childhood Glioblastoma	disease		Neoplastic Process	0.10	1	2003	2019	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C3898127	Non-Metastatic Childhood Soft Tissue Sarcoma	disease		Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C3898709	Intestinal-Type Sinonasal Adenocarcinoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C3899645	Childhood Pleomorphic Xanthoastrocytoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C3900097	Adult Penile Carcinoma	disease	C04;C12	Neoplastic Process	0.03	1	2013	2016	   3	   3	BEFREE
     1956	EGFR	0.295	0.885	C4013426	Bronchial carcinoid	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4015130	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2	disease		Disease or Syndrome	0.70	1	2014	2015	   2	   1	CLINVAR;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1956	EGFR	0.295	0.885	C4015136	Recurrent bronchiolitis	phenotype		Finding	0.10				   0	   0	HPO
     1956	EGFR	0.295	0.885	C4023149	Acute disseminated intravascular coagulation	disease	C15	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4048305	Neuroepithelioma	disease		Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.40	1	2000	2019	  40	   4	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C4048329	Immunosuppression	disease		Disease or Syndrome	0.03	1	2004	2018	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C4049711	Lepidic Predominant Adenocarcinoma	disease	C04	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4054891	Grade III Chondrosarcoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4082937	Necrotizing enterocolitis in fetus OR newborn	disease	C06	Disease or Syndrome	0.02	1	1997	2012	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4085370	Fibromatosis, Palmar	disease	C04;C17;C05	Disease or Syndrome	0.01	1	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.10	1	1985	2019	  12	   0	BEFREE
     1956	EGFR	0.295	0.885	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.10	1	1988	2019	  19	   1	BEFREE
     1956	EGFR	0.295	0.885	C4087141	Skin squamous cell carcinoma metastatic	disease		Neoplastic Process	0.02	1	2001	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4283978	Primary adenocarcinoma of lower third of esophagus due to Barrett esophagus	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4284013	Primary cholangiocarcinoma of intrahepatic biliary tract	disease	C04	Neoplastic Process	0.06	1	2008	2018	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4288304	Recurrent Lung Non-Squamous Non-Small Cell Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4288305	Recurrent Glioblastoma	disease	C04	Neoplastic Process	0.10	1	2003	2019	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C4288754	Metastatic urothelial carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4288755	Metastatic Lung Non-Squamous Non-Small Cell Carcinoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4289580	Epithelioid glioblastoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4324656	Non-squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.10	1	2014	2020	  17	   3	BEFREE
     1956	EGFR	0.295	0.885	C4329280	Advanced Head and Neck Carcinoma	disease		Neoplastic Process	0.06	1	2002	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4509816	Squamous non-small cell lung cancer	disease	C04;C08	Neoplastic Process	0.10	0.938	2011	2020	  32	   0	BEFREE
     1956	EGFR	0.295	0.885	C4511687	Pancreatic Intraductal Papillary Mucinous Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.03	1	2008	2015	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C4517098	Endometrial carcinosarcoma	disease		Neoplastic Process	0.02	1	2006	2013	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4518223	Fibromatosis-like metaplastic carcinoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4518333	Clear cell papillary renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4520821	Stage 0 Breast Cancer AJCC v6 and v7	disease	C04;C17	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4520843	Pterygium of eye	disease	C11	Disease or Syndrome	0.02	1	2005	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4520983	Congenital atresia of extrahepatic bile duct	disease	C16;C06	Congenital Abnormality	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4521042	Complete Trisomy 21 Syndrome	disease	C23;C16;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4521966	Stage I Lung Cancer AJCC v7	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4522160	Invasive Mucinous Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4523846	MSI-high	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4524268	Advanced lung cancer	disease		Neoplastic Process	0.10	0.933	2003	2019	  30	   5	BEFREE
     1956	EGFR	0.295	0.885	C4524839	Recurrent Head and Neck Squamous Cell Carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525059	Refractory Neuroblastoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525297	Stage 0 Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2010	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525300	Stage IIA Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2010	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525301	Stage IIB Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2010	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525302	Stage III Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2010	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4525305	Stage IV Gallbladder Cancer AJCC v8	disease		Neoplastic Process	0.06	1	2010	2019	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4526713	Stage I Lung Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4526725	Stage IV Lung Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4528408	Advanced Head and Neck Squamous Cell Carcinoma	disease		Neoplastic Process	0.05	1	2013	2019	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C4528576	Malignant Neoplasm of Lung - Multiple Primary Sites	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4528699	Devil Facial Tumor Disease	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4529962	Fatty Liver Disease	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4531083	Mucinous gastric carcinoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4543929	Primary osteosarcoma	disease	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551548	Grade III Childhood Astrocytoma	disease	C04	Neoplastic Process	0.07	1	2001	2015	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551642	Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551683	Adrenal Gland Pheochromocytoma	disease	C04;C19	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.10	0.92	1990	2019	  25	   1	BEFREE
     1956	EGFR	0.295	0.885	C4551687	Sarcoma of soft tissue	group	C04	Neoplastic Process	0.04	1	2016	2018	   4	   0	BEFREE
     1956	EGFR	0.295	0.885	C4551868	Stage IIB Cervical Cancer AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4552000	Episodic Kinesigenic Dyskinesia 1	disease	C23;C10	Disease or Syndrome	0.03	1	2011	2020	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.02	1	2012	2018	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4553703	Stage IV Ovarian Cancer AJCC v8	disease		Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4554065	Childhood Brain Glioblastoma	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4684861	Recurrent Malignant Glioma	disease	C04	Neoplastic Process	0.02	1	2005	2006	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4684880	Advanced Bile Duct Carcinoma	disease		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4688308	Advanced Lung Non-Squamous Non-Small Cell Carcinoma	disease		Neoplastic Process	0.10	1	2008	2019	  19	   0	BEFREE
     1956	EGFR	0.295	0.885	C4688318	Refractory Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2014	2017	   2	   1	BEFREE
     1956	EGFR	0.295	0.885	C4703473	Atherosclerotic lesion	disease	C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.31	1	2001	2013	   7	   0	BEFREE;CTD_human
     1956	EGFR	0.295	0.885	C4721209	Metastatic human epidermal growth factor 2 positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.05	1	2008	2018	   5	   0	BEFREE
     1956	EGFR	0.295	0.885	C4721414	Mantle cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.03	0.667	2006	2013	   3	   1	BEFREE
     1956	EGFR	0.295	0.885	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.10	0.983	2003	2020	 353	   4	BEFREE
     1956	EGFR	0.295	0.885	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.10	0.984	1995	2019	  64	   4	BEFREE
     1956	EGFR	0.295	0.885	C4721779	Ovarian cancer stage IV	disease		Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4721780	Stage IV Ovarian Cancer AJCC v6 and v7	disease		Neoplastic Process	0.01	1	2000	2000	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.10	0.9	1995	2019	  10	   0	BEFREE
     1956	EGFR	0.295	0.885	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.10	0.989	1993	2020	 277	   6	BEFREE
     1956	EGFR	0.295	0.885	C4722099	High grade glioma	disease	C04	Neoplastic Process	0.06	1	2002	2018	   6	   0	BEFREE
     1956	EGFR	0.295	0.885	C4722172	Primary differentiated carcinoma of thyroid gland	disease		Neoplastic Process	0.02	1	2005	2006	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4722419	Extrapulmonary Small Cell Carcinoma	disease	C04	Neoplastic Process	0.03	1	2014	2017	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.10	0.948	2009	2020	 154	   4	BEFREE
     1956	EGFR	0.295	0.885	C4723619	Brain Ependymoma	disease	C04	Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4725861	Metastatic Malignant Neoplasm in the Viscera	disease		Neoplastic Process	0.01	0	1997	1997	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727069	Advanced Renal Cell Carcinoma	disease		Neoplastic Process	0.01	1	1989	1989	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727087	Metastatic Lung Carcinoma	disease		Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727169	Metastatic Gastric Carcinoma	disease		Neoplastic Process	0.01	1	1999	1999	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727578	Locally Advanced Squamous Cell Carcinoma	disease		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727773	Refractory Lung Non-Small Cell Carcinoma	disease	C04;C08	Neoplastic Process	0.07	1	2004	2019	   7	   0	BEFREE
     1956	EGFR	0.295	0.885	C4727838	Advanced Melanoma	disease		Neoplastic Process	0.01	1	2013	2013	   1	   1	BEFREE
     1956	EGFR	0.295	0.885	C4727916	H3N2 influenza	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4733092	estrogen receptor-negative breast cancer	disease		Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     1956	EGFR	0.295	0.885	C4733095	HER2-negative breast cancer	disease		Neoplastic Process	0.10	1	2010	2019	  19	   0	BEFREE
     1956	EGFR	0.295	0.885	C4733575	newly diagnosed non-small cell lung cancer	disease		Neoplastic Process	0.01	1	2018	2018	   1	   3	BEFREE
     1956	EGFR	0.295	0.885	C4733576	progressive non-small cell lung cancer	disease		Neoplastic Process	0.03	1	2017	2019	   3	   0	BEFREE
     1956	EGFR	0.295	0.885	C4744444	Metastatic Lung Adenocarcinoma	disease	C04	Neoplastic Process	0.10	1	2009	2020	  23	   3	BEFREE
     1956	EGFR	0.295	0.885	C4744562	Metastatic Lung Non-Small Cell Carcinoma	disease	C04;C08	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4744564	Metastatic Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2007	2019	  20	   2	BEFREE
     1956	EGFR	0.295	0.885	C4744565	Metastatic Colon Carcinoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4744700	Locally Advanced Pancreatic Adenocarcinoma	disease		Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4745063	Biliary Tract Carcinoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     1956	EGFR	0.295	0.885	C4751120	Neonatal inflammatory skin and bowel disease	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     1956	EGFR	0.295	0.885	C4759295	Non-metastatic prostate cancer	disease	C04;C12	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.02	1	2001	2008	   2	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0001430	Adenoma	group	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.03	1	2002	2011	   3	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.02	1	2004	2005	   2	   0	LHGDN
     5604	MAP2K1	0.439	0.846	C0003175	Anthrax disease	disease	C01	Disease or Syndrome	0.03	1	2005	2012	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0003492	Aortic coarctation	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0003850	Arteriosclerosis	disease	C14	Disease or Syndrome	0.03	1	2015	2020	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0003857	Congenital arteriovenous malformation	disease	C16;C14	Congenital Abnormality	0.03	1	2017	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.02	1	2010	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.03	1	2015	2020	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.01	1	2000	2000	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0005745	Blepharoptosis	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.08	1	2000	2014	   8	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.946	2002	2019	  37	   1	BEFREE;CGI
     5604	MAP2K1	0.439	0.846	C0007095	Carcinoid Tumor	phenotype	C04	Neoplastic Process	0.02	1	2004	2010	   2	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0007097	Carcinoma	group	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.05	1	2009	2019	   5	   2	BEFREE
     5604	MAP2K1	0.439	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2003	2016	   2	   2	CLINVAR;RGD
     5604	MAP2K1	0.439	0.846	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.04	1	2007	2019	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.50	1	1995	2019	  19	   3	BEFREE;CGI;CLINVAR
     5604	MAP2K1	0.439	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.15	1	2006	2017	   6	   1	BEFREE;GWASCAT
     5604	MAP2K1	0.439	0.846	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.01	1	1996	1996	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.12	1	2012	2019	   2	   1	BEFREE;HPO
     5604	MAP2K1	0.439	0.846	C0007785	Cerebral Infarction	disease	C23;C10;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.10	0.938	2008	2019	  16	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.12	1	2005	2016	   3	   4	CLINVAR;LHGDN
     5604	MAP2K1	0.439	0.846	C0009806	Constipation	phenotype	C23	Sign or Symptom	0.10	1	2006	2009	   7	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.02	1	2008	2018	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0011311	Dengue Fever	disease	C01	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   3	BEFREE
     5604	MAP2K1	0.439	0.846	C0013274	Patent ductus arteriosus	disease	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.11	1	2005	2005	   1	   0	BEFREE;HPO
     5604	MAP2K1	0.439	0.846	C0013362	Dysarthria	disease	C23;C10	Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0014116	Endocardial Cushion Defects	group	C16;C14	Congenital Abnormality	0.02	1	2015	2017	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0015526	Factor XII Deficiency	disease	C16;C15	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.02	1	2015	2020	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0016057	Fibrosarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0016842	Congenital pectus excavatum	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0017168	Gastroesophageal reflux disease	disease	C06	Disease or Syndrome	0.01	1	2008	2008	   1	   0	LHGDN
     5604	MAP2K1	0.439	0.846	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.02	1	2008	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0018817	Atrial Septal Defects	group	C16;C14	Congenital Abnormality	0.11	1	2017	2017	   1	   0	BEFREE;HPO
     5604	MAP2K1	0.439	0.846	C0018818	Ventricular Septal Defects	group	C16;C14	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0018920	Hemangioma, Cavernous	disease	C04;C15;C14	Neoplastic Process	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0019618	Histiocytosis	disease	C15	Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0019621	Histiocytosis, Langerhans-Cell	disease	C08;C15	Neoplastic Process	0.10	1	2014	2019	  13	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0019624	Histiocytosis, Non-Langerhans-Cell	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0019625	Sinus histiocytosis	disease	C15	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0020255	Hydrocephalus	disease	C10	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0020295	Hydronephrosis	disease	C13;C12	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.01	1	2010	2010	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0020458	Hyperhidrosis disorder	phenotype	C17	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0020534	Orbital separation excessive	phenotype	C16;C05	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.02	1	2015	2020	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0020757	Ichthyoses	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0022821	Kyphosis deformity of spine	phenotype	C05	Anatomical Abnormality	0.10	1	2006	2009	   7	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0023418	leukemia	disease	C04	Neoplastic Process	0.06	1	2011	2019	   6	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.04	1	2012	2019	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023443	Hairy Cell Leukemia	disease	C04;C20;C15	Neoplastic Process	0.31	1	2014	2014	   1	   0	BEFREE;CTD_human
     5604	MAP2K1	0.439	0.846	C0023448	Lymphoid leukemia	disease	C04;C20;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.03	1	2001	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023470	Myeloid Leukemia	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.02	1	2007	2015	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023481	Chronic Neutrophilic Leukemia	disease	C15	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.02	1	2005	2018	   2	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.20	1	2004	2004	   1	   0	RGD
     5604	MAP2K1	0.439	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.02	1	2006	2006	   2	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0024131	Lupus Vulgaris	disease	C01;C17	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024236	Lymphedema	disease	C15	Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.03	1	2016	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024421	Macroglossia	disease	C07	Disease or Syndrome	0.10	1	2008	2008	   1	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0024433	Macrostomia	disease	C16;C07	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0024530	Malaria	disease	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.04	1	2014	2018	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0024636	Malocclusion	disease	C07	Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.70	1	2003	2019	  44	  14	BEFREE;CGI;CLINVAR;CTD_human;LHGDN
     5604	MAP2K1	0.439	0.846	C0025239	Melorheostosis	disease	C05	Disease or Syndrome	0.04	1	2018	2019	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0025990	Micrognathism	disease	C16;C05;C07	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0026827	Muscle hypotonia	phenotype	C23;C10	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0027092	Myopia	disease	C11	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.08	1	2003	2018	   8	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0027651	Neoplasms	group	C04	Neoplastic Process	0.20	0.927	1996	2019	  41	   8	BEFREE;CLINVAR;HPO
     5604	MAP2K1	0.439	0.846	C0027796	Neuralgia	phenotype	C23;C10	Sign or Symptom	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.02	1	2016	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.07	0.857	2007	2019	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0027832	Neurofibromatosis 2	disease	C16;C04;C10;C09	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.68	1	2007	2019	  14	   3	BEFREE;CLINGEN;CLINVAR;CTD_human;LHGDN
     5604	MAP2K1	0.439	0.846	C0028738	Nystagmus	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0028840	Ocular Hypertension	disease	C11	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0028880	Odontogenic Tumors	group	C04	Neoplastic Process	0.01	1	2004	2004	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0029124	Optic Atrophy	disease	C11;C10	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0029182	orbit (eye disorders)	group	C11	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0029531	Other cataract	disease	C11	Disease or Syndrome	0.20	1	2001	2001	   1	   0	RGD
     5604	MAP2K1	0.439	0.846	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5604	MAP2K1	0.439	0.846	C0033377	Ptosis	disease	C23	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0033822	Pseudomyxoma Peritonei	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0034951	Refractive Errors	group	C11	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0036220	Kaposi Sarcoma	disease	C04;C01	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2008	2008	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0036439	Scoliosis, unspecified	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0036857	Severe intellectual disability	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0038379	Strabismus	disease	C11;C10	Disease or Syndrome	0.10	1	2006	2009	   7	   1	CLINVAR;HPO
     5604	MAP2K1	0.439	0.846	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.02	1	2017	2018	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0038525	Subarachnoid Hemorrhage	disease	C23;C10;C14	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0039103	Synovitis	disease	C05	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.03	1	2007	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0041409	Turner Syndrome, Male	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2017	   2	   2	BEFREE;PSYGENET
     5604	MAP2K1	0.439	0.846	C0042769	Virus Diseases	group	C01	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0043395	Yellow Fever	disease	C01	Disease or Syndrome	0.01	1	2014	2014	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.02	1	2002	2018	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.10	1	2008	2008	   1	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0151526	Premature Birth	phenotype	C13	Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0151611	Electroencephalogram abnormal	phenotype	C10	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.40	1	2016	2016	   1	   6	CGI;CLINVAR
     5604	MAP2K1	0.439	0.846	C0151908	Dry skin	phenotype	C17	Sign or Symptom	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.65	0.857	2008	2019	   7	   6	BEFREE;CGI;CLINVAR;CTD_human
     5604	MAP2K1	0.439	0.846	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0152421	Macrotia	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0153574	Malignant Uterine Corpus Neoplasm	disease	C04;C13	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
     5604	MAP2K1	0.439	0.846	C0158465	Acquired cubitus valgus	disease		Acquired Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0175704	LEOPARD Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.52	1	2006	2015	   5	   0	BEFREE;CLINGEN;GENOMICS_ENGLAND
     5604	MAP2K1	0.439	0.846	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.02	1	2008	2014	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0206620	Lymphangioma, Cystic	disease	C04	Neoplastic Process	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0206663	Neuroectodermal Tumor, Primitive	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.02	1	2006	2007	   2	   0	BEFREE;LHGDN
     5604	MAP2K1	0.439	0.846	C0206729	Neurofibrosarcoma	disease	C04;C10	Neoplastic Process	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0220605	Adult Non-Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0220612	Childhood Non-Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0220630	Adult Liver Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0221217	Neck webbing	disease	C16;C17	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0221354	Frontal bossing	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0221357	Brachydactyly	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0231274	Intolerant of heat	phenotype		Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.05	1	2012	2020	   5	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0238461	Anaplastic thyroid carcinoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.03	1	2010	2018	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0239676	High forehead	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0240635	Byzanthine arch palate	disease	C16;C05;C10;C07	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0241074	Hyperextensible skin	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0241654	Abnormal heart valve morphology	phenotype	C16;C14	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	0.9	1997	2019	  10	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C0242381	Lyme Arthritis	disease	C01	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0263490	Brittle hair	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0265610	Clinodactyly of fingers	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0266617	Congenital anomaly of face	group	C16;C13;C05	Congenital Abnormality	0.10	1	2006	2009	   7	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0275524	Coinfection	phenotype	C01	Disease or Syndrome	0.01	1	2005	2005	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278595	Adult Fibrosarcoma	disease	C04	Neoplastic Process	0.02	1	2010	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.10	1	2016	2016	   1	   4	CLINVAR
     5604	MAP2K1	0.439	0.846	C0278764	Adult Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.01	1	2003	2003	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278878	Adult Glioblastoma	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278879	Childhood Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.07	1	2012	2019	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.02	1	2019	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.10	1	2016	2016	   1	   2	CLINVAR
     5604	MAP2K1	0.439	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.04	0.75	2006	2017	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.02	1	2016	2017	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0280474	Childhood Glioblastoma	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334299	Carcinoid tumor no ICD-O subtype	phenotype	C04	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334463	Malignant Fibrous Histiocytoma	disease	C04	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334533	Arteriovenous hemangioma	disease	C16;C04;C14	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.01	1	2002	2002	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334586	Pleomorphic Xanthoastrocytoma	disease	C04	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0334663	Histiocytic sarcoma	disease	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0343082	Senile angioma	disease	C04;C17	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0345392	Congenital kyphoscoliosis	disease	C16;C05	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.05	1	2012	2020	   5	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0349588	Short stature	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.03	1	2002	2018	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0393591	AICARDI-GOUTIERES SYNDROME	disease	C16;C20;C10	Disease or Syndrome	0.01	1	2007	2007	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0398639	Amegakaryocytic thrombocytopenia	disease	C15	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0398738	Leukocyte adhesion deficiency type 1	disease	C16;C20	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0400822	Colitis, Lymphocytic	disease	C06	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.01	1	2001	2001	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0423110	Downward slant of palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0423867	Fine hair	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.02	1	2011	2017	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0424492	Coarse features	phenotype		Finding	0.10	1	2008	2008	   1	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C0432072	Dysmorphic features	disease		Congenital Abnormality	0.10	1	2002	2017	  12	   2	CLINVAR
     5604	MAP2K1	0.439	0.846	C0432103	Submucous cleft of hard palate	disease	C16;C08;C07;C09	Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0494165	Secondary malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5604	MAP2K1	0.439	0.846	C0521525	Short neck	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0521858	Decreased drug resistance	phenotype		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.04	1	2007	2019	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0558165	Curly hair (finding)	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0575158	Kyphoscoliosis deformity of spine	disease	C05	Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0576093	Knee joint valgus deformity	disease	C05	Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0581342	Redundant skin	phenotype	C16;C17	Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0585442	Osteosarcoma of bone	disease	C04	Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.55	1	2007	2016	   6	   0	BEFREE;CLINGEN;CTD_human
     5604	MAP2K1	0.439	0.846	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.10	0.938	2008	2020	  16	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0596887	mathematical ability	phenotype		Mental Process	0.10	1	2018	2018	   1	   1	GWASCAT
     5604	MAP2K1	0.439	0.846	C0598766	Leukemogenesis	disease	C23;C04	Neoplastic Process	0.03	0.667	2010	2016	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0600033	Acquired Kyphoscoliosis	disease	C05	Acquired Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.13	1	2002	2018	   4	   1	BEFREE;GWASCAT
     5604	MAP2K1	0.439	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0677886	Epithelial ovarian cancer	disease	C04;C13;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0677936	Refractory cancer	phenotype	C04	Neoplastic Process	0.03	1	2014	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.07	1	2000	2014	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0678230	Congenital Epicanthus	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.08	0.875	1997	2019	   8	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C0686377	CNS metastases	phenotype	C04;C10	Neoplastic Process	0.01	1	2016	2016	   1	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.06	1	2009	2019	   6	   2	BEFREE
     5604	MAP2K1	0.439	0.846	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2014	2018	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.02	1	2012	2012	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.07	0.857	2007	2019	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0750952	Biliary Tract Cancer	disease	C06;C04	Neoplastic Process	0.02	1	2011	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.02	1	2014	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.02	1	2016	2017	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0858004	Influenza A virus infection	disease	C01;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0860564	Retinoic acid syndrome	disease	C23	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0869083	Other specified congenital malformation syndromes, not elsewhere classified in ICD10CM	disease		Disease or Syndrome	0.20				   0	   0	MGD
     5604	MAP2K1	0.439	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2017	2017	   1	   0	BEFREE;GENOMICS_ENGLAND
     5604	MAP2K1	0.439	0.846	C0878675	Erdheim-Chester Disease	disease	C15	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.33	1	2003	2014	   3	   0	BEFREE;CGI;LHGDN
     5604	MAP2K1	0.439	0.846	C1096666	Thyroid cancer metastatic	disease	C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	1	2003	2014	   2	   0	BEFREE;CGI
     5604	MAP2K1	0.439	0.846	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.11	1	2016	2019	   2	   2	BEFREE;CLINVAR
     5604	MAP2K1	0.439	0.846	C1261473	Sarcoma	group	C04	Neoplastic Process	0.02	1	2011	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2017	   2	   2	BEFREE;PSYGENET
     5604	MAP2K1	0.439	0.846	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.10	1	2003	2020	  11	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	1.00	1	2006	2019	  40	  11	BEFREE;CLINGEN;CLINVAR;CTD_human;GENOMICS_ENGLAND;MGD;ORPHANET
     5604	MAP2K1	0.439	0.846	C1275126	TNF receptor-associated periodic fever syndrome (TRAPS)	disease	C23;C16;C17	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1305855	Body mass index	phenotype		Clinical Attribute	0.10	1	2019	2019	   1	   1	GWASCAT
     5604	MAP2K1	0.439	0.846	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.96	2002	2019	  25	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.08	0.875	1997	2019	   8	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     5604	MAP2K1	0.439	0.846	C1321872	Stage IV Skin Melanoma	disease	C04;C17	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1328931	Multiple lentigines	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1332206	Adult Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2016	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1332884	Central nervous system leukaemia	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1332977	Childhood Leukemia	disease	C04	Neoplastic Process	0.04	1	2013	2019	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1332979	Childhood Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2016	2019	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1332986	Childhood Osteosarcoma	disease	C04	Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1368683	Epithelioma	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1391732	Cancer cachexia	disease		Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.02	1	2012	2018	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.10	1	2019	2019	   1	   1	CLINVAR
     5604	MAP2K1	0.439	0.846	C1512409	Hepatocarcinogenesis	disease	C23;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1519346	Skin Carcinogenesis	disease	C23;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1527404	Female Pseudo-Turner Syndrome	disease	C16;C17;C05;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1658953	tumor vasculature	phenotype		Neoplastic Process	0.01	1	2006	2006	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1832348	Slow-growing hair	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.03	1	2014	2018	   3	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1834124	Shield chest	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1835884	Triangular face	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1836047	Long face	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1836189	Radial deviation of finger	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1836542	Depressed nasal bridge	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1837249	Malformations of Cortical Development, Group II	disease	C16;C10	Congenital Abnormality	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1837404	High, narrow palate	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1837732	Thickened helices	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1837770	Sparse hair	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1840077	Anteverted nostril	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1843181	Noonan syndrome-like disorder with loose anagen hair	disease	C23;C17	Disease or Syndrome	0.30				   0	   0	CLINGEN
     5604	MAP2K1	0.439	0.846	C1845847	Coarse facial features	phenotype	C23	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1848934	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	disease	C16;C05	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1849340	Long palpebral fissure	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1854114	Short nose	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1854418	Biparietal narrowing	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1855728	Low posterior hairline	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1857486	Low-set, posteriorly rotated ears	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1857539	Deep palmar crease	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1859778	Postnatal growth retardation	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1861869	Underdeveloped supraorbital ridges	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1861975	Cafe au lait spots, multiple	disease	C23;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1864795	Superior pectus carinatum	phenotype	C16;C17;C05	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1864796	Pectus excavatum of inferior sternum	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1865014	Long philtrum	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1866231	Full cheeks	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1867873	Failure to thrive in infancy	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1956257	Pulmonary Stenosis	disease	C14	Disease or Syndrome	0.10	1	2008	2008	   1	   1	CLINVAR;HPO
     5604	MAP2K1	0.439	0.846	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2005	2005	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C1963094	Dry Skin, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C1963184	Nystagmus, CTCAE 3.0	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C2063866	Depressive Disorder, Treatment-Resistant	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	BEFREE;PSYGENET
     5604	MAP2K1	0.439	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.05	1	2010	2018	   5	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2242472	Infection of bone	disease	C23;C01;C05	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2363741	HIV-1 infection	disease		Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2674432	Reduced bone mineral density	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C2674608	Feeding difficulties in infancy	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C2699508	Splenic diffuse red pulp small B-cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.01	1	2020	2020	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2919142	Short Stature, CTCAE	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.02	1	2015	2017	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.02	1	2013	2018	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2938924	Oestrogen receptor positive breast cancer	disease		Neoplastic Process	0.02	1	2012	2019	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3149631	MELORHEOSTOSIS, ISOLATED	disease		Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3266262	Multiple Chronic Conditions	disease	C23	Disease or Syndrome	0.02	1	2011	2016	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3501846	Noonan-Like Syndrome With Loose Anagen Hair	disease	C23;C16;C17;C05;C14	Disease or Syndrome	0.30				   0	   0	CLINGEN
     5604	MAP2K1	0.439	0.846	C3539878	Triple Negative Breast Neoplasms	disease	C04;C17	Neoplastic Process	0.04	1	2012	2017	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3544205	Ovarian clear cell carcinoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3551426	Dystrophic fingernails	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C3551431	Sparse or absent eyelashes	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.11	1	2017	2017	   1	   0	BEFREE;HPO
     5604	MAP2K1	0.439	0.846	C3809006	CARDIOFACIOCUTANEOUS SYNDROME 3	disease		Disease or Syndrome	0.60	1	2006	2017	   7	   8	CLINVAR;GENOMICS_ENGLAND;UNIPROT
     5604	MAP2K1	0.439	0.846	C3898569	Low Grade Astrocytic Tumor	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3899645	Childhood Pleomorphic Xanthoastrocytoma	disease		Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3899655	Childhood Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.06	1	2014	2018	   6	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C3900100	Adult Langerhans Cell Histiocytosis	disease	C08;C15	Neoplastic Process	0.06	1	2014	2018	   6	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4021242	Hypoplasia of the zygomatic bone	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4021789	Abnormality of the vertebral column	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4021956	Aplasia/Hypoplasia of the eyebrow	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4022755	Functional abnormality of the gastrointestinal tract	phenotype		Pathologic Function	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4024692	Reduced factor XIII activity	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4024750	Abnormality of the palpebral fissures	disease		Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4024878	Generalized hyperpigmentation	phenotype	C17	Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4024890	Excessive wrinkled skin	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4025662	Abnormality of the ulna	phenotype		Anatomical Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4025846	Abnormality of vision	disease		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4073145	Hyperkeratosis pilaris	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4086152	Childhood Astrocytoma	disease	C04	Neoplastic Process	0.02	1	2002	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.07	0.857	2007	2019	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4317126	Niacin deficiency	disease	C18	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.02	1	2012	2019	   2	   1	BEFREE
     5604	MAP2K1	0.439	0.846	C4551484	Leopard Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     5604	MAP2K1	0.439	0.846	C4551485	Clinodactyly	disease		Congenital Abnormality	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4551583	Cerebral cortical atrophy	disease		Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4551602	Noonan Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.40	1	2007	2007	   1	   2	CLINVAR;CTD_human
     5604	MAP2K1	0.439	0.846	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.02	1	2011	2013	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4554036	Nystagmus, CTCAE 5.0	phenotype		Finding	0.10				   0	   0	HPO
     5604	MAP2K1	0.439	0.846	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.11	1	2016	2018	   2	   2	BEFREE;CLINVAR
     5604	MAP2K1	0.439	0.846	C4721579	Secondary malignant neoplasm of colon and/or rectum	disease	C06;C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.02	1	2003	2014	   2	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.07	1	2008	2019	   7	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     5604	MAP2K1	0.439	0.846	C4722518	Triple-Negative Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.04	1	2012	2017	   4	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4725091	metastatic intraocular melanoma	disease	C04;C11	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4727838	Advanced Melanoma	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
     5604	MAP2K1	0.439	0.846	C4733092	estrogen receptor-negative breast cancer	disease		Neoplastic Process	0.02	1	2012	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.55	1	2005	2019	   5	   0	BEFREE;CGI;CTD_human
     5170	PDPK1	0.588	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.10	0.917	2009	2018	  12	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.05	1	2013	2019	   5	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0007785	Cerebral Infarction	disease	C23;C10;C14	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0008626	Congenital chromosomal disease	group	C16	Congenital Abnormality	0.01	1	2014	2014	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.01	0	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2010	2018	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.02	1	2019	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.04	1	2011	2018	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0021400	Influenza	disease	C01;C08	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.03	1	2010	2019	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0025322	Premature Menopause	disease	C13	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.02	1	2014	2017	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.03	1	2009	2018	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.09	1	2005	2019	   9	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0029401	Osteitis Deformans	disease	C05	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0032897	Prader-Willi Syndrome	disease	C16;C18;C10	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2007	2007	   1	   0	LHGDN
     5170	PDPK1	0.588	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2011	2018	   2	   0	BEFREE;CTD_human
     5170	PDPK1	0.588	0.808	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.04	1	2011	2018	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.03	1	2012	2015	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.02	1	2014	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.02	1	2005	2018	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.04	1	2015	2019	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.02	1	2017	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0280321	Squamous cell carcinoma of the hypopharynx	disease		Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0280324	Laryngeal Squamous Cell Carcinoma	disease	C04;C08;C09	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.02	1	2014	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.01	0	2009	2009	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     5170	PDPK1	0.588	0.808	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.04	1	2011	2018	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.06	1	2005	2017	   6	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.01	0	2009	2009	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.55	1	2005	2019	   5	   0	BEFREE;CGI;CTD_human
     5170	PDPK1	0.588	0.808	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.04	1	2015	2019	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0686619	Secondary malignant neoplasm of lymph node	disease	C23;C04	Neoplastic Process	0.03	1	2014	2019	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2016	2017	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     5170	PDPK1	0.588	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.07	1	2012	2019	   7	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	0.909	2009	2018	  11	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.04	1	2015	2019	   4	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2005	2014	   2	   0	BEFREE;CTD_human
     5170	PDPK1	0.588	0.808	C1512127	HER2 gene amplification	disease		Disease or Syndrome	0.01	1	2009	2009	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.02	1	2013	2019	   2	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1854181	FIBROMATOSIS, GINGIVAL, 2	disease	C16;C07	Disease or Syndrome	0.01	1	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.03	1	2014	2020	   3	   0	BEFREE
     5170	PDPK1	0.588	0.808	C3642347	Basal-Like Breast Carcinoma	disease		Neoplastic Process	0.01	1	2007	2007	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C4321245	Cleft lip or lips	phenotype		Anatomical Abnormality	0.01	0	2019	2019	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C4721414	Mantle cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
     5170	PDPK1	0.588	0.808	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.03	1	2010	2018	   3	   0	BEFREE
    27436	EML4	0.569	0.577	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.10	1	2008	2018	  33	   0	BEFREE
    27436	EML4	0.569	0.577	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.10	1	2008	2019	  14	   0	BEFREE
    27436	EML4	0.569	0.577	C0007097	Carcinoma	group	C04	Neoplastic Process	0.04	1	2008	2018	   4	   0	BEFREE
    27436	EML4	0.569	0.577	C0007120	Bronchioloalveolar Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	0.994	2007	2020	 177	   1	BEFREE;CTD_human
    27436	EML4	0.569	0.577	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.04	1	2013	2018	   4	   0	BEFREE
    27436	EML4	0.569	0.577	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.02	1	2012	2015	   2	   0	BEFREE
    27436	EML4	0.569	0.577	C0017185	Gastrointestinal Neoplasms	group	C06;C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0023440	Acute Erythroblastic Leukemia	disease	C04;C15	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0023827	liposarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.10	1	2019	2019	   1	   1	GWASCAT
    27436	EML4	0.569	0.577	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.08	1	2008	2018	   8	   0	BEFREE;LHGDN
    27436	EML4	0.569	0.577	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0025202	melanoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.33	1	2012	2019	   5	   0	BEFREE;CTD_human
    27436	EML4	0.569	0.577	C0027651	Neoplasms	group	C04	Neoplastic Process	0.10	0.957	2008	2019	  46	   1	BEFREE
    27436	EML4	0.569	0.577	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0028259	Nodule	phenotype		Acquired Abnormality	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0032227	Pleural effusion disorder	group	C08	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0037054	Sickle Cell Trait	disease	C16;C15	Disease or Syndrome	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0080032	Pleural Effusion, Malignant	disease	C04;C08	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0151436	Vasculitis, Leukocytoclastic, Cutaneous	disease	C20;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.40	0.98	2009	2019	  49	   0	BEFREE;CTD_human
    27436	EML4	0.569	0.577	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0153676	Secondary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0153690	Secondary malignant neoplasm of bone	disease	C23;C04;C05	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0178874	Tumor Progression	phenotype	C23	Neoplastic Process	0.02	1	2015	2016	   2	   0	BEFREE
    27436	EML4	0.569	0.577	C0206180	Ki-1+ Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.02	1	2011	2018	   2	   0	BEFREE
    27436	EML4	0.569	0.577	C0206623	Adenosquamous carcinoma	disease	C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0206687	Carcinoma, Endometrioid	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0206696	Carcinoma, Signet Ring Cell	disease	C04	Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0220611	Childhood Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0220650	Metastatic malignant neoplasm to brain	disease	C23;C04;C10	Neoplastic Process	0.06	1	2013	2016	   6	   0	BEFREE
    27436	EML4	0.569	0.577	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	1	2008	2019	  65	   0	BEFREE
    27436	EML4	0.569	0.577	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0278608	Adult Liposarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0278983	Non-small cell lung cancer stage IIIA	disease		Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0278987	Metastatic non-small cell lung cancer	disease	C04	Neoplastic Process	0.02	1	2012	2016	   2	   0	BEFREE
    27436	EML4	0.569	0.577	C0279550	Adult Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0279682	Bladder Adenocarcinoma	disease	C04	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0279984	Childhood Liposarcoma	disease	C04	Neoplastic Process	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0280100	Solid Neoplasm	phenotype	C04	Neoplastic Process	0.03	1	2008	2018	   3	   0	BEFREE
    27436	EML4	0.569	0.577	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.03	1	2014	2018	   3	   0	BEFREE
    27436	EML4	0.569	0.577	C0334276	Adenocarcinoma in Situ	phenotype	C23;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0334371	Secretory breast carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0334459	Infantile fibrosarcoma	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.01	1	2008	2008	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0424295	Hyperactive behavior	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0497156	Lymphadenopathy	phenotype	C15	Disease or Syndrome	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.06	0.833	2008	2018	   6	   0	BEFREE
    27436	EML4	0.569	0.577	C0600139	Prostate carcinoma	disease	C04;C12	Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.10	1	2008	2019	  45	   0	BEFREE
    27436	EML4	0.569	0.577	C0700095	Central neuroblastoma	disease	C04;C10	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C0700639	Pyloric Stenosis, Hypertrophic	disease	C06	Congenital Abnormality	0.11	1	2019	2019	   1	   1	BEFREE;GWASCAT
    27436	EML4	0.569	0.577	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    27436	EML4	0.569	0.577	C0855073	Undifferentiated (Embryonal) Sarcoma	disease		Neoplastic Process	0.01	1	2014	2014	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.01	1	2019	2019	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1145670	Respiratory Failure	disease	C08	Disease or Syndrome	0.01	1	2008	2008	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1261473	Sarcoma	group	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1269955	Tumor Cell Invasion	phenotype		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1306459	Primary malignant neoplasm	group	C04	Neoplastic Process	0.10	1	2008	2019	  11	   0	BEFREE
    27436	EML4	0.569	0.577	C1306460	Primary malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.10	1	2008	2019	  45	   0	BEFREE
    27436	EML4	0.569	0.577	C1321546	Anaplastic large B-cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.03	1	2011	2013	   3	   0	BEFREE
    27436	EML4	0.569	0.577	C1332079	Anaplastic Large Cell Lymphoma, ALK-Positive	disease	C04;C20;C15	Neoplastic Process	0.01	1	2010	2010	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.01	1	2009	2009	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1332965	Congenital Mesoblastic Nephroma	disease	C04;C13;C12	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1335433	Pleural Carcinomatosis	disease	C04	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1402294	Primary Lesion	phenotype		Disease or Syndrome	0.01	0	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.31	1	2012	2014	   2	   0	BEFREE;CTD_human
    27436	EML4	0.569	0.577	C1608408	Malignant transformation	phenotype		Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1704231	Metastatic Malignant Neoplasm to the Leptomeninges	disease	C10	Neoplastic Process	0.01	1	2020	2020	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1708781	Sarcomatoid carcinoma of the lung	disease	C04;C08	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	disease	C15	Disease or Syndrome	0.01	1	2016	2016	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C1960398	HER2-positive carcinoma of breast	disease	C04;C17	Neoplastic Process	0.01	1	2015	2015	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C2939419	Secondary Neoplasm	group	C23;C04	Neoplastic Process	0.02	1	2013	2017	   2	   0	BEFREE
    27436	EML4	0.569	0.577	C2973529	Leukocytoclastic vasculitis	disease	C20;C14	Disease or Syndrome	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C3281200	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	disease	C16;C04;C18;C10	Disease or Syndrome	0.01	1	2013	2013	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C3665732	Metastatic Dermatofibrosarcoma Protuberans	disease	C04	Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C3842353	Mucinous (colloid) adenocarcinoma	disease		Neoplastic Process	0.01	1	2011	2011	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C3898222	mucosal melanoma	disease		Neoplastic Process	0.01	1	2018	2018	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C4086165	Childhood Neuroblastoma	disease	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C4551686	Malignant neoplasm of soft tissue	group	C04	Neoplastic Process	0.01	1	2017	2017	   1	   0	BEFREE
    27436	EML4	0.569	0.577	C4722085	Malignant neoplasm of colon and/or rectum	disease		Neoplastic Process	0.01	1	2012	2012	   1	   0	BEFREE
